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ABSTRACT 
 
Development of complex analytical scheme for determination of priority persistent 
organic pollutants in fish using high resolution mass specrometry. Začs D., supervisors Dr. 
chem., prof. Vīksna A. and Dr. chem., asoc. prof. Bartkevičs V. Doctoral thesis in analytical 
chemistry, 129 pages, 23 figures, 5 tables, 190 literature references, 11 appendices. In English. 
A new analytical scheme for efficient and reliable simultaneous analysis of seven groups of 
persistent organic pollutants (POPs) in fish from a single sample extraction procedure has been 
elaborated. Separation of components by gas chromatography (GC) or ultra high performance liquid 
chromatography (UHPLC) and detection by high resolution mass spectrometry (HRMS) was used 
to ensure selective determination of the analytes of interest at toxicologically significant levels. 
Intensive multi-stage column chromatography clean-up and fractionation procedure ensured the 
elimination of mass spectral interferants from the fraction containing poorly investigated 
toxicologically significant polyhalogenated (brominated and mixed bromo/chloro-substituted) 
dibenzo-p-dioxins and dibenzofurans (PBDD/Fs and PXDD/Fs). For the first time, the analytical 
capabilities of Orbitrap mass spectrometry were applied to the analysis of POPs. The application of 
13C12-labeled surrogates of the analyzed compounds allowed internal standardization and accurate 
measurement of selected contaminants. The developed procedure was robustly validated and used 
to measure the occurrence of selected POPs in Baltic wild salmon samples and eel samples 
collected from Latvian lakes. The universal presence of poorly studied PBDD/Fs and PXDD/Fs, as 
well as polyhalogenated mixed bromo/chloro-biphenyls (PXBs) was confirmed in the investigated 
samples. However, these compounds were found to be minor contaminants, compared to their 
chlorinated analogs.  
 
PERSISTENT ORGANIC POLLUTANTS, FISH, HIGH RESOLUTION MASS 
SPECTROMETRY, BROMINATED FLAME RETARDANTS, POLYHALOGENATED 
AROMATIC COMPOUNDS, ORBITRAP 
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ANOTĀCIJA 
 
Prioritāro noturīgo organisko piesārņotāju kompleksās analīzes shēmas izstrādāšana 
zivīs ar izšķirtspējas masspektrometrijas metodi. Začs D., zinātniskie vadītāji Dr. ķīm., asoc. 
prof. Bartkevičs V. un Dr. ķīm., asoc. prof. Vīksna A. Promocijas darbs, 129 lappuses, 23 attēli, 
5 tabulas, 190 literatūras avoti, 11 pielikumi. Angļu valodā. 
Tika izstādāta jauna analītiskā shēma efektīvai un drošai septiņu grupu noturīgo organisko 
piesārņotāju (NOP) vienlaicīgai analīzei zivīs no vienas ekstrakcijas procedūras. Komponentu 
atdalīšana ar gāzu hromatogrāfiju (GH) vai ultra augsti efektīvo šķidruma hromatogrāfiju 
(UAEŠH) un detektēšana ar augstas izšķirtspējas masspektrometriju (AIMS) nodrošina 
interesējošo analītu selektīvu noteikšanu toksikoloģiski nozīmīgākajos līmeņos. Intensīva multi-
soļu kolonnas hromatogrāfijas attīrīšanas un frakcionēšanas procedūra nodrošina traucējošo vielu 
izslēgšanu no frakcijas, kas satur maz pētīto toksikoloģiski nozīmīgos polihalogenētos bromētos 
un jauktos bromo/hloro-aizvietoto dibenzo-p-dioksīnus un dibenzofurānus (PBDD/F un PXDD/F). 
Pirmo reizi tika izvērtētas Orbitrap masspektrometrijas analītiskās iespējas NOP analīzēs. 13C12-
iezīmēto analīzējamo savienojumu surogātu izmantošana ļauj lietot iekšējo standartizēšanu un 
izmeklējamo kontaminantu precīzu noteikšanu. Izstrādātā procedūra tika validēta un pielietota 
izmeklēto NOP sastopamības noteikšanai Baltijas jūras savvaļas laša paraugos un zušu paraugos, 
kas tiek ņemti no Latvijas ezeriem. Universāla PBDD/F un PXDD/F, kā arī polihalogenēto jaukto 
bromo/hloro-bifenīlu (PXB) klātbūtne tiek apstiprināta izmeklētajos paraugos, taču tika konstatēts, 
ka šo savienojumi koncentrācija salīdzinot ar hlorētiem analogiem ir neliela. 
 
NOTURĪGIE ORGANISKIE PIESĀRŅOTĀJI, ZIVIS, AUGSTAS IZŠKIRTSPĒJAS 
MASSPEKTROMETRIJA, BROMĒTIE LIESMAS SLĀPĒTĀJI, POLIHALOGENĒTI 
AROMĀTISKIE SAVIENOJUMI, ORBITRAP  
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INTRODUCTION 
 
The 20th century was associated with rapid technological progress, which led to increased 
welfare in many parts of the world. A large number of halogenated aromatic chemical substances 
were developed and put to use in numerous applications, such as PCBs for insulating fluids in 
electrical equipment, halogenated pesticides to protect crops from insects and fungi, and 
polybrominated diphenyl ethers (PBDEs) as flame retardants incorporated into polymers to reduce 
the risk of fires. The majority of these chemicals were designed to be stable with regard to long 
lasting use in their applications. However, the chemical stability is also a significant drawback of 
these compounds, causing them to be persistent in the environment. The stability of these 
substances resulted in increasing environmental presence, and they were soon shown to cause 
adverse effects in wildlife, in particular at high trophic levels. Due to the unfavorable properties, 
production of these POPs was gradually phased out and the unintentional release was decreased by 
optimization of the industrial processes and stricter legislative control. Although production of most 
POPs has been phased out for over 20 years, we are still facing considerable POP levels in the 
environment [1-3]. 
The practical relevance of the problem. According to the sources of POPs in the 
environment, they can be sub-divided as (i) chlorinated pesticides, (ii) industrial chemicals (PCBs, 
brominated flame retardants (BFRs) (e.g., PBDEs), and (iii) unintentionally produced compounds 
(such as PCDD/Fs) [4]. The majority of these compounds are toxic and due to the persistency and 
lipophilicity tend to bioaccumulate in food chains. Many of them are known xenobiotics of high 
toxicological significance with an aryl hydrocarbon (Ah) receptor mediated mechanism of toxicity. 
The most toxic representative is 2,3,7,8-tetrachlorodibenzo-p-dioxin (2,3,7,8-TCDD or TCDD). The 
toxicities of other individual halogenated POPs are expressed relative to 2,3,7,8-TCDD. This toxic 
equivalency factor (TEF) concept is used to determine the toxic equivalent concentration (TEQ) in a 
sample, providing the information on overall toxicological hazard caused by "dioxin-like" (DL) 
contaminants present in the sample. In this context, DL-contaminants refer to substances that have 
similarities to 2,3,7,8-TCDD in terms of structure, physicochemical properties, and in the toxic 
responses they elicit. It has been suggested that for including a compound in the TEF concept, it 
should: (i) share certain structural relationships to the PCDD/Fs; (ii) bind to the Ah receptor; (iii) 
elicit Ah receptor-mediated biochemical and toxic responses; (iv) be persistent and accumulate in 
the food chain [5,6]. 
Only 17 out of the 210 PCDD/Fs and 12 out of the 209 PCBs have been assigned TEFs and 
meet the stated criteria. Nevertheless, a wide range of other potential DL-contaminants and other 
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toxicants could be present in the samples at high levels and alter their contamination status. Many 
laboratories have developed effective analytical protocols for the isomer-specific analysis of 
toxicologically significant 2,3,7,8-chlorine substituted PCDD/Fs and DL-PCBs in environmental 
samples, and many other DL-compounds may be included in the scope of analysis in the future. The 
lack of analytical and toxicological data precludes the assignment of TEFs to many DL-compound 
candidates. The toxicological data [7-10] on PBDD/Fs, PXDD/F, and PXBs reveal a similar mode 
of Ah receptor mediated toxicity seen in PCDD/Fs, with similar or, in some cases, higher relative 
potencies [11]. Therefore, the elaboration of reliable complex methodologies that are capable of 
simultaneously covering different classes of priority POPs, including organobromines, such as 
BFRs, PBDD/Fs, PXDD/Fs, PXBs, and their chlorinated analogs, is of great significance in terms 
of providing a complete information on the contamination status of analyzed samples. 
The aim of the work. Elaboration of an efficient and reliable analytical scheme for the 
simultaneous analysis of seven target groups of POPs (PCDD/Fs, PBDD/Fs, PXDD/Fs, PCBs, 
PXBs, and BFRs (including PBDEs and hexabromocyclododecanes (HBCD)) in fish by a single 
sample extraction procedure using high resolution mass spectrometric (HRMS) detection.  
The approach used. To achieve the aim of the work, several tasks were proposed: 
i) Development of an efficient sample extraction and clean-up procedure, and selection of 
optimal instrumental conditions for the analysis of compounds of interest; 
ii) Validation of the elaborated method for fish matrix; 
iii) Application of the developed method for analysis of selected POP groups in fish from the 
Baltic region; 
iv) Characterization of contamination of fish from the Baltic region with selected POPs, 
including the evaluation of the contribution of the less studied PBDD/Fs, PXDD/Fs, and PXBs to 
the overall contamination status. 
Scientific novelty.   
i) Improvement of analytical methodologies for the determination of brominated and mixed 
brominated/chlorinated POPs using HRMS; 
ii) Implementation of a new type of HRMS (Orbitrap-HRMS) in the analysis of POPs; 
iii) Comparative evaluation of Orbitrap-HRMS versus conventional MS detection approaches 
in the analysis of BFRs; 
iv) Characterization of the contamination status of fish from the Baltic region with largely 
unexplored brominated and mixed brominated/chlorinated contaminants. 
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Practical application of the work. The elaborated analytical scheme could be applied to 
performing continuous European monitoring programs for the selected POPs in fish and fish 
products. 
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1.  LITERATURE REVIEW 
 
1.1.  Compound classes included in the scope of the study 
1.1.1. Polychlorinated dibenzo-p-dioxins and dibenzofurans (PCDD/Fs) 
The impact of PCDD/Fs on the environment has been a source of great concern since the 
beginning of the 1970s. PCDD/Fs commonly referred to collectively as "dioxins", are two classes of 
"quasi-planar" tricyclic aromatic ethers representing 210 different compounds (congeners) in total, 
including 75 PCDDs and 135 PCDFs. The general structures of these classes of compounds are 
given in Figure 1.1. 
 
Fig. 1.1. The general molecular structure of PCDD/Fs 
 
PCDD/Fs have never been commercially produced, however they are present as trace 
contaminants in various industrial chemicals and technical products (chlorophenols, PCB 
formulations, "Agent Orange", etc.), or are formed unintentionally in various combustion processes 
such as waste incineration, in the production of metals, in the bleaching of pulp with chlorine gas 
[2,12,13]. The improvements and optimization of the treatment of industrial emissions resulted in 
reduced release of PCDD/Fs into the environment, and the relative significance of sources such as 
open burning of waste or secondary sources such as the release of pollutants from "hot spots" has 
increased [2,13,14]. A number of accidents, such as the explosion in Seveso, Italy and the Yusho 
accident in Japan when PCDD/Fs were released into the environment during the late 1960s and 
1970s increased public awareness and concern about these pollutants. 
PCDD/Fs have similar chemical and physical properties, and their toxicity is highly dependent 
on the chlorination degree and the position of the chlorine substituents. Congeners which are fully 
chlorinated at the positions 2, 3, 7, and 8 (Figure 1.1) are the most toxic ones, including 7 PCDDs 
and 10 PCDFs. The most toxicologically significant congener 2,3,7,8-TCDD is one of the most 
toxic chemicals ever described [15]. The extreme toxicity of 2,3,7,8-TCDD was first showed in 
acute toxicological experiments with guinea pigs where low lethal doses (LD50) of 0.6 – 2.5 μg kg-1 
OClx
Cly
PCDFs
O
O
Clx Cly
PCDDs
1
2
3
456
7
8
9 10
1
2
3
4
5
6
7
8
9
 14 
bodyweight (orally ingested) were determined for this congener [16]. The toxic action of the 
2,3,7,8-substituted congeners is mediated through binding to the Ah-receptor, which is present in 
most vertebrate tissues [6] and results in multisite carcinogenicity and other adverse effects. The 
difference of affinity of individual PCDD/F congeners to the Ah-receptor resulted in their different 
toxicities. In order to facilitate risk assessments and regulatory control, the concept of TEFs was 
proposed [5,6]. According to this approach, the toxicity of different congeners relates to the toxicity 
of the most toxicologically significant 2,3,7,8-TCDD which has a TEF 1, while other 
representatives have values ≤1. A number of TEF-systems have been developed (e.g., the Nordic-
TEF and the I-TEF), however the World Health Organization TEF (WHO-TEF) is the 
internationally used system today and the latest re-evaluation of the TEFs in 2005 provides TEF 
values ranged from 1 for 2,3,7,8-TCDD and 1,2,3,7,8-PeCDD to 0.0003 for OCDD and OCDF [6]. 
In order to express the toxicity of the sample due to the presence of PCDD/Fs, the concentration of 
each individual congener is multiplied by its respective TEF value, and all products are added, to 
give a single 2,3,7,8-TCDD equivalent (toxic equivalent or TEQ). This approach can be described 
mathematically by the equation 1.1. 
 
𝑇𝐸𝑄 = ∑ 𝐶𝑛 × 𝑇𝐸𝐹𝑛𝑘𝑛=1                                      (1.1)         
where: TEQ – toxic equivalent; 
 Cn – concentration of the individual congener in the sample; 
 TEFn – established TEF for the individual congener. 
 
1.1.2.  Polychlorinated biphenyls (PCBs)  
PCBs are a class of organic compounds characterized by two benzene rings linked by a C-C 
bond, which were first discovered in the late 1800s and first commercially synthesized in 1929 [17]. 
PCBs comprise a group of 209 structurally distinct congeners with 10 PCB homologue groups 
(mono- to deca-CBs) with different numbers of isomers. The general molecular structure and 
nomenclature of the PCBs is shown in Figure 1.2. Today, a numbering system (PCB 1 to PCB 209) 
developed in 1980 [18] is used for the identification of individual PCB congeners.  
Crude PCB formulations have been widely used in transformers, capacitors, heat transfer 
fluids, e.g., in the production of asphalt, sealants in the construction of buildings, as additive to 
paint and in carbonless copy paper. Properties like thermal stability, high resistance to oxidation and 
reduction, electrical conductance, low flammability, resistance to acids and alkali were 
advantageous in all of these applications. The total accumulated volume of crude PCBs produced in 
the world has been estimated to be more than 1.3 million tons [3], with the peak annual production 
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around 1970. PCBs are lipophilic and several of those are stable enough to be strongly 
bioaccumulative in wildlife and humans, and they are ubiquitously distributed almost in every 
matrix including air, water, soil, and sediments [19].  
 
 
Fig. 1.2. The general molecular structure of PCBs 
 
The degree of lipophilicity (octanol/water partition coefficient (log Kow) increases and 
solubility in water decreases with higher degree of chlorination (PCB 1, log Kow = 4.46; PCB 209, 
log Kow = 8.18) [20]. PCBs can be divided into sub-groups depending on the number of chlorine 
atoms at the ortho- positions (2, 2´, 6, 6´ positions) of the biphenyl ring system. These sub-groups 
(non-, mono-, di-, tri-, and tetra- ortho PCBs) include 20, 48, 72, 48 and 21 congeners, respectively. 
One of the most important conformational characteristic of PCB molecules is their ability to rotate 
around the phenyl-phenyl (1, 1’) bond, attaining a planar configuration (co-planar PCBs), similar to 
the PCDD/Fs. Some of these non- and mono-ortho substituted PCBs bind to the Ah-receptor and 
are therefore referred to as the dioxin-like PCBs (DL-PCBs), all having chlorine atoms in the meta- 
and para- positions. Likewise, 17 PCDD/Fs and twelve DL-PCBs were included into the TEF 
concept with assigned TEF values [5,6]. Four of them are congeners that lack chlorine atoms at the 
ortho-position, the non-ortho PCBs (77, 81, 126, 169), and eight have one chlorine substituent at 
the ortho-position, the mono-ortho PCBs (105, 114, 118, 123, 156, 157, 167, 189). The non- and 
mono-ortho PCBs overall have lower TEFs than the PCDD/Fs (0.1 – 0.00003) [6], but since the 
concentration of PCBs in environmental samples often far exceeds the concentration of PCDD/Fs, 
their contribution to the total TEQ can be significant [21].  
 
1.1.3. Polybrominated diphenyl ethers (PBDEs) 
PBDEs, also known as polybrominated diphenyl oxides, are flame retardants used as additives 
in a variety of plastics, textiles, surface coatings, foams, and man-made fibers. Like PCBs, the 
theoretical number of possible congeners is 209, and the same numbering system as proposed for 
PCBs is used [18]. The general molecular structure and nomenclature of the PBDEs is shown in 
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Figure 1.3. 
 
Fig. 1.3. The general molecular structure of PBDEs 
 
There are three major technical products of PBDEs: pentabromodiphenyl ether (Penta-mix), 
octabromodiphenyl ether (Octa-mix), and decabromodiphenyl ether (Deca-mix), which are mixtures 
of congeners with differing degree of bromination, similar to the commercial crude products of 
PCBs. Because of the chemical properties of the oxygen directing the bromine to para- and ortho- 
positions, and the steric hindrance of the substituted bromines, only a limited number of congeners 
are present in commercial mixtures [22]. The major congeners in the Penta-mix are tetra- and penta-
substituted BDEs, Octa-mix is composed mainly of hepta- and octa-BDEs, and in the Deca-mix 
formulation the main component is decabromodiphenyl ether or PBDE 209. Towards the end of the 
20th century, great concerns over PBDEs grew due to observations of bioaccumulation and toxic 
properties, and of rapidly rising concentrations in environmental and human tissue samples world-
wide [23,24]. PBDEs were one of the most utilized group of BFRs until the mid-2000s when strict 
bans were imposed on the production of PBDE formulations due to their persistency and 
bioaccumulation properties [25]. Nevertheless, significant quantities of PBDEs have been released 
into the environment, and as a result, these compounds have became ubiquitous and are found in 
various matrices (e.g., water, sediments, biota, and humans) [26]. Recent data show that PBDE 
levels tend to decrease in biota in Europe [27], while the concentrations of tetra- to hepta-BDEs in 
the Arctic region are increasing or possibly stagnating during the last 2 – 5 years, and BDE 209 
concentrations are still increasing in the Arctic air [28]. A growing number of published reports 
show that PBDEs can elicit toxicity and biological effects via several different mechanisms [29]. 
The developmental neurotoxicity of these substances currently is little understood [30]. It is 
believed that PBDEs present a risk to the developing brain [31]. The other possible source of 
concern attributed to the use of PBDEs is that these technical mixtures may contain highly toxic 
impurities, such as polybrominated dibenzo-p-dioxins and furans (PBDD/Fs), which have similar 
toxicities and long-range transport properties as their chlorinated analogues [7]. It was found that 
combustion processes in the presence of PBDEs can also lead to the production of PBDD/Fs [32]. 
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1.1.4. Hexabromocyclododecane (HBCD) 
Hexabromocyclododecane (HBCD, Figure 1.4.) is an aliphatic brominated flame retardant. 
HBCD is seen by manufacturers as a possible replacement to PBDEs. HBCD is an off-white, 
crystalline, free-flowing solid. It is soluble in organic solvents and has a melting range of 185 – 
195°C. HBCD is thermally quite labile, breaking down through dehydrobromination reactions 
between 240 and 270°C, forming a myriad of products, typically via a tribromocyclododecatriene 
intermediate [26]. HBCD was introduced to the market in the 1960s. HBCD is an additive flame 
retardant that is incorporated in synthetic materials and is one of the most widely used compounds 
among the BFRs with annual usage in Europe of 6000 tons [33]. The commercially available crude 
HBCD is a mixture of 1,2,5,6,9,10-hexabromocyclododecane isomers, consisting mainly of α-, β-, 
and γ-HBCD diastereomers [26]. The physical and chemical properties of HBCDs are similar to 
those of POPs, and HBCD was classified in 2008 by the European Commission (EC) as persistent, 
bioaccumulative, and toxic compound [34]. Discarding of HBCD-containing materials results in the 
release of this chemical to the environment, and HBCD has thus become a ubiquitous contaminant 
found in water, soil, sediments, fish, birds, mammals, and people [26,35].  
 
 
α-HBCD β-HBCD γ-HBCD 
Fig. 1.4. The structure of HBCD diastereomers  
HBCD is chemically closely related to the pesticide hexachlorocyclohexane and, as such, it is 
persistent and bioaccumulative [31]. The environmental transport and fate of HBCD is uncertain. It 
has been hypothesized that HBCD is unlikely to leach from most polymeric matrices and will only 
contaminate discrete areas surrounding point sources. Recent evidence has suggested that 
combustion of HBCD in the presence of aluminum can trigger polycondensation reactions during 
HBCD decomposition, leading to the formation of high molecular weight, highly toxic 
polyaromatic compounds such as PAHs and brominated polycyclic compounds [36]. It is worth 
noting that many modern automotive parts are manufactured of aluminum, with interiors being 
heavily flame retarded with BFRs, such as HBCD. It has been stated that HBCD may be a potential 
mutagen and liver toxicant [31]. HBCD caused statistically significant increases in intragenic 
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recombination of mammalian cells indicating that it may induce cancer via a nonmutagenic 
mechanism, similarly to other environmental contaminants, such as DDT and PCBs [37].  
 
1.1.5. Polybrominated dibenzo-p-dioxins and dibenzofurans (PBDD/Fs). 
The general structures of PBDD/Fs are shown in Figure 1.5. Similarly to PCDD/Fs, they are 
co-planar compounds with two aromatic rings coupled through one or two oxygen bridges. There 
are eight possible positions for bromine substitution, which gives 75 different PBDD congeners and 
135 different PBDF congeners, taking all bromination degrees into account. 
 
 
Fig. 1.5. The general molecular structure of PBDD/Fs 
 
The main sources of PBDD/Fs are combustion processes and the substantial use of BFRs, 
where these contaminants have been found to be present as by-products [38] or formed through 
photolytic [39,40] and thermal degradation of BFRs [41-43]. Chemical precursors, such as 
brominated phenols [44] or PBDEs form PBDD/Fs during reactions at 250 – 500°C temperatures on 
catalytically active surfaces, or also spontaneously at the relevant temperatures (Figure 1.6.). 
PBDD/Fs levels were found to correlate positively with PBDE levels in the atmosphere, revealing 
the pollution sources associated with using of these crude formulations [45]. Moreover, the 
detection of elevated PBDD/Fs concentrations, in relation to PCDD/Fs levels in industrialized areas 
near the factories of electric machinery and equipment [46,47], supports the connection between the 
use of BFRs and the PBDD/F emissions to the environment. 
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Fig. 1.6. Possible mechanisms for the formation of PBDD/Fs from PBDEs [26] 
 
The concentrations of PBDD/Fs in environmental and human tissue samples have begun to 
reach detectable levels and have been determined in various matrices, including ambient air 
[45,46,48] at electronic waste dismantling areas and in plastics [49], fuel gases [50,51], fly ash 
[52,53], sediments [54,55], food samples [56], shellfish [57,58] and fish [59,60], adipose tissue 
[61], and human breast milk [48]. 
The number of studies on the formation of PBDD/Fs during incineration of bromine 
containing waste shows that the formation is significant, although not as high as PCDD/F formation 
[51,62]. The majority of these studies were small scale experiments or on-line measurements during 
the incineration process, and few authors have investigated the PBDD/F levels that were emitted 
from the incineration facilities. The lower brominated dioxins were found to be produced by algae 
and cyanobacteria due to eutrophication, and assimilated in blue mussels in the Baltic Sea [63]. 
Nevertheless, these were mono- to tri- substituted PBDDs and would not contribute significantly to 
the toxic burden of PBDD/Fs. 
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PBDD/Fs exhibit somewhat different properties than the PCDD/Fs, due to the larger size of the 
bromine atom, as well as the weaker C-Br bond, compared to the C-Cl bond. PBDD/Fs have higher 
molecular weights, higher melting points, lower water solubilities and vapour pressures than 
PCDD/Fs. PBDD/Fs are believed to bioaccumulate similarly to their chlorinated homologues, but 
appear to be less persistent in the environment due to the higher sensitivity towards UV 
degradation. This is suggested to result from the fact that bromide is a better leaving group than 
chloride. Nonetheless, the toxic properties of these brominated contaminants are not completely 
known, some studies have shown that toxicity of 2,3,7,8-TBDD is even higher in comparison to 
2,3,7,8-TCDD, and PBDD/Fs seem to be more resistant against mammalian metabolism, compared 
to chlorinated analogs [8]. Moreover, PBDD/Fs show the same DL toxicity as their chlorinated 
analogues in both human and mammalian cell lines [9,64]. 
Despite the structural similarity to PCDD/Fs, the analysis of PBDD/Fs is more difficult due to 
the differences in physico-chemical properties. The unavailability of isotopically labeled standards 
and analytical interference from degradation products of PBDEs (i.e., brominated furans) also 
obstruct the analytical determination. 
 
1.1.6. Mixed bromo/chloro polyhalogenated dibenzo-p-dioxins and dibenzofurans 
(PXDD/Fs) and mixed bromo/chloro polyhalogenated biphenyls (PXBs). 
Relatively little is known about the environmental and toxicological significance of PXDD/Fs 
and PXBs. While chlorinated analogues have been studied for several decades, mixed bromo/chloro 
analogues are less known. However, they have also been identified as potentially toxic, 
environmental pollutants. Little research has been carried out on the toxicity of PXDD/Fs and 
PXBs, and limited studies have suggested an equivalent or even higher toxicity and biological 
activity of these compounds compared to chlorinated analogues [9,11]. By analogy to PCDD/Fs and 
PBDD/Fs, combustion and incineration in the presence of halogens are also the typical processes 
for the formation of PXDD/Fs [65]. A wide range of electrical equipment contains both chlorinated 
substances like polyvinyl chloride or polyvinylidene chloride and brominated flame retardants, 
which serve as precursors for PXDD/F formation. Because these organic pollutants are highly 
lipophilic and persistent, they tend to migrate and accumulate in the food chain. 
In contrast to PBDD/Fs and PCDD/Fs, and PCBs for which 210 and 209 congeners are 
theoretically possible, PXDD/Fs and PXBs (the respective structures are shown on Figure 1.7.) are 
far larger groups with 4600 and 9179 possible congeners, including about one thousand of 
potentially significant 2,3,7,8-substituted PXDD/F congeners. 
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Fig. 1.7. The general molecular structure of PXDD/Fs and PXBs 
 
The limited toxicological data on these compounds reveals a similar mode of Ah receptor 
mediated toxicity seen in PCDD/Fs, with similar or in some cases higher relative potencies [9]. This 
is confirmed by more recent studies [10,66], and in particular [11], that characterizes a number of 
PXDD/Fs and PXBs, and the proposal to introduce the TEF concept (as used for PCDD/Fs) to 
define the toxicity of PBDD/Fs [67]. 
The literature on these contaminants is scarce. A limited amount of the available data confirms 
the occurrence of these compounds in incineration process emissions [68-72], biota and food 
products [60,66,73,74]. The majority of this data deals with unspeciated homologue groups, relating 
to the different substitution pattern of chlorine and bromine on the parent dibenzo-p-dioxin, 
dibenzofuran or biphenyl molecule, and reflects the analytical difficulties in congener-specific 
determination due to the chromatographic and spectrometric interferences caused by the presence of 
other POPs, which in some cases could be isobaric compounds and are present in the samples at 
much higher levels (e.g., PCBs and PBDEs).  
 
1.2. The analytical approaches for determination of POPs 
The analytical methodologies for POP analyses are especially complex due to the diversity of 
the mixtures of possible congeners of interest (especially if mixed bromo/chloro-substituted POPs 
are included in the scope of the analysis) and the low detection limits required (from ppb to sub-
ppq). In addition, time consuming sample preparation and clean-up steps are needed because of the 
presence of matrix components and a large number of interfering compounds. Overcoming these 
analytical problems has only been possible with the application of rigorous clean-up protocols and 
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the use of highly selective and sensitive approaches, such as capillary GC, HPLC or UHPLC 
coupled to low resolution MS (LRMS) or HRMS. A principal analytical protocol to determine 
POPs is shown in Figure 1.8. The clean-up steps allow a suitable removal of the bulk matrix and 
some interfering compounds; GC or LC methods provide an appropriate separation between the 
different congeners or groups; and, finally, MS affords a sensitive and selective detection. In order 
to provide reliable and accurate quantification, a stable isotope dilution technique based on the use 
of internal standardization with 13C- or 2H-isotopically labeled surrogates is commonly used. 
 
Fig. 1.8. The principal analytical scheme used for the quantification of POPs 
 
1.2.1. Extraction 
For trace analysis of DL-contaminants, Soxhlet extraction is accepted as one of the most 
efficient approaches. However, the main drawback of this technique is the time required and the 
considerable consumption of solvents used for extraction procedure, which necessitates the 
evaporation of a large amount of usually hazardous liquids (such as dichloromethane) before the 
subsequent clean-up. Recent developments in extraction techniques with reduced solvent volumes, 
shorter times, and high levels of automation provide further advancements in the analysis of POPs. 
Microwave-assisted extraction (MAE) [75,76] and pressurized or accelerated liquid extraction (PLE 
or ASE) [77,78] have been applied by several laboratories in the extraction of priority POPs, such 
as of PCDD/Fs and PCBs. These advances resulted in a considerable shortening of extraction time 
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(to 1 hour) and low solvent consumption (approx. 30 mL) by the aforementioned techniques, in 
comparison with a conventional Soxhlet extraction. Although several parameters influence the 
extraction efficiency (e.g., extraction solvents, extraction time, pressure and temperature), these 
parameters should be optimized for complete extraction of the pollutants from matrix [79,80].  
 
1.2.2. Clean-up procedures 
The extract clean-up procedures should remove the potentially large quantities (up to a gram 
or even more) of organic material selectively, while retaining as much of the desired analytes as 
possible. This is a quite challenging task, especially for the DL-compounds, where the 
concentration factors of 106 or 108 are typically needed to meet the very low detection limits 
required for these compounds (in most cases sub-ppt (picogram per gram) for soils/sediments/biota 
and sub-ppq (picogram per liter) for aqueous samples). The basic principles and procedures behind 
sample clean-up in POP analyses have not changed in many years and are usually based on solid-
liquid destructive or non-destructive adsorption chromatography in open columns utilizing the 
combination of different sorbents, such as silica, Florisil, alumina, and various types of activated 
carbon [81,82]. Size exclusion chromatography (mostly gel permeation chromatography (GPC)) is 
also a frequently used method for the removal of the bulk of high molecular weight compounds 
(e.g., lipids) from the sample extracts. The most commonly applied sorbents are polystyrene – 
divinylbenzene based copolymeric materials (e.g., Bio-beads SX-3) [83-85]. The presence of 
isobaric compounds that could interfere with instrumental analysis is another problem in the 
analyses of DL-compounds, requiring intensive extract fractionation in order to achieve selective 
separation of the POP groups in several fractions [74,86,87]. Despite the fact that the typically used 
manual clean-up approaches are time- and labor-consuming, these are the most common routine 
procedures for the determination of POPs. Due to the advent of automated sample-handling 
techniques, automated clean-up systems are more preferable and recently have been developed and 
applied for routine purposes [88]. In most of the cases, sample extracts must be concentrated prior 
to clean-up, therefore a variety of sample concentration procedures, including nitrogen or gas blow 
down, rotary evaporation, Kuderna-Danish concentration, or automated evaporative concentration 
systems have been proposed [81,82]. 
 
1.2.3. Instrumental analysis 
The PCDD/F, PCB, and PBDE analysis involves the detection of multiple congeners at the 
levels from ppb to sub-ppq, for which isotope dilution techniques using GC-HRMS are the current 
methods of choice (US EPA Method 1613, US EPA Method 1668, US EPA Method 1614) [89-91]. 
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Conventionally, HRMS was used in the electron ionization (EI) mode, with the electron energy 
usually between 36 – 38 eV at a mass resolving power of 10 000. However, the analysis of mixed 
bromo/chloro-substituted compounds requires higher MS resolution due to the potential presence of 
isobaric compounds in the sample extracts [74,87]. Typically, MS systems are operated in selective 
ion recording mode (SIR) to achieve the best possible selectivity and sensitivity, while additionally 
applying the isotope dilution approach for reliable and accurate quantification. 
Regarding the chlorinated POPs, alternative techniques are electron capture detector (ECD) 
(for mono-ortho PCBs, but with possible selectivity problems due to the co-elution risks) [92], 
electron capture negative ionization (ECNI) coupled with LRMS (for non-ortho CBs) [93, 94], ion-
trap tandem mass spectrometry (IT-MS/MS) and two dimensional GC (GC×GC) coupled with time-
of-flight MS (TOF-MS) [95]. The optimization of collision characteristics in IT-MS/MS provided 
an improvement of the instrumental limit of detection (i-LOD) for 2,3,7,8-TCDD up to 50 fg, which 
satisfies the sensitivity requirements for screening methods [96]. The GC×GC-µECD and GC-IT-
MS/MS procedures were subjected to an extensive validation against the GC-HRMS technique 
[97], and it was found that for real samples the accuracy, precision, and limit of quantification 
(LOQ) were in the same range (fish oil, fish) or slightly lower (milk, pork), compared to the GC-
HRMS results [95,97,98], confirming the potential of these alternative techniques. Nevertheless, it 
should be pointed out that despite the lower investments for GC×GC-µECD and GC-IT-MS/MS 
equipment, the samples may require longer preparation times due to additional clean-up steps, the 
instrumental part requires more frequent maintenance of the MS systems (GC-IT-MS/MS) or more 
data treatment time to evaluate the complex chromatograms (GC×GC-µECD) [95]. Moreover, the 
space-charging effect in using of IT-MS/MS is a considerable disadvantage that affects the 
reproducibility. 
For BFRs such as PBDEs or HBCD, the most common detection techniques are EI-HRMS 
and ECNI-LRMS [99,100], but ECD or µECD could be used as well [101]. ECNI-MS provides a 
good sensitivity and selectivity for the detection of bromine containing compounds. Despite the 
poor specificity, the most commonly monitored ions are m/z 79 and 81, representing the two stable 
bromine isotopes [99]. Such a choice is explained by the low yields of molecular ions during the 
ionization process, resulting in insufficient sensitivity. For deca-brominated BDE (PBDE 209), the 
sufficiently strong m/z 485 and m/z 487 peaks can be monitored as well, and HBCD m/z 561 can be 
used as a qualifier ion. In EI-MS, the most commonly monitored ions are [M-Br2]+ and [M]+. They 
provide a good selectivity, but a lower sensitivity, especially for the higher brominated PBDE 
congeners [100]. Moreover, selectivity problems could be caused by the presence of PCBs in the 
samples, which could interfere with the GC-MS analysis of PBDEs [102]. EI-MS techniques, such 
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as GC-LRMS, GC-HRMS, or GC-MS/MS enable the use of isotopically labeled standards, which 
allows applying internal standardization – the most powerful approach for a reliable and accurate 
quantification. HRMS provides a good sensitivity and selectivity, but at higher instrumentation 
investment and maintenance costs. Alternatively, TOF-MS may be used for the detection of PBDEs 
at a sensitivity comparable to other MS techniques [103,104], but the restricted linear range of the 
instrument limits the use of this type of MS [104]. 
One of the most critical issues in the analysis of BFRs, such as PBDEs and HBCD, is the 
thermal lability of these compounds. In contrast to GC, the application of LC eliminates the 
problem of thermal lability or interconversion of BFRs during the analysis, providing an effective 
chromatographic resolution of components. The selective detection by mass spectrometry positions 
the LC-MS combination as a method of choice for the analysis of HBCDs. Several studies reported 
the application of LC-MS based methods in diastereomer-specific analysis of HBCDs in various 
types of matrices, including sewage sludge [105], sediments [106], indoor and airborne dust 
[107,108], food products [109], and fish [110-113]. The most frequently used detection technique 
for diastereomer-specific analysis of HBCD is LC-MS/MS, which utilizes triple quadrupole or IT-
MS analyzers operated in the selected reaction monitoring (SRM) mode [114]. Monitoring of the 
specific transition [M-H]- (m/z 639 and 641) → [Br]- (m/z 79 and 81) provides a selective analysis 
of trace levels of HBCDs. Typically, a sufficient ionization degree could be obtained by the means 
of using electrospray ionization (ESI) operated in negative mode. 
Fewer studies have reported the analysis of PBDEs using LC-MS techniques, which may be 
attributed to the availability of well-established, sensitive, and efficient analytical methodologies for 
the determination of these compounds using GC-MS based techniques. However, LC-MS analysis 
has a major advantage for the analysis of highly brominated PBDEs, which may undergo thermal 
degradation and/or extensive fragmentation during a GC-MS analysis [115]. The ESI mode in the 
LC-MS analysis of PBDEs is limited due to poor ionization in this source [116]. Recently, an 
isotope-dilution method for the determination of 14 major tetra- to deca-BDEs using LC coupled to 
MS/MS system equipped with atmospheric pressure photoionization (LC-APPI-MS/MS) under the 
conditions of reversed-phase LC has been reported [117]. The method was applied the soft APPI 
technique, to obtain stable pseudomolecular ions [M-Br+O]- and [M-2Br+O]- in Q1, with further 
detection of [Br]- (m/z 79 and m/z 81) ions for selective detection in Q3. LC-APPI-MS/MS based 
methods were successfully applied for the analysis of PBDEs in dust [118], air [119], fish [110], 
and human breast milk [120]. The performance of atmospheric pressure chemical ionization (APCI) 
has been also tested in the analysis of PBDEs in wastewater samples under the conditions of LC-
MS/MS [121], and it was found that the LC-APCI-MS/MS technique could provide 2 – 8 times 
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better sensitivity than APPI [122]. 
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2. EXPERIMENTAL PART 
 
2.1. General flow diagram of analytical methodology 
A multi-group analytical procedure was developed and used for the analysis of fish samples 
from the Baltic region, including Baltic wild salmon (Salmo Salar) and eels (Anguilla Anguilla) 
collected from Latvian lakes, as well as for other freshwater and saltwater fish species. This 
analytical procedure allowed to perform the analysis of seven groups of POPs, including the little 
studied brominated and mixed bromo/chloro-substituted compounds with further possibility to 
expand the list of analyzed contaminants (e.g., including pesticides and BFRs other than PBDEs 
and HBCDs). The method development procedures are described in detail in the Papers 5 – 7, while 
application of the elaborated methods to real samples is presented in the Papers 1 – 3 and 8. To 
evaluate the possibility of extending the number of analyzed matrices, the elements of the method 
have been applied to the analysis of several samples other than fish matrices, including fish 
products, food samples, and animal feed samples. The study was carried out in the frame of the 
official monitoring programme with regard to PCDD/Fs and PCBs, for which MLs and ALs have 
been established by the European Commission and the results are presented in Paper 4. 
An analytical flow diagram showing the principal clean-up and analysis steps for the various 
POP groups is showed in Figure 2.1. The analytical methodology was designed to enable the 
determination of various POPs in fish samples. The scheme is associated with the clean-up and 
analysis of planar DL-compounds (e.g. PCDD/Fs, PBDD/Fs, PXDD/Fs, and non-ortho PCBs and 
PXBs), and other DL and NDL contaminants, such as mono-ortho PCBs and PXBs, PBDEs, and 
HBCDs.  
After the collection, the samples were homogenized, subjected to extraction and a 
sophisticated, multi-step clean-up procedure. The analytes of interest were elicited from the sample 
matrix using Soxhlet extraction. After the extraction, a 1/10 aliquot of the extract was subjected to 
clean-up using destructive acidic treatment and Florisil column chromatography (alternatively, non-
destructive clean-up procedure could be applied by using of GPC for elimination of lipids from the 
sample extract) prior to the determination of HBCD diastereomers by means of LC-Orbitrap-
HRMS. For the analysis of PCDD/Fs, PBDD/Fs, PXDD/Fs, PCBs, PXBs, and PBDEs, a complex 
multi-column clean-up protocol was applied, including GPC, silica, and Florisil columns. The 
sample extract was split into three portions according to its potential toxicological significance, 
using carbon column chromatography in automated manner: the most toxicologically significant 
planar compounds (polyhalogenated DD/Fs), non-ortho substituted compounds which tend to attain 
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planar configuration, and the less toxicologically significant poly-ortho substituted contaminants. 
The final analysis of the target compounds was carried out using GC-HRMS, or either LC-Orbitrap-
HRMS or LC-MS/MS systems. 
 
2.2. Sample collection and storage 
2.2.1. Baltic wild salmon (Salmo Salar) samples  
A total of fifty three Baltic wild salmon specimens of various age, length, and weight were 
caught during the spawning period from the Daugava and Venta rivers from October 2010 and 
October 2012. Due to the large volume of POP data obtained during the practical application of the 
elaborated methodology (or its elements), only the results for the selected salmon samples are 
presented in this thesis. These were selected based on the frequency and levels of contamination, 
and in the case of the poorly studied POPs (e.g. PBDD/Fs and PXDD/Fs), also to emphasize the 
data not reported by other researchers. More detailed information on the analyzed samples that were 
measured as part of this work is presented elsewhere (Paper 1, 3 and 5).  
Analyzed salmons were migrating for spawning to the Latvian rivers and therefore represented 
the open Baltic Sea region (River Venta) and Riga Gulf region (River Daugava). The selection of 
salmons for the study was carefully designed in order to achieve an even representation of two 
different regions and sexes and to have a maximum variation in weight and length of fishes. All the 
specimens had gonads at a stage of development typical for spawning. After individual laboratory 
codes were given for all the caught salmon, lengths and weights were measured, and the sex was 
noted. Age of the fish was determined according to squama characteristics. Samples were delivered 
to the laboratory, placed in polyethylene bags, and packed in ice. Thirteen male and twelve female 
specimens were collected. Average length and weight of female salmon was 79 cm (range from 59 
to 86 cm) and 6.0 kg (range from 3.5 to 10.5 kg). Female fish had an age of 2 – 3 years, which is the 
typical spawning starting age for female wild Baltic salmon. Characteristics of male salmon were as 
follows: average length 68 cm (range from 56 to 93 cm) and average weight of 4.6 kg (range from 
2.0 to 11.3 kg). Generally, the male specimens were 1 – 3 years old with the most common age of 1 
year, which is typical for Baltic salmon; most males die during the spawning period. During the 
sample pretreatment the specimens were dissected, the edible fish fillets (including subcutaneous 
fat) were isolated and homogenized using a food blender (Kenwood FP101T, Kenwood Ltd., U.K.), 
and the homogenates were packed into polyethylene bags and stored at -18 °C until analysis. Baltic 
wild salmon samples were subjected for analysis of PCDD/Fs, PBDD/Fs, PXDD/Fs, PCBs, PBDEs 
and HBCDs. 
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2.2.2. Eel (Anquilla Anquilla) samples collected from Latvian lakes  
Fifty eight eel (Anquilla anquilla) specimens of various length and weight were caught from 
Latvian freshwater lakes during the period from September 2013 to May 2014. To get an overview 
of the actual contamination levels of selected POPs in eels, sampling locations were selected to 
evenly cover all territory of Latvia. The selection of eels for this study was carefully designed in 
order to achieve an even representation of five of the most essential eel stocks over Latvia and to 
have a maximum variation in weight and length of fishes. At least five eel specimens were collected 
to represent each sampling site. Samples were packed in polyethylene bags and stored with ice 
during delivery to the laboratory. The samples were uniquely coded and lengths and weights were 
measured. Average length and weight of eels was 76 cm (range from 39 to 101 cm) and 1.0 kg 
(range from 0.1 to 1.9 kg). During the sample pretreatment the specimens were dissected, the edible 
fish fillets (including subcutaneous fat) were isolated and homogenized using a food blender 
(Kenwood FP101T, Kenwood Ltd, UK), and the homogenates were packed into polyethylene bags 
and stored at -18 °C until analysis. Eel samples were subjected for analysis of PCDD/Fs, PBDD/Fs, 
PXDD/Fs, PCBs, PXBs, PBDEs and HBCDs and the results on the occurrence of these 
contaminants in analyzed samples are described in details in Papers 6 and 8. 
 
2.2.3. Other fish species  
To get an overview of the actual contamination levels of POPs in freshwater fish in Latvia, ten 
fish species were collected in Latvian freshwater lakes, at sampling locations selected to evenly 
cover all territory of Latvia. At least five specimens of each fish species of various weights were 
collected. Samples were packed in polyethylene bags and stored with ice during the delivery to the 
laboratory. Upon receiving at the laboratory, a unique code was given to each sample. To obtain a 
representative sample after the cutting and pooling of fish fillets, the material was homogenized in a 
food blender (Kenwood FP101T, Kenwood Ltd., UK), packed in polyethylene bags and stored at -
18°C until the analysis. An appropriate sample amount was analyzed for the content of PCDD/Fs 
and PCBs. More detailed information is presented in Paper 2. 
 
2.3.  Chemicals and materials 
All the solvents used were at least of pesticide purity grade. Hexane, toluene, 
dichloromethane, cyclohexane, and ethyl acetate were purchased from Lab-Scan (Glivice, Poland); 
silica gel (Kieselgel 60, 0.063 – 0.200 mm), Florisil, Celite-545, Carbopack B and Carbopack C 
were from Sigma-Aldrich Chemie GmbH (Buchs, Switzerland). Alumina (basic, 50 – 200 µm), 
sulfuric acid and sodium sulfate were obtained from Acros (New Jersey, USA). High-purity water 
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(18.2 MΩ) was prepared using Millipore Milli-Q purification system (Billerica, MA, USA). The 
native and isotopically-labeled standards for analyzed contaminants were purchased from 
Cambridge Isotope Laboratory, Inc. (CIL) (MA, USA), Wellington Laboratories, Inc. (Ontario, 
Canada) and AccuStandard, Inc. (New Haven, USA). Calibration solutions were prepared by serial 
dilution of stock solutions in toluene or nonane, evaporation of the organic solvent to dryness under 
gentle nitrogen stream and redissolving the residue in appropriate solvent or solvent mixture. The 
following seven groups of persistent organic pollutants were analyzed (for compounds given in 
bold, 13C12-labeled surrogates were available and were used as internal or recovery standards): 
1) Tetra-octa polychlorinated dioxins and furans (PCDD/Fs): 2,3,7,8-TetraCDF, 1,2,3,7,8-
PentaCDF, 2,3,4,7,8-PentaCDF, 1,2,3,4,7,8-HexaCDF, 1,2,3,6,7,8-HexaCDF, 2,3,4,6,7,8- 
HexaCDF, 1,2,3,7,8,9-HexaCDF, 1,2,3,4,6,7,8-HeptaCDF, 1,2,3,4,7,8,9-HeptaCDF, 
OctaCDF, 2,3,7,8-TetraCDD, 1,2,3,7,8-PentaCDD, 1,2,3,4,7,8-HexaCDD, 1,2,3,6,7,8-Hexa-
CDD, 1,2,3,7,8,9-HexaCDD, 1,2,3,4,6,7,8-HeptaCDD, OctaCDD; 
2) Tri-hepta polychlorinated biphenyls (PCBs): IUPAC numbers 18, 28, 33, 47, 49, 51, 52, 60, 66, 
74, 77, 81, 99, 101, 105, 110, 114, 118, 123, 126, 138, 153, 156, 157, 167, 169, 180, 189; 
3) Di-deca polybrominated diphenyl ethers (PBDEs): IUPAC numbers 7, 15, 17, 28, 47, 49, 66, 
71, 77, 85, 99, 100, 119, 126, 138, 153, 154, 155, 166, 181, 183, 190, 203, 204, 205, 206, 207, 
209; 
4) Tetra-octa polybrominated dioxins and furans (PBDD/Fs): 2,3,7,8-TetraBDF, 1,2,3,7,8-
PentaBDF, 2,3,4,7,8-PentaBDF, 1,2,3,4,7,8-HexaBDF, 1,2,3,4,6,7,8-HeptaBDF, OctaBDF, 
2,3,7,8-TetraBDD, 1,2,3,7,8-PentaBDD, 1,2,3,4,7,8-Hexa-BDD, 1,2,3,6,7,8-HexaBDD, 
1,2,3,7,8,9-HexaBDD,1,2,3,4,6,7,8-HeptaBDD, OctaBDD 
5) Tetra-octa mixed bromo/chloro- polyhalogenated dioxins and furans (PXDD/Fs): 3-B-2,7,8-
TriCDF, 2-B-3,7,8-TriCDD, 2,3-DiB-7,8-DiCDD, 1-B-2,3,7,8-TetraCDF, 1-B-2,3,7,8-
TetraCDD, 2-B-1,3,7,8-TetraCDD, 2-B-3,6,7,8,9-PentaCDD, 1-B-2,3,6,7,8,9-HexaCDD, 1-B-
2,3,4,6,7,8,9-HeptaCDD; 
6) Six penta- to hexa-,  mono- to tri-brominated/di- to penta-chlorinated PXBs with the 
arrangement of the halogen atoms in the molecules corresponding to the structures of DL-PCBs: 
4'-B-3,3',4,5-TetraCB (structure analog of non-ortho PCB 126), 3,4-DiB-3',4',5'-TriCB (analog 
of non-ortho PCB 126), 3',4',5-TriB-3,4-DiCB (analog of non-ortho PCB 126), 4'-B-2,3',4,5-
TetraCB (analog of mono-ortho PCB 118), 4'-B-2,3,3',4-TetraCB (analog of mono-ortho PCB 
105), 4'-B-2,3,3',4,5-PentaCB (analog of mono-ortho PCB 156); 
7) Hexabromocyclododecane diastereomers: α-HBCD, β-HBCD, γ-HBCD 
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2.4. Sample preparation and clean-up 
An overall diagram of clean-up procedure is shown in Figure 2.1. A sample aliquot was 
spiked with 13C-labeled POP mixture solution in toluene and equilibrated for at least 1 h. The 
weight of the sample aliquot was dependent on the species of the fish and lipid content in the 
sample, and usually was equivalent to not more than 8 g of lipids. After equilibration, the sample 
was freeze dried for 48 h and the lipids were extracted using Soxhlet extraction with 
dichloromethane/n-hexane (1:1, v/v) mixture with extraction time at least 16 h. The extracts were 
filled into pre-weighed round-bottom flasks, and the solvent was removed using rotary evaporator at 
< 30°C. The lipid content was determined gravimetrically and the residue was diluted with 
cyclohexane/ethyl acetate (1:1, v/v) mixture to obtain the proportion of 1 g of lipids per 5 mL of the 
final extract volume. An aliquot A of 90% of the final extract volume was subjected to clean-up for 
the analysis by PCDD/Fs, PBDD/Fs, PXDD/Fs, PCBs, PXBs, and PBDE, while the remaining 10% 
of the extract volume (aliquot B)) was reconstituted in dichloromethane/n-hexane mixture and 
treated prior to the analysis of HBCD diastereomers using destructive acidic clean-up procedure. 
Non-destructive clean-up procedure (GPC method) could be applied for the HBCD containing 
fraction as well, by means of taking 10% of the aliquot after GPC stage and treatment of this extract 
using Florisil column chromatography. 
 
2.4.1. Procedures applied for aliquot A): PCDD/Fs, PBDD/Fs, PXDD/Fs, PCBs, PXBs 
and PBDE 
The high molecular substances were removed by gel permeation chromatography (GPC). The 
system was equipped with a glass column (50 x 2.5 cm) filled with 50 g of Bio-Beads SX-3 (Bio-
Rad, Philadelphia, USA) stationary phase and eluted with cyclohexane/ethyl acetate (1:1, v/v) 
mobile phase at a flow rate of 5 mL min-1. The automated GPC program was as follows: dump time 
0 – 19 min, collection time 19 – 45 min; the collected eluate was concentrated by rotary evaporation 
at < 30 oC. The pre-purified sample extract was placed on top of a glass column (25 x 1.2 cm) filled 
with 2.5 g silica gel containing 50% of 18M sulfuric acid for degradation of remaining lipids. The 
analytes were eluted with 1.0 mL of toluene and subsequently with 25 mL of n-hexane, and the 
eluate volume was reduced by rotary evaporation to 0.5 mL. PBDD/Fs, PCDD/Fs and PXDD/Fs 
were chromatographically separated from PBDEs, PCBs and PXBs using a glass column (25 x 1.2 
cm) filled with 6.0 g of Florisil deactivated with 3% water: first the fraction of the PBDEs, PCBs 
and PXBs was eluted with 80 mL of n-hexane, followed by 120 mL toluene for elution of the 
PBDD/F, PCDD/F and PXDD/F fraction. After solvent removal and concentration of each of the 
two fractions by rotary evaporation to 1.0 mL, additional clean-up and separation steps using active 
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carbon column were performed in an automated manner using Waters (Milford, USA) preparative 
chromatography system consisting of Controller 600, Autosampler 717 plus and Fraction collector 
III. For the PBDD/Fs, PCDD/Fs and PXDD/Fs a glass column (25 x 1.0 cm) was consequently 
filled with 0.5 g of Carbopack C/Celite-545 (10/90, w.w.) and 0.5 g of Carbopack B/Celite-545 
(10/90, w.w.). After application of the sample extract to the top of the Carbopack C/Celite-545 
layer, the column was washed with n-hexane/dichloromethane (65:35, v/v) mixture at a rate of 1.5 
mL min-1 for 20 min and the PBDD/Fs, PCDD/Fs, and PXDD/Fs were eluted with toluene in the 
back flush mode at a flow rate of 2.5 mL min-1 for 40 min. PBDEs, DL-PCBs, NDL-PCBs and 
PXBs were separated in direct flow using a glass column (25 x 1.0 cm) filled with 2.0 g of a 1:1 
(w/w) mixture of Carbopack B and Celite-545; PBDEs, mono-ortho PCBs and PXBs and NDL-
PCBs were eluted with n-hexane at a flow of 2.0 mL min-1 within 25 min, the non-ortho PCBs and 
PXBs subsequently by elution with toluene at a flow rate of 2.5 mL min-1 within 30 min.  Finally, to 
remove potentially remaining interferants such as PBDEs and PCBs from the fraction containing 
PBDD/Fs and PXDD/Fs, the fraction was purified using glass column filled with 3.0 g of basic 
alumina (activated at 450 °C for 16 h) as follows: the fraction containing PBDD/Fs, PCDD/Fs, and 
PXDD/Fs was evaporated on rotary evaporator and the solvent was exchanged to n-hexane without 
traces of toluene; after addition of the n-hexane extract to column, the column was rinsed with 20 
mL of n-hexane/dichloromethane (90:10, v/v) mixture to waste and analytes of interest were 
collected with a 60 mL fraction of dichloromethane. After rotary evaporation to about 150 – 200 µL 
all three extracts were transferred to 2 mL chromatographic vials, treated with 37 N sulfuric acid 
(30 µL) and mixed. The mixture was allowed to stand for 20 min and centrifuged at 3000 rpm to 
separate the acid and organic layers. The acidic bottom layer was discarded and the organic layer 
was evaporated with addition of recovery standard solutions in n-nonane. As recovery standards, 
13C12-1,2,3,7,8-PentaBDF and 13C12-1,2,3,7,8,9-HexaBDD were used for PBDD/Fs, while 13C12-
1,2,3,4-TetraCDD and 13C12-1,2,3,7,8,9-HexaCDD were used for PCDD/Fs and PXDD/Fs. For 
PBDE, mono-ortho PCB and PXB, and non-dioxin-like PCB fraction, the 13C12-PBDE 138, 13C12-
PCB 101, and 13C12-PCB 138 surrogates were added as recovery standards, while for non-ortho 
PCB and PXB fraction the recovery standards were 13C12-PCB 101 and 13C12-PCB 138. The final 
volume of the PBDD/F, PCDD/F and PXDD/Fs fraction was 10 µL. The fraction containing 
PBDEs, mono-ortho PCBs and NDL-PCBs was evaporated to 50 µL. Non-ortho PCB fraction was 
also reduced to 50 µL. After the analyses of PBDEs and PCBs, the corresponding extracts were 
evaporated until 20 µL and analyzed on the content of PXBs. 
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2.4.2. Procedures applied for aliquot B): HBCDs 
2.4.2.1. Destructive removal of high molecular compounds (acidic method) 
The organic extract was evaporated to dryness, the residue was dissolved in 35 mL 
dichloromethane/n-hexane (1:1, v/v) mixture and treated with 10 mL of 18M sulphuric acid by 
intense shaking for 15 min. The mixture was allowed to stand for 15 min and centrifuged at 3000 
rpm using a Falcon 6/300 benchtop centrifuge (MSE, London, UK). The bottom (aqueous) layer 
was discarded and the organic extract was treated with 10 g of silica gel impregnated with sulphuric 
acid (50% of 18M sulphuric acid). After intense shaking of the mixture, the organic phase was 
filtered and silica residue was washed with 20 mL of extraction solvent mixture. The filtrate and 
washings were combined and transferred to a round-bottom flask and concentrated to approximately 
1 mL on a rotary evaporator, and the solvent was exchanged to 1 mL of n-hexane. The extract was 
further treated on a glass column (25 × 1.0 cm) filled with 3.0 g of Florisil deactivated with 3% of 
water: after the addition of the sample extract, the column was washed with 20 mL of n-hexane and 
the eluate was discarded. HBCD diastereomers were eluted from the column with 40 mL of n-
hexane/dichloromethane (1:1, v/v) mixture, the fraction was concentrated by rotary evaporation, 
reconstituted in 200 µL methanol-water-acetonitrile mixture (60:20:20, v/v/v), transferred to an 
autosampler vial and analyzed on the content of HBCDs. 
 
2.4.2.2. Non-destructive removal of high molecular compounds (GPC method) 
A sample aliquot of 10% for determination of HBCDs was taken after the removing of the bulk 
of the high molecular components (e.g. lipids) by means of GPC. The solvent was evaporated and 
the sample was reconstituted in 1mL of n-hexane. Further clean-up procedure was performed using 
Florisil column according to section 2.4.2.1. 
 
2.4.2.3. Preparation of the fish sample extracts for the comparative evaluation of 
the instrumental responses of UHPLC-Orbitrap-HRMS, UHPLC-TOF-
HRMS and UHPLC-QqQ-MS/MS systems 
For the establishing the influence of different sample clean-up steps on the instrument response 
to the analytes of interest, a butter fish homogenate was used as model matrix. The 5 g of the 
material was extracted with dichloromethane/n-hexane (1;1, v/v) using cold extraction and was 
treated according to the individual steps of the procedure, or their combinations (e.g. GPC method, 
acidic method and the addition to the scheme of Florisil column). The model matrix was previously 
analyzed for the content of HBCD diastereomers and found to contain only traces of α-HBCD 
(triplicate analysis of the material showed the average concentration of 11 pg g-1 sample fresh 
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weight (f.w.))whereas β- and γ-HBCDs were found to be below the LOQ. To evaluate the possible 
instrumental signal suppression by the matrix components, the sample extracts obtained after the 
corresponding clean-up stage were spiked with the appropriate volume of HBCD diastereomer 
solution in toluene and were evaporated until dryness under a gentle stream of nitrogen. The 
obtained samples were reconstituted in 200 µL of methanol-water-acetonitrile mixture (60:20:20, 
v/v/v), and transferred to an autosampler vial. The amount of the standard solution added before the 
instrumental analysis provided the final 10 pg µL-1 concentration for each HBCD stereoisomer. The 
samples for instrumental signal suppression experiments were prepared in triplicate (n=3) and each 
sample was injected in duplicate. It was found that the relative standard deviation (RSD) for the 
obtained instrumental responses for each set of samples corresponding to the evaluated sample 
preparation step or their combinations was below 20%. 
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Homogenized sample aliquot
Freeze drying or grinding with anhydrous Na2SO4
GPC (Bio-Beads SX-3)
elution with ethyl acetate/cyclohexane (1/1)
Spiking with 13C12-labeled internal standards
Soxhlet extraction
dichloromethane/n-hexane (1/1)
Acidic silica gel (2.5 g)
elution with n-hexane
Florisil  (6.0 g)
PCDD/Fs, PBDD/Fs, PXDD/Fs
elution with toluene
PCBs, PBDEs, PXBs
elution with n-hexane
Carb-B/Celite-545 (2.0 g)
NDL-PCBs, mono-ortho 
DL-PCBs/PXBs,
 PBDEs
elution with n-hexane
non-ortho 
DL-PCBs/PXBs,
elution with toluene
Carb-B/Carb-C/Celite-545 (1.0 g)
PCDD/Fs, PBDD/Fs, PXDD/Fs
backflush elution with toluene
Alumina column (3.0 g)
PCDD/Fs, PBDD/Fs, PXDD/Fs
 elution with dichloromethane
Treatment of  the fnal extract with 18M H2SO4, addition of  13C12-labeled recovery 
standards and GC-HRMS analysis
1/10 aliquot for destructive clean-up for HBCDs
Exchange of  the 
solvent to n-hexane
Treatment of  the extract 
with acidic silica gel
Florisil  (3.0 g)
Elution with  n-hexane
(discard eluate)
HBCDs
elution with 
dichloromethane/n-hexane
UHPLC-HRMS (MS/MS) 
analysis
Treatment of  the extract 
with 18M H2SO4
  1/10 aliquot for non-destructive
 clean-up for HBCDs (alternative)
 
Fig. 2.1. The analytical diagram, showing principal clean-up and analysis steps for PCDD/Fs, PBDD/Fs, PXDD/Fs, PCBs, PXBs, PBDEs and HBCDs
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2.5. Instrumental analysis 
2.5.1. Instrumental analysis and quantification of PCDD/Fs, PBDD/Fs, PXDD/Fs, 
PCBs, PXBs and PBDEs by GC-HRMS 
Selected analyte groups were analyzed by GC-HRMS. The measurements were performed on 
Micromass Autospec Premier high resolution mass spectrometer (Milford, USA) coupled with 
Agilent 6890 N gas chromatograph (Santa Clara, USA). Aliquots of 1 µL of the final sample 
extracts and calibration solutions were introduced into GC-HRMS system equipped with a silica 
capillary column and a split/splitless injector operated in splitless mode. The transfer line from the 
GC to the HRMS and the ion source temperatures were kept at 280 oC. Ion source was operated in 
the positive electron impact mode (EI+) with electron energy of 36 eV and a trap current of 600 µA. 
The resolution of the mass spectrometer was better than 10 000 (at 10% peak valley) for all analyte 
groups with the exception of PXDD/Fs and PXBs, for which resolution was in the range of 13 500 
– 15 000 (at 10% peak valley). Mass calibration for all analyzed compounds was obtained at 
acceleration voltage of 7.5 kV. Table 2.1 presents the GC conditions used for selected POP groups. 
 
Table 2.1 
GC conditions for the analysis of target compounds 
PCDD/Fs  
Column ZB-5MS, 60 m, 0.25 mm i.d., 0.25 µm film thickness (Phenomenex, Torrance, USA) 
Temperature program 140 °C (held for 3 min), 15 °C min-1 to 200 °C, 3 °C min-1 to 235 °C (held for 15 min),  4 °C 
min-1 to 300 °C (held for 12 min) 
Injection temperature 280 °C 
Carrier gas helium at flow rate of 1.0 mL min -1 
PCBs  
Column ZB-5MS, 60 m, 0.25 mm i.d., 0.25 µm film thickness (Phenomenex, Torrance, USA) 
Temperature program 75 °C (held for 2 min), 15 °C min-1 to 150 °C, 2.5 °C min-1 to 290 °C (held for 1 min) 
Injection temperature 270 °C 
Carrier gas helium at flow rate of 1.0 mL min -1 
PBDD/Fs  
Column DB-5MS, 18 m, 0.25 mm i.d., 0.10 µm film thickness (J&W Scientific, Folsom, USA) 
Temperature program 100 °C (held for 4 min), 40 °C min-1 to 200 °C (held for 3.5 min), 10 °C min-1 to 320 °C (held 
for 2.5 min) 
Injection temperature 260 °C 
Carrier gas helium at flow rate of 1.0 mL min -1 
PXDD/Fs  
Column DB-5MS, 30 m, 0.25 mm i.d., 0.10 µm film thickness (J&W Scientific, Folsom, USA) 
Temperature program 120 °C (held for 2 min), 20 °C min-1 to 240 °C, 5 °C min-1 to 320 °C (held for 4 min) 
Injection temperature 250 °C 
Carrier gas helium at flow rate of 1.0 mL min -1 
PXBs  
Column ZB-5MS, 60 m, 0.25 mm i.d., 0.25 µm film thickness (Phenomenex, Torrance, USA) 
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Table 2.1continuation 
GC conditions for the analysis of target compounds 
 
Temperature program 70 °C (held for 3 min), 100 °C min-1 to 140 °C, 15 °C min-1 to 210 °C ,4 °C min-1 to 310 °C 
(held for 10 min), 10 °C min-1 to 315 °C (held for 4 min) 
Injection temperature 290 °C 
Carrier gas helium at flow rate of 1.0 mL min -1 
Di-hepta BDEs  
Column DB-5MS, 30 m, 0.25 mm i.d., 0.10 µm film thickness (J&W Scientific, Folsom, USA) 
Temperature program 100 °C (held for 3 min), 5 °C min-1 to 320 °C (held for 15 min) 
Injection temperature 250 °C 
Carrier gas helium at flow rate of 1.0 mL min -1 
Octa-deca BDEs  
Column DB-5MS, 15 m, 0.25 mm i.d., 0.10 µm film thickness (J&W Scientific, Folsom, USA) 
Temperature program 100 °C (held for 3.5 min), 40 °C min-1 to 200 °C (held for 4 min), 10 °C min-1 to 320 °C (held 
for 3 min) 
Injection temperature 280 °C 
Carrier gas helium at flow rate of 1.0 mL min -1 
 
All analyte groups were determined by selected ion recording (SIR) using the two most 
abundant ions of the respective molecular ion cluster of both the native and the 13C12-labeled 
surrogates. The run was time segmented and SIR descriptors changed according to elution times for 
analytes of interest. Quantification was carried out using isotope dilution method applying the 
13C12-labeled surrogates as internal standards. Masslynx™ software was used for raw data 
interpretation and for targeting/quantification of selected contaminants. 
 
2.5.2. Instrumental analysis and quantification of HBCD diastereomers 
2.5.2.1. UHPLC separation of the target analytes 
Within the framework of this study UHPLC separation of target compounds was carried out 
using Kinetex C18, 100 mm × 2.1 mm, 1.7 µm reversed-phase analytical column at 25°C, applying a 
flow rate of 250 µL min-1 with a mobile phase gradient based on (A) methanol-water (75:25, v/v) 
and (B) acetonitrile. The effective gradient began at the initial composition (A/B) of 20:80 (v/v) that 
was maintained for 1.0 min and then ramped to 55:45 over 0.1 min, where it was held for 6.0 min 
before returning to the initial conditions over 1.0 min. The column was equilibrated for 2.0 min 
between the runs. The injection volume of 10 µL was used both for the standard solutions and 
sample extracts. 
  
2.5.2.2. UHPLC-Orbitrap-HRMS system 
The UHPLC-Orbitrap-HRMS system used in this study consisting of Thermo Accela UHPLC 
system (Zwingen, Switzerland) coupled to an Orbitrap Q Exactive mass spectrometer (Bremen, 
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Germany) equipped with heated electrospray ionization (HESI-II) interface. The negative ion mode 
was used for acquisition of the mass spectra. During the tuning procedure the signal of HBCD 
diastereoisomers was preliminarily optimized for the highest response of the [M-H]  ion. Direct 
introduction of the target compounds (native and 13C12-labeled α-, β-, and γ-HBCDs, 1 ng µL−1 of 
each in methanol) into the HESI-II interface of MS system was performed at 10 µL min−1using a 
Chemyx Fusion 100T (Stafford, USA) infusion pump. Orbitrap-MS detection in targeted selected 
ion monitoring (t-SIM) mode was used for a quantitative determination of selected compounds 
using the two [M-H]  most abundant ions of the respective molecular ion cluster for both the 
native and the 3C12-labeled surrogates. The channels monitored for HBCD diastereoisomers were 
m/z 640.6374 (quantification) and m/z 638.6396 (confirmation) for the native components, and m/z 
652.6782 (quantification) and m/z 650.6804 (confirmation) for the 13C12-labeled surrogates. 
External calibration of the Orbitrap-MS system was performed before each batch of samples over 
the mass range of m/z 50 – 2000 according to the guidelines provided by the instrument supplier. 
The details of the optimized instrumental conditions are summarized in Table 2.2. Thermo 
XcaliburTM and TraceFinderTM 3.0 software were used for raw data interpretation and for targeting/ 
quantification of selected contaminants.  
 
2.5.2.3. UHPLC-TOF-HRMS system 
The UHPLC-TOF-HRMS instrument consisted of an Agilent Technologies 1290 Infinity 
UHPLC system coupled to a 6230 TOF mass spectrometer (Santa Clara, CA, USA) equipped with a 
heated ESI interface. The negative ion mode was used for the acquisition of mass spectra. A TOF-
HRMS detection in the scan mode over the m/z range 600 – 700 was used for a quantitative 
determination of selected compounds using the two most abundant [M-H]  ions of the respective 
molecular ion cluster for both the native and the 13C12-labeled surrogates. The nominal channels 
monitored for HBCD diastereomers were the same as for Orbitrap-HRMS. External calibration of 
the TOF-HRMS instrument was performed before each batch of samples over the mass range of m/z 
100 – 3200 and achieving mass resolving power greater than 10 000 FWHM according to the 
guidelines provided by the instrument supplier. For the raw data treatment and targeting/ 
quantification of selected contaminants, Agilent Technologies MassHunter Workstation software 
was used. The details of the optimized instrumental conditions are summarized in Table 2.2.  
 
2.5.2.4. UHPLC-QqQ-MS/MS system 
For MS/MS analyses an AB SciexQTrap 5500 mass spectrometer (AB SCIEX, Framingham, 
−
−
−
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MA, USA) equipped with heated ESI interface and a Waters Acquity UHPLC system (Waters, 
Milford, MA, USA) were used. The data acquisition was performed in the negative SRM mode to 
obtain sufficient number of quantification points for the confirmation of each HBCD diastereomer.  
Analyst® software was used to control all the components of the instrument and for the data 
acquisition and processing. The channels monitored for the three HBCD diastereomers were m/z 
640.6 → 78.9 (quantification) and m/z 640.3 → 80.9 (confirmation), and the internal standard 
channels were m/z 652.6 → 78.9 and m/z 652.6 → 80.9. External calibration of the mass 
spectrometer was performed according to the manufacturer requirements. Detailed instrumental 
conditions of the system are summarized in Table 2.2. 
Table 2.2 
The optimised instrumental conditions for determination of HBCD diastereomers using different 
MS techniques 
 Orbitrap-HRMS TOF-HRMS QqQ-MS/MS 
ESI- conditions    
Drying gas temperature - 260°C - 
Drying gas flow - 13 L min-1 - 
Nebulizer pressure - 25 psig - 
Sheath gas temperature - 280°C - 
Capillary voltage  - 3.0 kV - 
Nozzle voltage - 3.0 kV - 
Fragmentor voltage - 150 V - 
Skimmer voltage - 75 V - 
Sheath gas flow/pressure 15 a.u.* 12 L min-1 60 psi 
Auxiliary gas flow/pressure 5 a.u.* - 30 psi 
Capillary temperature 250°C - - 
Source heater temperature  250°C - 400°C 
Spray voltage 4.5 kV - 4.5 kV 
S-lens radio frequency 50 - - 
MS conditions    
Maximum injection time 100 ms - - 
Automatic gain control (AGC target) 5 × 104 - - 
MS resolution  35 000 FWHM 15 000 FWHM UNIT 
Detection mode t-SIM FULL SCAN SRM 
Declustering potential - - 90 V 
Collision energy - - 60 V 
a.u.* – arbitrary units. 
 
2.6. Quality assurance and quality control 
Before use, all the glassware was solvent washed to remove possible background 
contamination. To prevent the degradation of potentially photolabile compounds such as HBCDs, 
PBDD/Fs and PBDEs, all stages of analytical procedure, including sample extraction, purification 
and handling of the final extracts were performed under ‘‘UV-protect’’ conditions (e.g. using amber 
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glassware or wrapping the glassware with aluminum foil). To compensate the losses of the analytes 
during the extraction and clean-up steps, each sample was spiked before the analytical procedure 
with 13C12-labeled congeners and quantification was carried out on the basis of stable isotope 
dilution and internal standardization. Recovery standards added after clean-up procedure were used 
for internal standard recovery control and calculation. Five to six point calibration curves were used 
for quantification of congener concentrations in each sample run. At the end of the analytical run, a 
reference standard solution was analyzed to check the system performance and calibration validity. 
Linearity of the calibration curves was checked with relative response factors (RRFs). 
The following internal quality control criteria for the positive identification of analytes of 
interest were applied:  
i) The retention time of native compound should be within a window of +3 to 0 seconds 
compared to the corresponding 13C12-labeled internal standard.  
ii) The isotope ratios of the two molecular ions of the halogen ion distribution cluster 
analyzed in SIR-mode should be within ± 15% of the theoretical values. 
iii) The signal-to-noise ratio should be equal to or greater than 3 (S/N ≥ 3); 
iv) Procedural blanks and quality control samples should be run in each sample sequence, 
consisting of not more than 10 samples; 
v) Recovery of 13C12-labeled internal standards was in the range of 60 – 120% (with exception 
of HBCDs, for which recovery of internal standards was not evaluated for each analyzed sample). 
To control the ongoing precision and recovery of the selected POPs, quality control samples 
were routinely added in each sample sequence. Quality control samples consisted of “in house” 
prepared fish oil or freeze-dried salmon fillet naturally contaminated with PCDD/Fs, PCBs, PBDEs, 
and HBCDs which was tested by four different laboratories. To control the ongoing precision and 
recovery of the PBDD/Fs, PXDD/Fs and PXBs quality control samples were spiked with the 
analytes of interest. To reveal the performance in analysis of POPs, laboratory participates on a 
regular basis in international proficiency tests on determination of PCDD/Fs and PCBs in food and 
feed matrices. 
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3. RESULTS AND DISCUSSION 
 
3.1. Clean-up and fractionation 
The sample preparation procedure applied in the present study was based on the 
dehydratation of fish tissue using freeze drying (lyophilization) followed by the extraction of 
lipophilic target compounds into a dichloromethane/n-hexane mixture. Alternatively, the 
dehydration procedure could be performed with anhydrous sodium sulphate or other drying agent 
(e.g., magnesium sulphate) suitable for these purposes. Extraction of POPs from the samples was 
performed using Soxhlet extraction approach as one of the simplest and most effective methods, 
which does not require sophisticated and expensive equipment [81]. The sample extract was split 
into two portions after the extraction step: 90% was subjected to the clean-up and fractionation 
steps required for the analysis of PCDD/Fs, PBDD/Fs, PXDD/Fs, PCBs, PXBs, and PBDEs, while 
the remaining 10% portion was used for the analysis of HBCDs. 
 
3.1.1. Clean-up and fractionation for the fraction containing PCDD/Fs, PBDD/Fs, 
PXDD/Fs, PCBs, PXBs and PBDEs 
Because of the structural similarity of PBDD/Fs and PXDD/Fs to PCDD/Fs, and PXBs to 
PCBs, for which a robust method has been successfully used over the course of many years for food 
and feed matrices, a similar analytical approach with modifications to better suit PBDD/F and 
PXDD/F analysis was used. Taking into account the typically low levels (ppt or sub-ppt) at which 
PBDD/Fs and PXDD/Fs are represented in food products and environmental matrices, relatively 
high sample aliquots were taken for analysis with a concentration factor up to 10 000 to provide 
better sensitivity for PBDD/Fs PXDD/Fs and PXBs. The most commonly used procedures to 
remove the bulk of high molecular compounds from the samples of animal origin are destructive 
(acid/base treatment) and nondestructive methods (size exclusion chromatography (e.g. GPC), 
dialysis through the semi-permeable membranes) [123]. Although under the conditions of well 
established analytical procedures for POPs destructive methods give reliable results, there are some 
potential risks. On one hand, the acid treatment of large sample amounts with high fat content leads 
to a risk of losing of analytes of interest by adsorption on the treated carbonaceous matrix. On the 
other hand, sample digestion with alkali could cause the breakdown of highly halogenated 
compounds resulting in formation of respective congeners with lower halogenation pattern [124]. 
Moreover, the acid treatment alone is not effective for some types of matrices (e. g. materials of 
plant origin), due to the presence of waxes, which are relatively stable to hydrolysis. To prevent the 
possible risks related to the usage of destructive lipid elimination methods, GPC was used to 
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remove the bulk (up to 95%) of high molecular compounds from the sample. Furthermore, GPC 
presented several advantages: this type of chromatography is flexible and robust; a column could be 
used repetitively without regeneration and could be easily operated in automated manner. 
Additionally an acidic silica column was used for the degradation of the remaining part of lipids, as 
well as for retaining the polar matrix components. 
As it was reported previously [41,74,125-127], the separation of PBDEs and PCBs from 
PBDD/Fs and PXDD/Fs has been of great concern to prevent the mass spectral interference from 
similar fragments during the ionization. Table 3.1 shows the example of possible interference of 
PCBs in mass spectral analysis of monobromo-trihloro and monobromo-tetrachloro DD, and 
dibromo-dichloro and dibromo-trichloro DFs. 
Table 3.1 
Possible example of mass spectral interference of PCBs in analysis of PXDD/Fs 
Component Isotopic fragment and mass (m/z) Isotope ratio (± 15%) Required MS resolution (R) 
Br1Cl3DD 
[M]+ [M+2]+ 0.51 (± 0.08) 
> 35 000 363.8455 365.8430 
HexaCB [M+6]
+ [M+8]+ 4.1 (± 0.62) 363.8351 365.8321 
Br1Cl4DD 
[M+2]+ [M+4]+ 1.2 (± 0.18) 
> 37 000 399.8040 401.8013 
HeptaCB [M+8]
+
 [M+10]+ 5.2 (± 0.78) 399.7932 401.7902 
Br2Cl2DF 
[M+2]+ [M+4]+ 1.1 (± 0.17) 
> 110 000 393.7878 395.7955 
HeptaCB [M+2]
+ [M+4]+ 1.0 (± 0.15) 393.8020 395.7991 
Br2Cl3DF 
[M+2]+ [M+4]+ 0.93 (± 0.14) 
> 113 000 427.7588 429.7563 
Br2Cl3DF [M+2]
+ [M+4]+ 0.89 (± 0.13) 427.7630 429.7601 
   
On one hand, it is clearly seen that the interference of PCBs could not be distinguished by 
using conventional MS with the high resolution of R = 10 000. On the other hand, increasing of the 
MS resolution in magnetic sector HRMS instruments dramatically decreases the sensitivity. The 
isotope ratios of the two molecular ions of the halogen ion distribution cluster, which are constant 
for the selected groups of compounds, serve as a clear indicators of the presence of the component 
of interest in the sample. Nevertheless, in the case of the presence of selected components in the 
sample at ultra-trace levels, isotope ratios could be affected due to the background of the 
instrument, leading to an incorrect interpretation of the SIR chromatograms.  Moreover, 
overlapping of the retention ranges of different classes of compounds prevents unequivocal 
chromatographic identification of the analytes. As it could be seen from Papers 1 – 4, typically, fish 
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is the matrix most contaminated with PCBs and PBDEs among the food products and the latter 
compounds reach ppb or even higher concentrations on f.w. basis. Due to the significant difference 
of concentration profiles of target compound groups in the samples and the ability of some 
compounds to affect or interfere with instrumental analysis, these groups should be eliminated from 
the extracts as completely as possible during the clean-up procedure, thus extensive sample 
fractionation should be used. In our study an elaborated clean-up procedure with three-step 
fractionation for the fraction containing PBDD/Fs and PXDD/Fs was used in order to provide a 
more complete exclusion of possible interferants. The first fractionation stage involved a Florisil 
column chromatography, taking advantage of the almost complete separation of PCBs, PXBs and 
PBDEs from PBDD/Fs, PCDD/Fs and PXDD/Fs [127,128]. The elution profile for all these classes 
of analytes is shown in Figure 3.1. 
 
 
Fig. 3.1. Elution profiles of PCBs, PXBs, PBDEs, PCDD/Fs, PBDD/Fs and PXBs in Florisil column 
 
Although the Florisil column was capable of separating up to 99.5% of PBDEs from the 
sample extract, taking into account the differences in typical levels of PBDEs and PBDD/Fs (ppb 
and ppt or sub-ppt, respectively), the remaining 0.5% of PBDEs could provide undesirable GC-MS 
interference. Due to the different retention characteristics of planar and non-planar aromatic 
molecules on activated carbon, based on different interactions between the p-electrons of the 
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aromatic molecules and p-electrons of the carbon graphite structure, carbon column 
chromatography was suggested for the separation of PCBs and PBDEs from PBDD/Fs and 
PXDD/Fs [50,57,74,86], and it was applied in this study in automated manner as a second 
fractionation step. Polyhalogenated dioxins and furans have planar aromatic structures and tend to 
interact stronger with the carbon surface in comparison to the mono- to tetra-ortho substituted PCBs 
and PBDEs, which have restricted rotation around the phenyl-phenyl bond and remain relatively 
non-planar. This results in weak or intermediate retention of PCBs and PBDEs on activated carbon 
and by using moderately polar solvent mixtures (e.g., n-hexane/dichloromethane) it is possible to 
isolate these potential interferants from the extract. Moreover, the using of dual-layer reversible 
carbon column consisting of activated carbon sorbents with different surfaces areas (Carbopack C 
with surface area of 10 m2 g-1 and Carbopack B with surface area of 100 m2 g-1) provides a better 
and more reproducible recoveries for 13C12-labeled hepta- and octa-substituted dioxins and furans, 
which is common issue for these compounds [129]. The benefit is associated with the fact that the 
sample extract is applied on the additional Carbopack C layer, which has weaker adsorption 
strength to low chlorinated congeners, compared to Carbopack B, while the highly chlorinated 
congeners are retained on this material with further possibility to elute them with smaller volumes 
of solvent. The comparison of the recoveries for 13C12-PCDD/Fs obtained by using conventional 
and dual-layer carbon columns is shown in Figure 3.2. 
 
Fig. 3.2. Improvement of the recoveries for 13C12-PCDD/Fs obtained by using of dual-layer carbon 
column 
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The final purification stage for fraction containing polyhalogenated DD/Fs utilizes a basic 
alumina column to exclude the possible remaining mass interferants, and this step is particularly 
useful in analysis of matrices with high PCB and PBDE contamination (e.g., Baltic wild salmon and 
other fish from the Baltic Sea). 
Finally, due to the fact that non-ortho PCBs can attain a planar configuration, these 
compounds are more toxic in comparison with ortho PCBs and PBDEs [6]. Taking into account the 
toxicological significance of non-ortho PCBs and the occurrence of these compounds in the 
samples at lower concentrations compared to other PCBs, this group of contaminants was isolated 
as an individual fraction using carbon column, to improve the sensitivity and robustness of the 
method. 
 
3.1.2. Clean-up and fractionation for the fraction containing HBCDs 
 For analysis of HBCDs after the extraction procedure an aliquot of the sample extract was 
subjected to the destructive clean-up procedure with additional purification stage on a Florisil 
column. This approach was chosen as the simplest and less time consuming in comparison with 
non-destructive methods such as GPC in development of a target-oriented method where the 
analytes (HBCDs) are stable under the aggressive conditions.  Although the bulk of high-molecular 
compounds (e.g., lipids) were decomposed with concentrated sulphuric acid, polar matrix 
components could remain in the sample extract, thus the additional treatment with acidic silica gel 
was introduced in order to remove these interferants. Fish is a matrix known to be potentially highly 
contaminated with brominated organic compounds [130,131], and some of those (e.g., PBDEs) 
could interfere with the mass spectrometric analysis of HBCD by giving rise to similar mass 
fragments during the ionization of the sample extract. In order to remove these potentially isobaric 
mass interferants from the sample extract, additional clean-up on a Florisil column was used with 
the successful elution of analytes of interest from the column with a medium polarity solvent 
mixture (dichloromethane/n-hexane). Moreover, a three-stage sample clean-up procedure provided 
the final sample extracts of the desired purity, which was essential for the analysis of 
organobromine compounds, since the matrix components tended to adhere on the hot surfaces of 
the ion source and the thermally labile compounds such as HBCDs were destroyed on these spots 
resulting in a drop of method sensitivity. Since the clean-up procedure might become the most 
critical step, elution profiles of the analytes of interest were tested first and found to acceptably 
provide the absolute recoveries of the HBCD diastereoisomers in the range of 70 – 110%, without 
correction for the isotopically labeled internal standards. 
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Alternatively, clean-up for analysis of HBCDs could be performed under conditions of non-
destructive clean-up protocol by means of using of GPC as the first step for the elimination of high-
molecular compounds. Such approach could be more affordable with respect of extension of the list 
of the analytes by ensuring of more flexible conditions of the method and to minimizing the 
degradation of susceptible compounds. Moreover, sample extracts obtained in such way could be 
analyzed in full scan modes using either UHPLC-Orbitrap-HRMS or UPLC-TOF-HRMS with the 
possibility of retrospective post-run evaluation of the instrumental raw data and screening of 
unknown compounds (e.g. other BFRs). 
 
3.2. Instrumental analysis 
3.2.1. GC-HRMS in analysis of PCDD/Fs, PBDD/Fs, PXDD/Fs, PCBs, PXBs and 
PBDEs 
Although the increase in the halogenation degree of dibenzo-p-dioxins and furans is linked to a 
decrease in their potential toxicity, some of the PBDD/Fs with high degree of bromination (e.g., 
hepta- and octa-brominated congeners) might be of high toxicological concern. Unfortunately, in 
most studies data on highly brominated congeners is scarce. Although the sensitivity of reported 
GC-HRMS methods for analysis of PBDD/F congeners with low degree of substitution, such as di- 
to penta-brominated dioxins and furans, is comparable to the methods reported for chlorinated 
analogs, the analysis of highly brominated components is often complicated, resulting in increased 
LOQs for these toxicologically significant compounds. Due to the thermal lability of highly 
brominated congeners, the transit time through the GC column becomes critical for these 
compounds. To avoid thermal degradation problems during the GC separation of brominated POPs, 
such as PBDD/Fs and PBDEs, shorter columns with a thinner internal coating are more preferable 
[86,115,132]. In this study an 18 m GC column with phase coating of 0.10 µm that offered both 
adequate chromatographic resolution and sensitivity for PBDD/Fs was used. Taking into account 
the possibility of thermal degradation of PXDD/Fs, especially at high degree of halogenation, the 
latter were checked by application of two columns with different lengths and phase loadings (a 60 
m column with phase loading of 0.25 µm and 30 m column with phase loading of 0.10 µm). As was 
expected, the 30 m column with film thickness of 0.10 µm provided much better sensitivity for 
hepta- and octa-halogenated PXDDs without significant loss of chromatographic resolution for low 
halogenated congeners. Since only penta- and hexa-substituted PXBs were included in the scope of 
the study, no sensitivity problems due to the thermal degradation were obtained for these 
compounds during the GC run, thus 60 m GC column with phase loading of 0.25 µm was used with 
regard to provide better selectivity. For chromatographic separation of PBDEs, where thermal 
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degradation was of great concern during the GC-MS analysis [115,132], columns with phase 
loading of 0.10 µm were used to improve the sensitivity. 
In spite of the extensive multistep sample clean-up and fractionation, the possible presence of 
mass interferants (e.g., PBDEs and PCBs) in the final PBDD/F and PXDD/F extracts could not be 
excluded. During the analysis of PBDD/Fs, possible thermal degradation of potentially present 
PBDEs and debromination with release of two bromine atoms can be expected, resulting in the 
formation of intensive fragment peaks with the same number of bromines and molecular weight as 
the PBDF congeners [86]. To prevent the false-positive identification of PBDFs, simultaneous 
monitoring of the fragment ions of PBDEs with one and two extra bromines in comparison with 
PBDFs of interest was carried out and no signals with the retention times corresponding to the 
analytes of interest were found. Taking into account previous studies [74,133], the corresponding 
ions for PXDD/Fs and PXBs were chosen in the way to prevent the overlapping of the analyte ions 
with the main mass interferants (PBDEs and PCBs) as much as possible. In addition, higher mass 
resolution (13 500 – 15 000) was used during the analyses of PXDD/Fs and PXBs. Within the scope 
of this study [M]+ fragments for GC-MS determination of di- to hepta-BDEs were chosen, although 
for octa- to deca-BDEs [M-2Br]+ type ions were used because of the higher peak intensity in the 
mass spectrum compared to ions from [M]+ ion cluster [134]. The selected mass descriptors for 
measurement of PBDD/Fs, PBDEs, PXDD/Fs and PXBs are overviewed in Annexes 1, 2 and 3. 
Specific m/z fragments for the determination of PCDD/Fs and PCBs were selected according to the 
standard methods US EPA 1613 and US EPA 1668A [89,90]. 
 
3.2.2. LC-Orbitrap-HRMS in analysis of HBCD diastereomers 
3.2.2.1. LC separation 
Until this study there was no available literature on the analysis of BFRs or other contaminants 
using Orbitrap-HRMS based methods, thus special attention was paid on the capabilities of this 
emerging type of mass spectrometry in analysis of POPs. Since an analytical approach based on 
LC-MS for determination of HBCD was proposed [135], several studies have documented the 
chromatographic separation of HBCD diastereoisomers under reversed-phase conditions 
[106,112,113,136,137]. In this study the three HBCD diasteromers found to be baseline separated 
under the UHPLC conditions described in Section 2.5.2., using methanol, acetonitrile, and water 
gradient on C18 reversed-phase analytical column.  
 
3.2.2.2. Q Exactive Orbitrap-HRMS system 
The Q Exactive Orbitrap-HRMS used in this study consists of five main modules: ion source, 
 48 
quadrupole mass filter for precursor ion selection, intermediate storage device (C-Trap) for short 
pulse injection, collision cell for performing HCD (Higher Energy Collisional Dissociation) 
experiments and Orbitrap analyzer for Fourier transform mass analysis. After the chromatographic 
separation, sample components are introduced into the heated ionization source. The observed ions 
are transferred into the C-Trap through the quadrupole rod assembly which operates as ion 
transmission device with the possibility to filter the transmitted ions according to its m/z ratios. In 
the C-Trap, the ions are accumulated and their energy dampened using a bath gas (nitrogen). The 
ions are then injected using a lens system into the Orbitrap analyzer where mass spectra are 
acquired via image current detection. In the case of operation of the instrument in targeted-MS2 (t-
MS2) mode, before the injection into the Orbitrap analyzer ions are passed through the C-Trap into 
the HCD cell where higher energy collision induced dissociation takes place. In combination with 
the quadrupole mass filter this allows MS/MS experiments. After the ions have been fragmented in 
the HCD cell, the HCD cell voltages are ramped up and the ions are transferred back into the C-
Trap from where they are injected into the Orbitrap analyzer for detection. The principal scheme of 
the Q Exactive Orbitrap-HRMS system is shown on Figure 3.3. 
 
 
Fig. 3.3. Principal scheme of the Q Exactive Orbitrap-HRMS system 
 
3.2.2.3. Detection mode selection 
To gain the optimal MS sensitivity, infusion experiments were performed in a full scan mode 
over the m/z range of 50 – 700. The [M-H]− peaks with different bromine isotopic content were 
predominant in the MS spectra of HBCD after the pair of the ions with m/z 78.9173 and m/z 
80.9152 corresponding to [Br]  ions with different isotopic pattern. No other specific peaks were 
found to be present, which is in accordance with previous studies [135,136]. Two different targeted 
detection modes were attempted during the method development process: t-MS2 and t-SIM (analog 
−
 49 
of SIR mode) modes. Initially the t-MS2 mode was checked in order to achieve a potentially better 
selectivity of the method in comparison to t-SIM detection. This type of detection utilized the 
tandem MS option and comprised a full MS scan done by the Orbitrap analyzer with a defined 
isolation window set by the quadrupole mass filter followed by a data dependent scan with the 
fragmentation energy applied and selected mass resolution adjusted. The fragmentation of the 
precursor ions of m/z 638.6396 and m/z 640.6374 in the HCD collision cell resulted in the intensive 
formation of m/z 78.9173 and m/z 80.9152 pair corresponding to [Br]  and, these specific transitions 
were used for evaluation of the t-MS2 mode efficiency in analysis of HBCD. Contrary to t-MS2 
mode, application of the t-SIM mode did not rely on the tandem mass spectrometry option. This 
type of scanning comprised a full MS scan with an adjusted mass resolution within a defined 
isolation window, and further registration of target ions with selected m/z values. The results of 
analysis of the standard solutions using above mentioned detection modes showed a strong 
prevalence of the t-SIM mode over the t-MS2 mode in terms of sensitivity. The t-SIM method 
provided at least ten times lower LOQs for selected HBCDs in comparison to the t-MS2 method. 
The chromatograms of spiked butter fish sample (0.40 pg g-1 f.w. of each HBCD diastereoisomer) 
analyzed in the t-MS2 and t-SIM modes are shown in Figure 3.4. The decreased sensitivity of the t-
MS2 mode can be logically explained by taking into account the losses/incomplete fragmentation of 
precursor ions during the collision process in HCD cell, or different detector response factors for 
ions with different m/z. During the analysis of spiked samples no selectivity problems or 
interferences were observed under the t-SIM conditions. Taking into account the aforementioned 
results, the t-SIM mode with the registration of two specific fragments corresponding to the [M-H]  
peaks of the respective molecular ion clusters both for the native and 13C12-labeled HBCDs, and the 
adjusted mass resolution of 35 000 FWHM was considered to be the most suitable option for the 
application of high-resolution Q Exactive Orbitrap-HRMS system in analysis of these 
contaminants. 
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Fig. 3.4. The chromatograms of spiked butter fish sample (0.40 pg g-1 f.w. of each HBCD 
diastereoisomer) analyzed in the t-MS2 and t-SIM modes 
 
3.2.2.4. Ion population in the Orbitrap mass analyzer 
To provide the most accurate data in terms of spectral resolution, the ion population transferred 
into the Orbitrap mass analyser should be controlled. This can be achieved by the curved C-trap 
operated in different modes according to the trapped ion count. The insufficient ion count leads to 
the signal and spectral instability; on the contrary, if the ion count is too high, the overcharge per 
unit area results in the “space charging” effect, thus a shift in mass accuracy could be observed. The 
optimal ion count of 5 × 104 controlled by the automatic gain control (AGC target) option was 
determined on the basis of S/N ratio, peak area, peak shape, and reproducibility of the results in the 
analysis of fortified fish oil samples at background concentrations. 
 
3.2.2.5. Orbitrap-HRMS resolution 
The use of high resolution mass spectrometry involves a compromise between the selectivity 
and sensitivity. Increasing of mass resolution provides higher mass accuracy resulting in better 
selectivity of the developed MS conditions. However, because of the reduced scanning speed 
provided by the Q Exactive MS system at maximum possible mass resolution mode, selecting the 
higher possible resolution of 140 000 FWHM in combination with the processing of the data with 
appropriate scan filter option and smoothing of the raw chromatograms affects the sensitivity and 
reproducibility of the results obtained at background contamination levels compared to those 
obtained at lower mass resolution modes. On the contrary, the application of lower resolution 
modes creates higher background noise and could lead to reduced S/N ratios and false 
positive/negative results because of the degraded mass accuracy. On the basis of the results 
obtained in analysis of the spiked samples and naturally contaminated salmon samples employing 
different mass resolution modes (17 500, 35 000, 70 000 and 140 000 FWHM), a resolution of 
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35 000 FWHM was found to be optimal for the analysis of HBCD diastereoisomers as a 
compromise between selectivity, sensitivity and reproducibility of the analytical data. Figure 3.5 
illustrates the chromatograms of spiked fish oil sample obtained at different mass resolution modes. 
The raw data were processed by application of the Fourier Transform Mass Spectrometry (FTMS) 
filter option and negative ion profile signal acquired in the single stage t-SIM mode within the mass 
window of m/z 640.14 – 641.14. The raw chromatograms were treated employing Gaussian 
smoothing with the degree of 13 points. 
 
3.2.2.6. Mass extraction window 
For confirmation of the analytes of interest in the analyzed samples the exact masses of analyte 
fragments were extracted within a specific mass window after the UHPLC-MS analysis in t-SIM 
mode. On the one hand, the narrowing of the mass extraction window during the interpretation of 
the raw data resulted in increased intensity of selected peaks in comparison to the background, thus 
improving the S/N ratio for selected fragments and providing better results in terms of selectivity. 
On the other hand, the significantly narrowed mass extraction window potentially could decrease 
the sensitivity and provide false negative results. In this study the difference of 5 ppm between the 
mass window and the theoretical mass of selected fragments was used with no significant matrix 
interference at the levels around the limit of quantification (LOQ). Figure 3.6 shows the effect of 
different mass extraction windows during the processing of the raw chromatogram of salmon 
sample contaminated with β- and γ-HBCDs at background levels. 
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Fig. 3.5. The effect of using different mass resolution modes in analysis of spiked fish oil at the level corresponding to injection of 10 pg of each 
HBCD diastereoisomer on the column (t-SIM chromatograms for m/z 640.6374 (quantification ion))
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Fig. 3.6. The effect of different mass extraction windows in the processing of the raw 
chromatogram of naturally contaminated salmon sample (t-SIM chromatograms for m/z 640.6374 
(quantification ion) and m/z 638.6396 (confirmation ion)) 
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3.2.3. Orbitrap-HRMS full scan mode capabilities  
After targeted analytical method for determination of HBCD diastereoisomers was successfully 
established, the perspective of HBCD detection in a full scan mode was evaluated. The principal 
aim of these experiments was to establish the method capability for the detection of target analytes 
at the levels of interest using non-targeted full scan detection mode, with the opportunity to store 
and post-process the raw data. The retrospective post-targeted evaluation of experimental data 
offered the possibility to screen for non-targeted analytes and offered the possibility to 
simultaneously perform a screening of virtually unlimited number of compounds. The analyses of 
standard solutions, as well as spiked samples of fish oil and fish tissue were performed using both 
the t-SIM mode and a full scan mode over the m/z range of 50 – 750. The results were compared in 
terms of S/N ratio for chromatographic peaks of target compounds, by replicated analyses of the 
same samples using different detection modes. The obtained analytical data showed the possibility 
of reliable detection and confirmation of selected HBCDs in a full scan mode without degradation 
of the sensitivity. Thus, it could be concluded that considerable extension of the analyte list and 
post-targeted detection of new compounds is possible. Moreover, the possible modification of 
clean-up procedure with the exchange of destructive matrix component removal methods (e.g. 
acidic digestion) to non-destructive treatment of the sample (e.g. gel permeation chromatography) 
would provide the possibility to analyse compounds that are labile in the conditions of destructive 
sample clean-up (e.g. organophosphorus flame retardants) and persistent contaminants in one run, 
thus a more complete information on the sample contamination status could be obtained.  
 
3.2.4. Comparative evaluation of Orbitrap-HRMS versus TOF-HRMS and MS/MS in 
analysis of HBCD diastereomers 
In order to provide a more complete information regarding the analytical capabilities of the 
UHPLC-Orbitrap-HRMS additionally to optimization of the instrumental conditions, importance of 
sample clean-up stages in the detection of HBCD was evaluated. Moreover, taking into account the 
absence of comparative evaluation of the most frequently used LC-MS based HBCD detection 
techniques, a detailed information on the analytical capabilities of UHPLC-TOF-HRMS and 
UHPLC-QqQ-MS/MS systems in the analysis of this contaminant in fish samples, including the 
influence of sample clean-up steps on the response of the employed MS systems is presented. To 
compare the examined LC-MS techniques for the analysis of HBCD, the previously mentioned 
clean-up and UHPLC conditions (Sections 2.4.2.1, 2.4.2.2 and 2.5.2.1) were kept constant and three 
types of MS systems – TOF-HRMS, Orbitrap-HRMS, and QqQ-MS/MS were applied for the 
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detection of this BFR in fish. The elaborated analytical methods were robustly validated and used 
for the analysis of eel samples collected in Latvia, and these results were compared.  
One of the most important factors that can affect the performance of the LC-MS system is the 
signal suppression caused by matrix components. Several papers in the field of LC-MS are devoted 
on this effect, and it could be seen from the literature that MS systems coupled to ESI are more 
vulnerable to signal suppression in comparison to atmospheric-pressure chemical ionization (APCI) 
or atmospheric-pressure photo-ionization (APPI) techniques [138,139]. The signal suppression 
effect depends mostly on the efficiency of ionization interface of the LC-MS system and is not 
connected to the type of MS analyzer. The possible reasons of the signal suppression are: 1) the 
charge competition between the analyte and signal suppressing substances, resulting in a decreased 
conductivity of the liquid phase and reduced ionization of the analyte; 2) the reduction of the 
droplet evaporation efficiency due to the increasing surface tension and viscosity of the liquid phase 
in the presence of large amounts of signal suppressing substances; 3) the reduction of the ionization 
efficiency due to the reactions in gas phase between the analyte and signal suppressing molecules 
[138]. Due to the complexity of the food and environmental matrices, the primary concern of the 
signal suppression phenomenon in LC-MS is the severe decrease of the sensitivity of the method. 
An investigation of the importance of proposed clean-up steps was carried out by evaluation of the 
signal suppression for three LC-MS techniques. The influence of the signal suppression effect was 
estimated by adding known amounts of analytes of interest to the final sample extracts, which were 
processed using different clean-up steps (or their combinations). The influence of the sample weight 
taken for analysis was evaluated as well. The S/N ratios, which were calculated for the 
chromatographic peaks of HBCD diastereomers obtained for the investigated extracts, were 
compared to those obtained for standard solution of equivalent analyte concentrations in the mobile 
phase. The data for the analyte solution in mobile phase provide a relative 100% response (S/N) 
value, whereas the data for the same amount of compound added to processed samples show the 
effect of sample matrix on MS response and on the obtained S/N. The Figure 3.7 shows decreasing 
S/N values obtained by the investigated LC-MS techniques for each HBCD diastereomer, by 
application of different clean-up steps or their combinations and using different sample amounts for 
analysis. 
Firstly, the efficiency of destructive (acidic treatment) and non-destructive (GPC) approaches 
for removing matrix components was evaluated. Both methods and their combinations are well 
known in the sample preparation for POP analysis (particularly for HBCD [115]). Acidic treatment 
was chosen as one of the most efficient and simplest ways to remove high molecular matrix 
components (e.g., lipids) from the sample extract. However, it should be noted that such destructive 
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approach could be used only when the stability of the compounds of interest under the harsh 
conditions of acidic treatment is assured. On the contrary, GPC provides a non-destructive 
procedure for high molecular compound removal, which is based on the separation of the sample 
components according to molecular size, and this type of chromatography offers great advantages 
in the sample preparation for potentially labile compounds, particularly for non-targeted analysis 
[81]. Nevertheless, the efficiency of the separation of high molecular matrix components is usually 
not more than 95%, therefore additional clean-up steps are needed in some cases. The results of our 
study indicate that significant signal suppression effects could be observed in the analysis of HBCD 
using the examined LC-MS methods. The UHPLC-TOF-HRMS system seems to be most 
influenced by the signal suppression in comparison with UHPLC-QqQ-MS/MS and UHPLC-
Orbitrap-HRMS. Application of the one-stage clean-up protocol including only acidic treatment of 
the sample extract or GPC caused a more than 90% sensitivity drop for the UHPLC-TOF-HRMS 
system, while the analytical response of the UHPLC-QqQ-MS/MS and UHPLC-Orbitrap-HRMS 
systems was suppressed by about 50%. No significant differences between these analytical 
techniques in terms of signal suppression were obtained neither with destructive nor non-destructive 
clean-up.  
A significant improvement of S/N values was achieved by implementing an additional 
adsorption chromatography clean-up stage on a Florisil column. For UHPLC-TOF-HRMS system 
the S/N ratio for chromatographic peaks due to analytes of interest could reach up to 50% of the 
instrumental response obtained for standard solution. For the UHPLC-QqQ-MS/MS and UHPLC-
Orbitrap-HRMS systems, the application of a two-stage clean-up procedure including removal of 
high molecular substances and Florisil column chromatography could provide S/N ratios up to 80 – 
90% of the ratios obtained for standard solution. Florisil column chromatography provides better 
sensitivity of analysis because the signal suppressors originating from the matrix could be either 
fractionated or permanently adsorbed during this clean-up stage. Moreover, taking into account the 
fact that fish samples usually contain significant amounts of organobromines (e.g. PBDEs) which 
could potentially interfere with the mass spectrometric analysis of HBCD by providing similar mass 
fragments during the ionization of the sample extract, the using of Florisil column could ensure an 
additional benefit due to the ability to isolate these potential mass interferants in separate fractions. 
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Fig. 3.7. Changes of the S/N values obtained for the investigated LC-MS techniques for each HBCD 
diastereomer by application of different clean-up steps or their combinations and different sample 
amounts taken for analysis 
 
In addition to evaluating the importance of the proposed clean-up steps or their combinations, 
the influence of the sample amount taken for analysis was investigated for aliquots of 5, 10, and 15 
grams of butter fish homogenate. The observed degree of signal suppression indicates that this 
effect plays a significant role, and it was more expressed for UHPLC-TOF-HRMS and UHPLC-
Orbitrap-HRMS systems, while the UHPLC-QqQ-MS/MS system seems to be more robust in terms 
of this phenomenon (Figure 3.7).  
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3.3. Validation of the developed method 
3.3.1. Validation of GC-HRMS method for analysis of PCDD/Fs, PBDD/Fs, PXDD/Fs, 
PCBs, PXBs and PBDEs 
Since there were no specific requirements or guidelines for the validation of analytical 
procedures for determination of PBDD/Fs, PXDD/Fs, PXBs and PBDEs a validation protocol based 
on the criteria of Commission Regulation (EU) No 252/2012 which related to the criteria for 
PCDD/Fs and PCBs was used [129]. The validation study was performed in terms of recovery, 
precision and limit of quantification. The experiments were carried out at two spiking levels with 
six parallel samples and each fortification level was repeated on two different days. The precision, 
repeatability and recovery were calculated for fish oil spiked with native compounds. The detailed 
validation results are summarized in Table 3.2. For reproducibility estimation of the developed 
method within laboratory, in-house prepared reference material (freeze-dried salmon tissue) was 
used which was naturally contaminated with PCDD/Fs, PCBs and PBDEs and was fortified with 
native PBDD/Fs, PXDD/Fs and PXBs. Repeated analyses of this material were performed in 
different routine sample sequences. The results showed good consistency at selected fortification 
levels. Reproducibility for selected compounds appeared to be similar to that found for PCDD/Fs 
and PCBs in routine analyses. There were no proficiency tests or certified reference materials for 
PBDD/Fs, PXDD/Fs and PXBs, but in order to confirm the performance in persistent organic 
pollutant analysis, our laboratory successfully participated in international proficiency tests for 
determination of PCDD/Fs, PCBs, PBDEs and HBCDs in food and feed matrices organized by 
European Union Reference Laboratory for Dioxins and PCBs in Feed and Food, Freiburg, 
Germany. 
In spite of multi-stage sample preparation and fractionation, typical quantitative recoveries of 
used 13C12-labeled internal standards were in the range 60 – 110% with exception of 13C12-labeled 
octa-brominated and octa-chlorinated dibenzo-p-dioxins and furans and octa- through deca-
brominated diphenyl ethers, for which typical recoveries were in the range of 30 – 50%. The 
reagent blanks were free of PBDD/Fs and PXDD/Fs. Some insignificant concentrations of PCDD/F, 
PBDE and PCB congeners were usually found in the reagent blank extracts and the calculated 
concentrations in the samples were subjected to correction. The limits of quantification (LOQ) of 
selected POPs for the developed analytical procedure were calculated on the basis of investigated 
unspiked matrix. As it was anticipated, the sensitivity of the method decreased with higher degree 
of halogen substitution in the molecules of investigated compounds. This phenomenon was 
particularly emphasized for PBDD/Fs and, to a lesser extent, for PXDD/Fs, as expected from the 
thermal lability of highly halogenated organobromines [86,140]. The sensitivity of the elaborated 
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method for PBDD/Fs and PXDD/Fs was in the range of 0.03 – 1.6 pg g-1 fat, which was sufficient 
for determination of these contaminants in fish, while taking into account the toxicological 
properties and typical distribution of these compounds in aquatic biota.    
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Table 3.2. 
Validation results for PBDD/F, PCDD/F, PXDD/F, PXB, PCB and PBDE groups 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a – parameters differ for individual congeners depending on halogenation degree; 
b – recovery range (%) for selected contaminant group for corresponding fortification level calculated from the data obtained on two different days; 
c – intraday precision range (%) for selected contaminant group for corresponding fortification level calculated from the data obtained on two different days; 
d – interday precision range (%) for selected contaminant group for corresponding fortification level calculated from the data obtained on two different days. 
 
 
 
  
Congener group Linearity of 
measurement,  
pg 
LOQ a , 
 pg g-1 
product  
 1st spiking level 
 
2nd spiking level 
Spiking 
level a, 
 pg g-1 fat 
Recovery 
(n=2) b, % 
Intra-day 
presision, 
(n=2) c, % 
Inter-day 
presision 
(n=2) d, % 
Spiking  
level a,  
pg g-1 fat 
Recovery 
(n=2) b, % 
Intra-day 
presision, 
(n=2) c, % 
Inter-day 
presision 
(n=2) d, % 
PBDD/Fs 0.05 – 30 0.04 – 1.6  0.53 – 4.5 86 – 117 5 – 23 4 – 24  1.1 – 8.9 81 – 117 3 – 18 3 – 17 
PCDD/Fs 0.05 – 200 0.02 – 0.11  0.25 – 2.5 90 – 120 3 – 13 3 – 14  0.50 – 5.0 94 – 119 2 – 10 2 – 10 
PXDD/Fs 0.05 – 3.8 0.03 – 0.10  0.33 – 1.3 92 – 106  7 – 12  8 – 14  0.67 – 2.7  89 – 114 3 – 15  4 – 14 
PXBs 0.05 – 20 0.03 – 0.11  0.33 – 1.3 89 – 108 4 – 14 4 – 15  0.67 – 2.7 87 – 117 2 – 8 3 – 9 
DL-PCBs 0.10 – 200 0.17 – 0.34  100 94 – 115  2 – 8 4 – 9   200 93 – 114 2 – 4 3 – 5 
NDL-PCBs 1.0 – 700 0.25 – 0.65  620 – 940 81 – 120  4 – 9  6 – 9  1200 – 1900 84 – 120  6 – 9  6 – 10 
PBDEs 0.50 – 500 0.11 – 2.2  190 – 940 75 – 123  3 – 10 4 – 11  380 – 1900  79 – 120 5 – 10  6 – 10 
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3.3.2. Validation of UHPLC-Orbitrap-HRMS method for analysis of HBCDs and 
comparison of performance characteristics versus UHPLC-TOF-HRMS and 
UHPLC-QqQ-MS/MS 
Since a target-oriented approach was used for the determination of HBCD diastereomers, 
destructive acidic treatment clean-up protocol with additional purification stage on a Florisil 
column was chosen for validation exercises as the simplest and less time consuming in comparison 
with a GPC based clean-up procedure. Essential analytical characteristics such as linearity, 
accuracy (recovery), repeatability (intra-day precision), intermediate precision (inter-day precision), 
instrumental limit of quantification (i-LOQ) and method limit of quantification (m-LOQ) were 
examined in order to evaluate the analytical performance of the compared analytical procedures. 
The methods were provisionally validated using butter fish homogenate, and the performance of the 
methods was evaluated by run-to-run (n=5) and day-to-day (n=3) analyses of spiked matrix at three 
concentration levels (200, 1000, and 2000 pg g-1 f.w. of each HBCD diastereomer). The 
repeatability and intermediate precision were expressed as RSD from the results obtained during the 
recovery experiments. Table 3.3 outlines the above mentioned analytical performance parameters 
for the three applied MS systems.  
During the linearity experiments, both the matrix matched and solvent matched calibration 
experiments were performed at five calibration levels from 1.0 to 100 pg µL-1, and each calibration 
solution was analyzed in triplicate. The working range was selected by taking into account the 
typical distribution profiles (e.g., strong predominance of α-HBCD in comparison to β-and γ-
HBCDs in biota samples and predominance of the γ-HBCD for environmental objects), and the 
levels of HBCD diastereomers in the most frequently analyzed objects, as well as sample intake and 
the amount of analyte injected on-column limited by the final volume and injection volume of the 
sample extract. For the Orbitrap-HRMS and QqQ-MS/MS instruments, the equations of the 
calibration curves were fitted to a linear function and the relationship obtained by internal standard 
method was found to be rectilinear with correlation coefficients of 0.995 or greater, and residual 
values less than 15% for both matrix matched and solvent matched calibration experiments. There 
were no differences in the plots of calibration curves obtained by matrix matched and solvent 
matched linearity experiments. Contrary to the Orbitrap-HRMS and QqQ-MS/MS techniques, for 
TOF-HRMS the non-linear calibration curve was observed within the examined working range 
from 1.0 to 100 pg µL-1 for all analyzed compounds, thus a quadratic type of the curve was selected 
as an appropriate fit. There are several mentions in the literature on non-linear behavior of the TOF-
HRMS techniques, which could be attributed to analyte "saturation" effect during the charge 
competition phenomena inside the analyzer [141-143]. The Figure 3.8 shows the typical matrix 
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matched quadratic type standard curve for α-HBCD. Although the non-linear relationship for the 
TOF-HRMS technique may at first glance be considered as a disadvantage for quantitative 
determination, correlation coefficients of 0.999 or greater were obtained for the quadratic type 
calibration curves for all three HBCD diastereomers within the working range, and these were 
successfully used for quantification purposes during the validation experiments and analyses of real 
samples. Similarly to Orbitrap-HRMS and QqQ-MS/MS techniques, in the case of TOF-HRMS 
system no difference was observed between the matrix matched and solvent matched calibration 
plots. 
 
Fig. 3.8. An example of the matrix matched quadratic type standard curve for α-HBCD within the 
working range from 1.0 to 100 pg µL-1, generated by the TOF-HRMS system 
 
There was a good agreement between the studied LC-MS techniques in terms of recovery, 
repeatability, and intermediate precision. According to the obtained results, the evaluated 
instruments demonstrated similar performance in diastereoselective analysis of HBCD. All three 
applied analytical systems provided adequate recovery values at 200, 1000, and 2000 pg g-1 f.w. for 
each HBCD diastereomer, which were as follows: α-HBCD 102 – 114%, β-HBCD 99 – 116%, and 
γ-HBCD 99 – 112%. The UHPLC-QqQ-MS/MS system provided a slightly better repeatability and 
intermediate precision in comparison to the other two studied techniques. The RSD values of run-
to-run and day-to-day validation experiments were 1 – 7% and 2 – 8%, respectively. 
The i-LOQ values for the studied HBCD diastereomers were all within a similar range and 
suitable for confirmatory purposes. The S/N ratio used for the calculation of i-LOQ values was 
10:1. The calculated values for i-LOQ for the studied LC-MS techniques were expressed as analyte 
amount injected on-column and were the following: 1.1 – 4.5 pg for α-HBCD, 1.4 – 3.0 for β-
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HBCD, and 0.7 – 1.4 pg for γ-HBCD, respectively. The m-LOQ values were assessed by 
calculations taking into account the sample preparation procedure (sample weight taken for analysis 
and the final volume of the sample extract), and the signal suppression effect obtained by using 
acidic treatment procedure with additional purification on Florisil column. The m-LOQs were 
expressed as pg g-1 of sample f.w., and were in the range from 4.0 to 29 pg g-1 for α-HBCD, from 
7.0 to 13 pg g-1 for β-HBCD, and from 4.0 to 7.0 pg g-1 for γ-HBCD. 
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Table 3.3. 
Analytical characteristics of the compared LC-MS techniques for analysis of HBCD diastereomers 
 
a – average recovery (%) for a selected diastereomer at the corresponding fortification level, calculated from the data obtained on three different days; 
b – average intra-day precision (%) for a selected diastereomer at the corresponding fortification level, calculated from the data obtained on three different days; 
c – average inter-day precision (%) for a selected diastereomer at the corresponding fortification level, calculated from the data obtained on three different days. 
Compound 
Linearity of 
measurement, 
pg µL-1 
 UHPLC-QqQ-MS/MS  UHPLC-Orbitrap-HRMS  UHPLC-TOF-HRMS 
 Detection traces i-LOQ, pg 
m-LOQ, 
pg g-1 f.w.  Detection traces 
i-LOQ, 
pg 
m-LOQ, 
pg g-1 f.w.  Detection traces 
i-LOQ, 
pg 
m-LOQ, 
pg g-1 f.w. 
α-HBCD 1.0 - 100  640.6→78.9/80.9 1.3 5.0  638.6396/640.6374 1.1 4.0  638.6396/640.6374 4.5 29 
β-HBCD 1.0 - 100  640.6→78.9/80.9 2.1 9.0  638.6396/640.6374 3.0 13  638.6396/640.6374 1.4 9.0 
γ-HBCD 1.0 - 100  640.6→78.9/80.9 0.9 4.0  638.6396/640.6374 1.4 7.0  638.6396/640.6374 0.9 7.0 
1st validation level 
Compound Spiking level, pg g-1 f.w. 
 UHPLC-QqQ-MS/MS  UHPLC-Orbitrap-HRMS  UHPLC-TOF-HRMS 
 Recovery (n=3)a, % 
Intra-day 
precision, 
(n=3)b, % 
Inter-day 
precision 
(n=3)c, % 
 Recovery  (n=3)a, % 
Intra-day 
precision, 
(n=3)b, % 
Inter-day 
precision 
(n=3)c, % 
 Recovery (n=3)a, % 
Intra-day 
precision, 
(n=3)b, % 
Inter-day 
precision 
(n=3)c, % 
α-HBCD 200  109 3 4  114 4 4  104 5 5 
β-HBCD 200  103 3 4  111 7 7  102 5 5 
γ-HBCD 200  107 3 4  112 5 5  99 2 4 
2nd validation level 
Compound Spiking level, pg g-1 f.w. 
 UHPLC-QqQ-MS/MS  UHPLC-Orbitrap-HRMS  UHPLC-TOF-HRMS 
 Recovery (n=3)a, % 
Intra-day 
precision, 
(n=3)b, % 
Inter-day 
precision 
(n=3)c, % 
 Recovery (n=3)a, % 
Intra-day 
precision, 
(n=3)b, % 
Inter-day 
precision 
(n=3)c, % 
 Recovery (n=3)a, % 
Intra-day 
precision, 
(n=3)b, % 
Inter-day 
precision 
(n=3)c, % 
α-HBCD 1000  107 2 3  106 4 8  110 3 3 
β-HBCD 1000  104 6 7  105 3 5  112 3 4 
γ-HBCD 1000  103 2 2  105 2 3  106 3 3 
3rd validation level 
Compound Spiking level, pg g-1 f.w. 
 UHPLC-QqQ-MS/MS  UHPLC-Orbitrap-HRMS  UHPLC-TOF-HRMS 
 Recovery (n=3)a, % 
Intra-day 
precision, 
(n=3)b, % 
Inter-day 
precision 
(n=3)c, % 
 Recovery (n=3)a, % 
Intra-day 
precision, 
(n=3)b, % 
Inter-day 
precision 
(n=3)c, % 
 Recovery (n=3)a, % 
Intra-day 
precision, 
(n=3)b, % 
Inter-day 
precision 
(n=3)c, % 
α-HBCD 2000  104 1 3  102 3 5  105 6 6 
β-HBCD 2000  99 4 4  103 2 3  116 7 8 
γ-HBCD 2000  101 2 2  103 3 4  101 6 6 
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In order to compare the applicability of the elaborated LC-MS procedures for analysis of real 
fish samples, and to obtain the information on the actual levels of HBCD diastereomers in eels from 
Latvian lakes (Section 2.2.2), the determination of three HBCD diastereomers in eight samples was 
performed. The samples were extracted and purified according to the destructive acidic treatment 
clean-up protocol with the additional purification stage on Florisil column described in Section 
2.4.2.1. The obtained extracts were analyzed using the above mentioned LC-MS systems as rapidly 
as possible after the sample preparation to prevent the possible changes of the final extracts. As it 
could be seen from the results, good agreement was observed between the analytical data obtained 
by applying the studied LC-MS systems for the analysis of fish samples contaminated with HBCD 
at sub-ppb levels (Figure 3.9). The maximum RSD between total-HBCD concentrations obtained 
for the analyzed samples was 9%. The RSD values between the concentrations obtained for α- and 
β-HBCDs were in the range of 3 to 9% and 3 to 27%, respectively. Higher deviations were obtained 
at concentrations near the m-LOQ. Thus, for γ-HBCD, which was generally found in the samples at 
concentrations near the m-LOQ, the RSD values varied from 5% up to 60%. The total-HBCD and 
individual diastereomer concentrations obtained with each studied LC-MS technique were 
statistically compared using a Friedman non-parametric statistical test and the probability value (p-
value) was evaluated. The p-value was used to decide whether or not the null hypothesis (H0) 
according to which the results come from the same population, was true. In the case if the p-value 
for some of components was smaller than the pre-established significance level (α = 0.05), the H0 
was rejected, indicating that the alternative hypothesis could be true. No statistically significant 
differences were found for α-, β-, γ-, and total-HBCD with the p-values 0.197, 0.054, 0.065, and 
0.233, respectively, and therefore these results indicated that the studied techniques produced 
adequate and similar results on HBCD content in fish samples. However, it should be pointed out 
that the Friedman test was performed only for samples in which all analytes were detected above 
the m-LOQ, in order to obtain more realistic results. In the case of calculating p-values for 
upperbound analyte concentrations (if the analyte was not detected in the sample or detected at 
concentrations below the m-LOQ, the m-LOQ was used for calculation), γ-HBCD showed p-value 
of 0.046, thus the H0 for this component should be rejected. Nevertheless, the factor of statistical 
significance could not be estimated in such a way with high degree of confidence, because of the 
inability to provide the real analyte concentration in the sample, but giving only the most 
pessimistic approximation on the occurrence of the contaminant in the analyzed object. Moreover, 
the concentrations of β- and γ-HBCDs determined in the analyzed samples were in the range near 
the m-LOQ (especially for the γ-diasteroisomer), and this could be an additional source of increased 
dispersion of the results due to the higher measurement uncertainty at these low levels.  
 66 
 
Fig. 3.9. Comparison of the total-HBCD concentrations in eel samples obtained by applying 
different LC-MS techniques (error bars indicate measurement uncertianty of 20%) 
 
3.4. Application of the method to fish samples and evaluation of contamination status of fish 
from Baltic region 
The developed methodology was used in a study of fish samples (Section 2.2) for the 
quantitative determination of selected persistent organic pollutants. Taking into account the 
bioaccumulative properties and formation mechanisms of poorly studied PBDD/Fs, PXDD/Fs and 
PXBs, the presence of these compounds in fish tissues might be expected. Due to the lack of 
analytical standards, from the wide range of possible bromo-, and particularly mixed bromo/chloro-
substituted congeners, only selected PBDD/Fs, PXDD/Fs and PXBs were analyzed. For the 17 
PCDD/Fs and 12 DL-PCBs, which had TEFs2005 set by the WHO, the rounded result of each 
congener was multiplied by the corresponding TEF [6], and TEQs were calculated by summarizing 
the obtained values for selected POP groups. For comparative purposes for eel samples TEQ values 
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have not been established for PBDD/Fs and PXDD/Fs, for tentative estimation of the possible 
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Baltic wild salmon. Length, weight, lipid content and place of sampling where the corresponding 
specimen was collected are also included. For salmon samples age and sex additionally reported. 
 
3.4.1. Levels and congener profiles of POPs in Baltic wild salmon samples 
PCDD/Fs and PCBs. The data showed an extremely high level of Baltic wild salmon 
contamination with PCDD/Fs and DL-PCBs, and this information is in good agreement with 
previous studies on Baltic wild salmon [144,145]. The congener profile typical of Baltic Sea fish 
was observed for all samples, and the major contributors to the total-WHO2005-TEQ were tetra-, and 
penta-chlorinated DD/Fs and PCBs 118, 126 and 156. For most of the analyzed salmon samples, 
MLs established by European Commission [146] for PCDD/Fs and DL-PCBs were exceeded. The 
analyzed samples showed PCDD/F concentrations in the range of 2.1 – 6.1 pg WHO2005-PCDD/F-
TEQ g-1 f.w., with an average of 3.8 pg WHO2005-PCDD/F-TEQ g-1 f.w., and DL-PCBs were found 
in the concentration range of 2.4 – 8.5 pg WHO2005-PCB-TEQ g-1 f.w.  Only for six samples out of 
the twenty five analyzed the ML of 6.5 pg total-WHO2005-TEQ g-1 f.w. was not exceeded. The 
results are in agreement with the fact that salmon is the largest fish in the Baltic Sea, at the top of 
food chain, and tend to accumulate high levels of chlorinated POPs.  
The NDL-PCBs represented in the samples had a wide range of concentrations, depending on 
the congener. The total sum of NDL-PCB concentrations was within the range of 26 – 65 ng g-1 
f.w., with an average of 46 ng g-1 f.w. The congener pattern of NDL-PCBs in the samples consisted 
mainly of penta-, hexa-, and hepta-chlorinated biphenyls and was in good agreement with previous 
studies of the Baltic fish [130,147]. Out of the analyzed PCBs, the group of so called indicator 
PCBs (namely PCBs: 28, 52, 101, 138, 153 and 180) represented about 80% of total PCB 
concentration, with the main contributors PCB 153 and PCB 138. Other significant congeners were 
PCB 99 and PCB 110, which constituted about 13% of the total measured PCB concentration.  
In 2011, the maximum level of 75 ng g-1 f.w. for ∑ind.PCB in fish was included in Commission 
Regulation (EU) No 1259/2011 [146]. Analyzed salmon samples show the levels for this parameter 
in the range of 20 – 51 ng g-1 f.w. with an average of 37 ng g-1 f.w. According to the obtained 
results, none of the analyzed salmon samples exceeded the ML. These levels are in line with a 
recent study [145], in which 2-year salmon samples collected in the open Baltic Sea showed the 
∑ind.PCB in the range of 39 – 55 ng g-1 f.w., while the ∑ind.PCB concentration in salmon from the Gulf 
of Finland and Bothnian Sea was up to 2 times higher. 
PBDD/Fs and PXDD/Fs. Deatiled information on the occurence of PBDD/Fs and PXDD/Fs in 
analyzed salmon samples is represented in Annex 5. The analyzed salmon samples contained a 
wide range of detectable PBDD/F congeners with the domination of PBDFs, which was in 
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accordance with the formation mechanisms of these compounds and reflected the typical 
composition of these contaminants in industrial emissions [47], food [57,58,74] and environmental 
matrices [148,149]. Three congeners (1,2,3,7,8-PentaBDF, 1,2,3,7,8-PentaBDD and OctaBDD) 
were not detected above the LOQ in any of samples. The most abundant congeners 2,3,7,8-
TetraBDF, 1,2,3,4,6,7,8-HeptaBDF and OctaBDF were detected in the range of 0.16 – 0.92 pg g-1 
f.w., on average 0.41 pg g-1 f.w.; 0.27 – 1.4 pg g-1 f.w., average 0.76 pg g-1 f.w. and 0.32 – 2.1 pg g-
1 f.w., average 0.88 pg g-1 f.w., respectively. In most cases, the concentrations of PBDDs were 
below the LOQ, with the exception of 1,2,3,4,6,7,8-HeptaBDD, which was found in all samples. 
Potentially the most significant from toxicological point of view was 2,3,7,8-TetraBDD, which was 
detected above the LOQ in four of twenty five samples in the concentration range from 0.002 to 
0.01 pg g-1 f.w., with an average of 0.01 pg g-1 f.w. Only one HexaBDF congener (1,2,3,4,7,8-
HexaBDF) was analyzed in this study, and it was present in all samples in the range from 0.03 and 
0.13 pg g-1 f.w., with an average value of 0.08 pg g-1 f.w. Chromatographically unseparated 
1,2,3,4,7,8/1,2,3,6,7,8-HexaBDD congeners and 1,2,3,7,8,9-HexaBDD were each detected in four 
samples with average concentrations of 0.01 pg g-1.  
Due to the fact that very few references are available regarding PBDD/F content in biota, the 
systematization and evaluation of these data is problematic. Available references emphasized 
mainly the low brominated components (e.g. di-, through hexa-brominated congeners). Generally 
PBDD/Fs are far less represented in environmental samples and food products compared to their 
chlorinated analogs, and at the moment there are no established MLs for these contaminants. For 
tentative estimation of the possible toxicity risks of salmon tissue caused by presence of PBDD/Fs, 
TEQs were calculated as described above. Taking into account the TEFs2005 [6], the analyzed 
salmon samples show PBDD/F-TEQ (UB) concentrations in the range of 0.04 – 0.14 pg g-1 f.w., 
with an average of 0.07 pg g-1 f.w. On the basis of the obtained results, it could be concluded that 
the presence of PBDD/Fs in the analyzed salmon samples is less pronounced than the chlorinated 
analogs, and therefore the PBDD/F-TEQ values are considerably lower compared to those found for 
PCDD/F-TEQs. The approximate calculations on the upper bound basis indicate that for the 
analyzed salmon PBDD/F-TEQ could contribute to the total PCDD/F-PBDD/F-TEQ in the range 
from 1% to 4%, with an average of 2%. Although the average contribution of PBDD/Fs to the 
aggregated POP contamination background of Baltic wild salmon is of secondary importance, 
calculation of individual congener concentrations and PBDD/F-TEQ values on lipid weight basis in 
some cases shows dramatically high levels of these contaminants. Some analyzed salmon samples 
reached contamination up to 4.8 pg PBDD/F-TEQ g-1 l.w., what might be a source of concern due 
to the tendency of such POPs to bioaccumulate and migrate through food chains. 
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The profile of thirteen 2,3,7,8-substituted PBDD/F congeners analyzed in tissue of Baltic wild 
salmon and the contribution of each congener to PBDD/F-TEQ is shown in Figure 3.10. The 
OctaBDF was the predominant congener, followed by 1,2,3,4,6,7,8-HeptaBDF and 2,3,7,8-
TetraBDF (Figure 3.10 A). These congeners constitute more than 90% of the total sum of detected 
2,3,7,8-substituted PBDD/F concentrations. Although the impact of the 2,3,7,8-TetraBDF (TEF 0.1) 
on the total sum of concentrations was only about 20%, due to its high toxicological significance 
compared to other contributors (TEF 0.001 – 0.0001) present in the samples at elevated 
concentrations, influence of this congener on the PBDD/F-TEQ reached up to 55% (Figure 3.10 B).  
The total contribution of 1,2,3,4,6,7,8-HeptaBDF and OctaBDF to the PBDD/DF-TEQ was about 
20%. Several studies show the intensive formation of PBDFs, especially of highly brominated 
dibenzofurans, during the incineration and recycling of electronic waste [149,150]. High levels of 
1,2,3,4,6,7,8-HeptaBDF and OctaBDF were reported as impurities in commercial PBDE mixtures 
as well [151]. According to the obtained results, the presence of bioaccumulated PBDFs in large 
aquatic top predators such as salmon indicates anthropogenic sources, although the metabolic 
persistence of such contaminants is under question. 
Out of the nine analyzed PXDD/F congeners, only one compound (3-B-2,7,8-TriCDF) was 
present in quantifiable concentrations. It was found in all samples in the concentration range of 0.02 
– 0.08 pg g-1 f.w., with an average of 0.04 pg g-1 f.w. Some of the analyzed samples showed the 
presence of potentially much more toxicologically significant 2-B-3,7,8-TriCDD and 2,3-DiB-7,8-
DiCDD, but in all cases the concentrations were not quantifiable, although were above the LOD. 
Mixed bromo/chloro-substituted dibenzo-p-dioxins and furans are usually minor impurities formed 
during the unintentional formation of polyhalogenated dibenzo-p-dioxins and furans, and the 
obtained data are in line with the formation pattern and data on distribution of PXDD/Fs in the 
environment [152,153]. 
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Fig. 3.10. Congener profiles (A) of PBDD/Fs in Baltic wild salmon and contributions (B) of individual 
components to the PBDD/F-TEQ (UB) 
0.0 
0.1 
0.2 
0.3 
0.4 
0.5 
0.6 
0.7 
0.8 
0.9 
1.0 
C
on
ce
nt
ra
tio
n 
(U
B
), 
pg
/g
 f.
w
. 
Congener 
A                               Profile of individual PBDD/F congeners (UB) 
  
0.0 
10.0 
20.0 
30.0 
40.0 
50.0 
60.0 
C
on
tri
bu
tio
n,
 %
 
Congener 
B       Contribution of individual congeners to the PBDD/F-TEQ (UB) 
 71 
PBDEs. The total concentrations of twenty seven PBDE congeners in the analyzed salmon 
samples were in the range of 1.3 – 5.6 ng g-1 f.w., with an average of 3.3 ng g-1 f.w. (Annex 7). 
Tetra- through hexa-, and deca-brominated homologues were the predominant congeners 
contributing about 85% of the total PBDE load with the following order of contribution to the total 
sum of PBDEs: PBDE 47 > PBDE 49 > PBDE 100 > PBDE 99 > PBDE 154 > PBDE 209. The 
main contributor PBDE 47 was presented in the range of 0.47 – 2.1 ng g-1 f.w, with an average of 
1.2 ng g-1 f.w. The levels of PBDEs in this study were comparable to those found for wild salmon 
from other references [131,154]. Generally, due to the strong contamination of the Baltic region 
with POPs, Baltic wild salmon shows higher levels of bioaccumulated PBDEs than salmon from 
other regions [155,156]. The obtained congener profile and distribution is typical for aquatic biota 
from the Baltic region found in other references [130,131] and is shown in Figure 3.11. Correlation 
of the total sum of PBDEs with concentrations of tetra-, and penta-brominated congeners 
(correlation of PBDE 47 with total PBDE sum up to R2 = 0.98) reflects the source of contamination 
from widely used commercial “penta-BDE” mixture (Figure 3.11), in which PBDE 47, 49, 99 and 
100 congeners are predominant [157]. Despite the widespread use of “octa-BDE” mixture 
containing mainly octa- and nona-brominated congeners, as well as the “deca-BDE” mixture 
containing mainly PBDE 209, contribution of those congeners to the sum of PBDEs was only about 
6%, and there was no correlation between concentrations of octa-, nona-, and deca-brominated 
congeners with the total PBDE concentration. The explanation for such PBDE distribution in 
salmon was found in the different aquatic bioaccumulation and biotransformation potential of 
congeners with different extent of bromination. Highly brominated PBDEs are characterized by low 
uptake potential and are more susceptible to metabolic transformation, compared to congeners with 
low degree of bromine substitution [157,158]. There are reports on the short half-life times of 
highly brominated congeners in humans and biotransformation to lower brominated congeners in 
fish [159,160]. Species-selective bioaccumulation and biotransformation, probably via 
debromination of different PBDE congeners, was revealed for some types of fish and shellfish 
[58,161,162], and should be taken into account during the estimation of PBDE bioaccumulation and 
biotransportation in living organisms.  
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Fig. 3.11. Congener profile of PBDEs in Baltic wild salmon and potential sources of contamination 
 
HBCDs. Twenty-five salmon samples were analyzed on the content of HBCD. The total-HBCD 
concentrations within the samples ranged from 390 to 3800 pg g-1 f.w, with an average of 1600 pg 
g-1 f.w. The biological parameters of the analyzed fishes, concentrations of individual HBCD 
diastereoisomers and the total HBCD for all analyzed samples are summarized in Annex 4. The 
concentrations determined in this study were of similar magnitude to those detected in fish from 
Baltic Sea in other studies [163-166]. The diastereomer pattern typical for aquatic biota was 
observed in all samples with strongly pronounced domination of α-HBCD over β- and γ-HBCDs 
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which domination of γ-HBCD was usually observed due to the straight accumulation from the crude 
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shown). Unfortunately the data on the correlation between the α-, β- and γ-HBCDs in selected fish 
species are not provided in the available literature, although some studies indicate the absence of 
correlation between these diastereoisomers in the eggs of predatory sea birds [169,170]. Such 
behavior could be provided by the differences in long range transport properties of selected 
contaminants in the sequence: contamination source  – feeding area – target species. 
 
 
Fig. 3.12. Correlations between α- and γ-HBCDs in the tissue of Baltic wild salmon 
 
3.4.2. Levels and congener profiles of POPs in eel samples from Latvian lakes 
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European Commission [146] for eel tissue. When TEFs1998 were used, PCDD/F-TEQs values 
ranging from 0.35 to 3.5 pg WHO1998-PCDD/F-TEQ f.w. (average 1.4 pg WHO1998-PCDD/F-TEQ 
f.w.) were obtained, with an increase of the PCDD/Fs-TEQ concentration value by about 18% on 
average, which is in line with previous reports [172]. In general, levels of the PCDD/F 
contamination obtained in our study were comparable or somewhat lower to those reported in the 
majority of studies for eels collected from other European sites. For example, levels in the range 
from 0.20 to 9.8 pg WHO1998-PCDD/F-TEQ g-1 f.w. were found in eels from Flanders [175]; eels 
from Irish waters showed contamination in the range of 0.20 – 4.4 pg WHO1998-PCDD/F-TEQ g-1 
f.w. [176] and 0.40 – 5.9 pg WHO1998-PCDD/F-TEQ g-1 f.w. were measured in eels from the 
Western Baltic Sea [147]. Higher concentrations of 0.48 – 22 pg and 5.0 – 23 pg WHO1998-
PCDD/F-TEQ g-1 f.w. were obtained for eels originating from the river Elbe and its tributaries, and 
from Greenland fjords, respectively [174,177]. Lower contamination with PCDD/Fs in the range 
0.29 – 1.9 pg WHO1998-PCDD/F-TEQ g-1 f.w. was observed for eels collected from Polish lagoons 
[173].  
The DL-PCB concentrations ranged from 0.56 to 13 pg WHO2005-PCB-TEQ f.w. with an 
average value of 3.5 pg WHO2005-PCB-TEQ g-1 f.w.  For some samples analyzed within the current 
study, application of TEFs1998 resulted in a large increase (up to 250%) of the recalculated PCB-
TEQs. An average increase of WHO-PCB-TEQ concentrations of 48% was observed, with the 
corresponding concentrations ranging from 0.71 to 27 pg WHO1998-PCB-TEQ g-1 f.w. (average 
value of 5.2 pg WHO1998-PCB-TEQ g-1 f.w.). The current observed levels of the DL-PCB 
contamination in Latvian eels represent the intermediate position in comparison to other European 
sites. Noticeably lower DL-PCB contamination was obtained for eels in Spain (0.09 pg WHO1998-
PCB-TEQ g-1 f.w. [178]; Greenland fjords (1.4 – 3.9 pg WHO1998-PCB-TEQ g-1 f.w. [177]; and 
Ireland (0.17 – 1.2 pg WHO1998-PCB-TEQ g-1 f.w. [176]. Somewhat similar DL-PCB levels were 
observed in eels originating from Poland (1.6 – 7.1 pg WHO1998-PCB-TEQ g-1 f.w. [173]; Western 
Baltic Sea (0.93 – 15 pg WHO1998-PCB-TEQ g-1 f.w. [147]; and France (0.24 – 14 pg WHO1998-
PCB-TEQ g-1 f.w. [172]. Considerably higher WHO1998-PCB-TEQ concentrations were measured 
in eels originating from Germany (8.5 – 47 pg g-1) [174]; and Belgium (up to 140 pg g-1) [171].  
Total-WHO2005-TEQ values for analyzed samples varied between 0.85 and 16 pg g-1 f.w., with 
an average value of 4.7 pg g-1 f.w. Five of the analyzed eels (9% of all samples) exceeded the 
current European Commission ML of 10 pg total-WHO2005-TEQ g-1 f.w. [146] for muscle of eels. 
The average total-WHO2005-TEQ value for the samples exceeding the ML was 13 pg g-1 f.w., which 
exceeds the ML by 25%.  
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 Overall, DL-PCB TEQ was much higher in comparison with PCDD/Fs. The contribution of 
individual PCDD/Fs and DL-PCBs to the WHO2005-PCDD/F-TEQ, WHO2005-PCB-TEQ and total-
WHO2005-TEQ values for the investigated lakes are shown in Figure 3.13.  
The total sum of NDL-PCB concentrations in the eel samples ranged from 6.4 to 320 ng g-1 f.w., 
with an average of 51 ng g-1 f.w. (Annex 10). The congener pattern of NDL-PCBs was in good 
agreement with previous studies for Baltic fish [147,130] and for European eels in other studies 
[179-181]. The distribution showed a congener profile typical of widely used PCB mixtures (e.g. 
Aroclor 1254 and 1260) dominated by penta-, hexa- and hepta-chlorinated congeners. The indicator 
PCBs (∑ind.PCB (namely PCBs: 28, 52, 101, 138, 153 and 180)) represented about 70% of total 
NDL-PCB concentration with values in the range of 4.8 – 190 ng g-1 f.w., with an average of 36 ng 
g-1 f.w. The ML for ∑ind.PCB in eel tissue of 300 ng g-1 f.w.  specified in Commission Regulation 
(EU) No 1259/2011 [146] was not exceeded in any of the samples. The obtained results are 
consistent with previous studies where large variations of ∑ind.PCB in European eel samples were 
observed: 1.7 – 290 and 3.4 – 530 ng g-1 f.w. (PCB 118 was included with the indicator PCBs) in 
Polish studies [173]; 69 – 250 ng g-1 f.w. in France [172]; 1.9 – 18 ng g-1 f.w. in Ireland [176]; 16 – 
1500 ng g-1 f.w. in Netherlands [182].  
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Fig. 3.13. Contribution of individual PCDD/Fs and DL-PCBs to the total-WHO2005-TEQ (A), 
WHO2005-PCB-TEQ (B) and WHO2005-PCDD/F-TEQ (C) values among the investigated lakes 
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PBDD/Fs, PXDD/Fs and PXBs. One of the focuses in this study was to investigate the 
possible occurrence of the less studied POPs such as PBDD/Fs, PXDD/Fs and PXBs, in eel tissue. 
To the best of our knowledge this is the first attempt to characterize the contamination status of 
Latvian freshwater fish with these ecotoxicants. Taking into account the high fat content and typical 
diet of eels (e.g. scavenger fish) they are suspected to contain elevated levels of POPs in 
comparison to other fish species, thus detectable amounts of PBDD/Fs, PXDD/Fs and PXBs could 
be expected in tissue of analyzed specimens. The detailed information on the content of PBDD/Fs, 
PXBs and PXDD/Fs in analyzed eel samples is summarized in Annex 9. 
The analyzed samples showed a wide range of detectable PBDD/F congeners with the 
domination of PBDFs, which was in accordance with the formation mechanisms of these 
compounds and reflects the typical composition of these contaminants in industrial emissions (47), 
food [57,58,183] and environmental matrices [148,149]. All of the PBDD/Fs included in the scope 
of the study were detected, however, in most cases the concentrations of PBDDs were below the 
LOQ. 2,3,7,8-TetraBDD and 1,2,3,7,8-PentaBDD were detected in three and one, respectively of 
fifty eight samples, showing   maximum concentrations of 0.09 and 0.05 pg g-1 f.w. The most 
abundant congeners bwere 2,3,7,8-TetraBDF (detected in 52% of samples) and 1,2,3,4,6,7,8-
HeptaBDF (detected in 100% of samples) and were observed in concentration ranges of 0.02 – 0.25 
pg g-1 f.w. and 0.03 – 1.1 pg g-1 f.w., respectively. Highly brominated dibenzofurans were found to 
be the most abundant PBDD/F congeners in stack flue gases [150], and this anthropogenic emission 
may account for the universal occurrence of these congeners in our eel samples. Only one 
HexaBDF congener (1,2,3,4,7,8-HexaBDF) was analyzed in this study, and it was present in 19% 
of analyzed eels in the range from 0.04 to 0.20 pg g-1 f.w., with an average value of 0.11 pg g-1 f.w., 
while penta-brominated dibenzofurans, namely 1,2,3,7,8-PentaBDF and 2,3,4,7,8-PentaBDF, were 
present in 14% and 16% of samples, with maximum concentrations of 0.06 and 0.04 pg g-1 f.w., 
respectively.  
Out of nine analyzed PXDD/Fs only three congeners (3-B-2,7,8-TriCDF, 1-B-2,3,7,8-
TetraCDF and 2-B-3,6,7,8,9-PentaCDD) showed quantifiable concentrations, 3-B-2,7,8-TriCDF 
being  the predominant congener presented in seven of fifty eight samples at maximum 
concentration of 0.04 pg g-1 f.w., whereas 1-B-2,3,7,8-TetraClDF and 2-B-3,6,7,8,9-PentaClDD 
were presented in one and five samples, respectively. Generally, detected PXDD/F congeners 
showed concentrations slightly above the LOQ and in accordance with the formation patterns from 
combustion/incineration sources and data on distribution of PXDD/Fs in the environment 
[152,153,184].  
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Among the above mentioned micro contaminants, three PXBs with the arrangement of halogen 
atoms corresponding to the non-ortho substitution pattern (4'-B-3,3',4,5-TetraCB (mono-bromo 
PXB 126), 3,4-DiB-3',4',5'-TriCB (di-bromo PXB 126) and 3',4',5-TriB-3,4-DiCB (tri-bromo PXB 
126)) and three PXBs with mono-ortho configuration (4'-B-2,3,3',4-TetraCB (mono-bromo PXBs 
105), 4'-B-2,3',4,5-TetraCB (mono-bromo PXB 118) and 4'-B-2,3,3',4,5-PentaCB (mono-bromo 
PXB 156)) were   analyzed  in twenty six of fifty eight samples (in 45% of all eel samples). The 
selection of the analytes of interest was based on the availability of reliable analytical standards and 
typical distribution and toxicity of corresponding PCB congeners (e.g. typical predominance of 
absolute concentrations of PCBs 118, 105 and 156 in fish samples and the highest toxicity of PCB 
126 within the DL-PCB group). The most prominent congeners among the analyzed PXBs were 
mono-ortho PXB 118 and PXB 105 found in every analyzed sample in the ranges of 0.07 – 3.18 pg 
g-1 f.w. and 0.03 – 0.77 pg g-1 f.w., respectively  followed by the mono-ortho substituted  PXB 156 
which was present in 58% of samples and showed concentrations from 0.04 to 0.30 pg g-1 f.w. A 
similar congener pattern following the order PXB 118 > PXB 105 > PXB 156 was observed in 
freshwater fish in a European study of foods in the UK showing the concentrations for the latter 
congeners of 3.4, 1.3 and 0.28 pg g-1 f.w., respectively [74]. Out of the three investigated non-ortho 
PXBs, only mono-brominated PXB 126 congener occurred in eels examined, while di-brominated 
and tri-brominated PXBs 126 were absent in all of the investigated samples. Mono-bromo PXB 126 
was presented in 92% of samples in the concentration range of 0.01 to 0.05 pg g-1 f.w. which is 
consistent with results for freshwater fish from the UK where the latter component was observed at 
the level of 0.07 pg g-1 f.w. [74]. Despite the fact that usually congeners containing a single 
substituted bromine atom (mono-bromo congeners) are presented in food and biota samples [184], a 
Japanese study showed unexpectedly high concentrations of tri-brominated 3',4',5-TriB-3,4-DiCB 
(tri-bromo PXB 126) (up to 10 pg g-1 f.w.) in fish samples with unclear source of contamination 
[73].  
Despite the extensive clean-up and fractionation procedures used for selective isolation of 
compounds of interest, it was not possible to identify some high intensity peaks that occurred on the 
SIR chromatograms of relevant m/z traces corresponding to the analyzed brominated or mixed 
bromo/chloro-substituted contaminants for which quality control criteria for positive identification 
(isotope ratio window ±15%) were fulfilled. This observation could reflect on the presence of 
potentially significant concentrations of unknown PBDD/Fs, PXBs and PXDD/Fs with different 
substitution patterns than those congeners included in this study.  Figure 3.14 shows an example of 
an intensive peak of the unknown compound on the representative SIR chromatogram of eel sample 
for the m/z traces corresponding to TBDD congeners. 
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Fig. 3.14. Representative SIR chromatogram of eel sample for the m/z traces corresponding to 
TBDD congeners (it should be noted however, in this example, that the peak may correspond to a non-
2,3,7,8-substituted PBDD, of undefined toxicity) 
 
Currently there are very few data available on the PBDD/Fs, PXBs and PXDD/Fs content in 
aquatic biota; nevertheless these isolated references show that brominated and mixed 
brominated/chlorinated congeners occur to a lower extent in samples, in comparison to their 
chlorinated analogs. In the absence of established TEFs for PBDD/Fs, PXBs and PXDD/Fs, values 
for chlorinated analogues (WHO2005-TEFs) have been used as suggested for PBDD/Fs [67], and 
although some REP values have been reported for PXDD/F and PXB compounds, they do not cover 
the higher mixed halogenated compounds measured in this work, so chlorinated analogue TEFs 
have also been used for these compounds. Thus the calculated TEQs obtained, provide only for a 
rough estimate of the potential toxicity presented by these contaminants.  Using this approach, 
analyzed samples showed PBDD/F-TEQ (UB) concentrations in the range of 0.02 – 0.14 pg g-1 
f.w., with an average of 0.05 pg g-1 f.w. Tentative TEQ values obtained for selected PXBs and 
PXDD/Fs were on average of 0.01 and 0.08 pg g-1 f.w., respectively.  A comparison of the TEQ 
values shows that the brominated and mixed halogenated TEQ values are considerably lower 
compared to those obtained for PCDD/Fs and DL-PCBs. This estimation on the UB basis, indicates 
that these minor contaminants could contribute from 3% to 5%, to the total-WHO2005-TEQ value 
with an average of 3%. With respect to TEQ levels provided by the presence of PCDD/Fs and DL-
PCBs and taking into account the established ML levels for these groups of compounds, generally 
the contribution of PBDD/Fs is small, but nevertheless these data are of great importance in terms 
of providing of more complete information on the contamination status of the examined objects. 
The complete contribution of PXDD/F and PXB TEQ is currently unquantifiable, as unlike the 
PCDD/Fs and PCBs, it is not possible to quantify all toxicologically significant congeners at the 
present. Thus, as observed elsewhere [66] the current data form only a limited part of the total 
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potential toxicity from PXDD/Fs and PXBs. Nonetheless, the detection of these contaminants in 
inland lakes is an important complement to the observations made on occurrence of PXDDs in 
marine creatures [185] from the Baltic Sea. 
PBDEs. Taking into account the recent EU recommendation on the monitoring of BFRs in 
food products [186], data on the occurrence of PBDEs in Latvian eels are of great relevance. The 
total concentrations of ∑PBDE (Annex 11) ranged from 0.28 to 27 ng g-1 f.w., with an average of 4.2 
ng g-1 f.w. The obtained congener pattern with domination of tetra-, and penta-brominated BDEs is 
typical for aquatic biota from the Baltic region found in other studies [130,131] and for eels from 
other European countries [187]. PBDEs 47, 49 and 100 were the dominant congeners and 
contributed 79% on average to ∑PBDE. Correlation of the ∑PBDE with concentrations of tetra-, and 
penta-brominated congeners (correlation of PBDE 47 with total PBDE sum was R2 = 0.97 on 
average) most likely reflects the source of contamination as the widely used and recently banned 
commercial “penta-BDE” formulation (in which the latter congeners are predominant [26]. The 
more highly brominated PBDEs (e.g. octa-, nona-, and deca-brominated BDEs) were present in 
significantly lower concentrations. Despite the widespread usage of “octa-BDE” formulation 
(consisting mainly of octa- and nona-brominated congeners) and “deca-BDE” formulation (the 
main component is PBDE 209), the average contribution of these PBDE congeners to the ∑PBDE 
was less than 2% and was in accordance with the fact that highly brominated congeners are 
characterized by the low uptake potential by aquatic biota and are more susceptible to metabolic 
transformation, compared to congeners with low degree of bromine substitution [157,158,160]. A 
similar distribution for highly brominated congeners was observed in other studies for different fish 
species and particularly for eels [162,188]. Generally, comparable levels of PBDEs were obtained 
in our study in context of overall European occurrence for this type of recently used BFRs 
[176,187]. Nevertheless, some studies showed extremely high contamination levels in industrialized 
areas, for example in the Belgian study, levels of PBDEs collected in 2006, in highly contaminated 
areas near textile factories, were up to 790 ng g-1 f.w. [189]. 
HBCDs. Taking into account the diet of eels ("scavenger" fish) and the typically high fat 
content, elevated contamination levels of POPs are often encountered in such species 
[164,174,180]. Bioaccumulation of HBCD was confirmed in all analyzed eel samples. The total-
HBCD concentrations within the samples ranged from 210 to 600 pg g-1 f.w, with an average of 300 
pg g-1 f.w. The biological parameters of the analyzed fishes, concentrations of individual HBCD 
diastereomers, and the total-HBCD for all analyzed samples are outlined in Annex 8. As for 
salmons, the diastereomer pattern typical for aquatic biota was observed in all samples with the 
strongly pronounced domination of α-HBCD over β- and γ-HBCDs (up to 95% of the total-HBCD) 
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[163]. Generally, the concentrations determined in this study were significantly lower in 
comparison to those detected in eel samples analyzed in the majority of earlier studies 
[164,180,190]. Some studies indicate strong difference between the HBCD concentrations obtained 
for eel samples collected from nearby areas. For example, the HBCD concentration in samples 
collected in the highly polluted south-west region in Netherlands was up to magnitude higher in 
comparison with the samples collected in relatively remote areas or upstream of the production 
regions for which total levels of HBCD between 100 and 1000 pg g-1 were observed [112]. The 
relatively low HBCD contamination levels detected in eel samples collected in Latvia seem to be 
logical, since there are no BFR production factories or plastics processing facilities, which could 
cause an intensive emission of HBCD into the environment. 
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CONCLUSIONS 
1. The developed analytical method presented in this study capable of the simultaneous 
determination of seven groups of priority POPs including PBDD/Fs, PCDD/Fs, PXDD/Fs, 
PBDEs, PCBs, PXBs, and HBCDs by applying a multistage clean-up and fractionation 
procedure and detection with GC-HRMS and UHPLC-Orbitrap-HRMS ensures a reliable 
detection of these contaminants at toxicologically significant levels. 
2. We propose an extensive fractionation procedure involving a series of column chromatography 
steps with Florisil, dual layered activated carbon, and basic alumina, which provides more 
complete removal of non-planar interferants such as PBDEs and PCBs from the fractions 
containing PBDD/Fs and PXDD/Fs, thus significantly increasing the selectivity of the method 
for these compounds and resulting in a better recovery rates for planar compounds. 
3. For the first time, a new rapid and reliable UHPLC-Orbitrap-HRMS based methodology was 
developed for the determination of HBCD diastereoisomers in fish matrices. This method 
provides a fast chromatographic separation, good selectivity, pg g−1 quantification levels, a wide 
range of linearity and acceptable precision, and it could be used as an effective tool to obtain 
detailed information on the HBCD diastereomer content in fish samples. 
4. A comparative evaluation of the analytical performance of UHPLC-Orbitrap-HRMS technique 
versus UHPLC-TOF-HRMS and conventional UHPLC-QqQ-MS/MS systems revealed a good 
agreement between the studied approaches in terms of recovery, repeatability, and intermediate 
precision. No statistically significant differences were found for α-, β-, γ-, and total-HBCD 
concentrations obtained in the analysis of real samples with the examined LC-MS systems 
indicating that the newly proposed Orbitrap-HRMS technique produces adequate and similar 
results on HBCD content in fish samples, compared to conventional approaches. 
5. Most of the analyzed Baltic wild salmon samples (75% of all samples) are highly contaminated 
with POPs above the MLs according to Commission Regulation No. (EC) 1259/2011 for 
PCDD/DFs and DL-PCBs, while freshwater fish, particularly eels, which due to its diet are 
proposed as a bioindicator for the environmental pollution, are far less contaminated with POPs, 
exceeding the MLs for PCDD/Fs and DL-PCBs in 9% of the analyzed samples. 
6. The distribution of PBDE congeners in fish samples with dominance of PBDE 47, 49, 99, and 
100 clearly reflects the bioaccumulation of these compounds from the recent usage of 
commercial PBDE mixtures. 
7. For the first time, the universal presence of a number of PBDD/F, PXDD/F, and PXB congeners 
was confirmed in almost all fish samples obtained from the Baltic Sea and Latvian lakes. 
Although the DL-toxicity arising from the latter POP groups is low (1 – 5%) compared to the 
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chlorinated analogs, these data are of great importance in terms of providing of more complete 
information on the contamination status of the examined objects. 
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ANNEXES 
Annex 1 
Mass descriptors used for measurement of PBDEs using GC-HRMS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PBDEs Unlabeled 
congener m/z 
Ion Isotope ratio 13C12 – labeled 
congener m/z 
Ion Isotope ratio 
Di-BDE 
325.8942 M+ 
0.51 
337.9344 M+ 
0.51 
327.8921 [M+2]+ 339.9324 [M+2]+ 
Tri-BDE 
405.8027 [M+2]+ 
1.03 
417.8429 [M+2]+ 
1.03 
407.8002 [M+4]+ 419.8409 [M+4]+ 
Tetra-BDE 
483.7132 [M+2]+ 
0.70 
497.7514 [M+4]+ 
1.54 
485.7111 [M+4]+ 499.7493 [M+6]+ 
Penta-BDE 
563.6216 [M+4]+ 
1.03 
575.6619 [M+4]+ 
1.03 
565.6196 [M+6]+ 577.6598 [M+6]+ 
Hexa-BDE 
641.5322 [M+4]+ 
0.77 
655.5704 [M+6]+ 
1.37 
643.5302 [M+6]+ 657.5683 [M+8]+ 
Hepta-BDE 
721.4406 [M+6]+ 
1.03 
733.4809 [M+6]+ 
1.03 
723.4386 [M+8]+ 735.4788 [M+8]+ 
Octa-BDE 
639.5165 [M-2Br+4]+ 
0.77 
651.5567 [M-2Br+4]+ 
0.77 
641.5144 [M-2Br+6]+ 653.5547 [M-2Br+6]+ 
Nona-BDE 
719.4250 [M-2Br+6]+ 
1.03 
731.4652 [M-2Br+6]+ 
1.03 
721.4229 [M-2Br+8]+ 733.4632 [M-2Br+8]+ 
Deca-BDE 
797.3355 [M-2Br+6]+ 
0.82 
809.3757 [M-2Br+6]+ 
0.82 799.3334 [M-2Br+8]+ 811.3737 [M-2Br+8]+ 
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Annex 2 
Mass descriptors used for measurement of PBDD/Fs using GC-HRMS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PBDD/Fs Unlabeled 
congener m/z 
Ion Isotope ratio 13C12 – labeled 
congener m/z 
Ion Isotope ratio 
Tetra-BDF 
483.6955 [M+4]+ 
1.54 
495.7357 [M+4]+ 
1.54 
485.6934 [M+6]+ 497.7337 [M+6]+ 
Penta-BDF 
561.6060 [M+4]+ 
1.03 
573.6462 [M+4]+ 
1.03 
563.6039 [M+6]+ 575.6442 [M+6]+ 
Hexa-BDF 
639.5165 [M+4]+ 
0.77 
651.5567 [M+4]+ 
0.77 
641.5144 [M+6]+ 653.5547 [M+6]+ 
Hepta-BDF 
719.4250 [M+6]+ 
1.03 
731.4652 [M+6]+ 
1.03 
721.4229 [M+8]+ 733.4632 [M+8]+ 
Octa-BDF 
797.3355 [M+6]+ 
0.82 
809.3757 [M+6]+ 
0.82 
799.3334 [M+8]+ 811.3737 [M+8]+ 
Tetra-BDD 
499.6904 [M+4]+ 
1.54 
511.7306 [M+4]+ 
1.54 
501.6883 [M+6]+ 513.7286 [M+6]+ 
Penta-BDD 
577.6009 [M+4]+ 
1.03 
589.6411 [M+4]+ 
1.03 
579.5988 [M+6]+ 591.6391 [M+6]+ 
Hexa-BDD 
657.5094 [M+6]+ 
1.37 
669.5496 [M+6]+ 
1.37 
659.5073 [M+8]+ 671.5476 [M+8]+ 
Hepta-BDD 
735.4199 [M+6]+ 
1.03 
747.4601 [M+6]+ 
1.03 737.4178 [M+8]+ 749.4581 [M+8]+ 
Octa-BDD 
813.3304 [M+6]+ 
0.82 
825.3706 [M+6]+ 
0.82 815.3283 [M+8]+ 827.3686 [M+8]+ 
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Annex 3 
Mass descriptors used for measurement of PXDD/Fs and PXBs using GC-HRMS 
 
 
 
 
 
 
 
 
PXDD/Fs 
PXBs 
Unlabeled 
congener m/z 
Ion Isotope ratio 13C12 – labeled 
congener m/z 
Ion Isotope ratio 
Br1Cl3DF 
349.8491 [M+2]+ 
1.54 
- - 
- 
351.8461 [M+4]+ - - 
Br1Cl3DD 
365.8440 [M+2]+ 
1.54 
- - 
- 
367.8410 [M+4]+ - - 
Br2Cl2DD 
409.7935 [M+2]+ 
1.12 
421.8337 [M+2]+ 
1.12 
411.7905 [M+4]+ 423.8308 [M+4]+ 
Br1Cl4DF 
383.8092 [M+2]+ 
1.20 
- - 
- 
385.8071 [M+4]+ - - 
Br1Cl4DD 
399.8041 [M+2]+ 
1.20 
411.8444 [M+2]+ 
1.20 
401.8021 [M+4]+ 413.8423 [M+4]+ 
Br1Cl5DD 
433.7651 [M+2]+ 
0.99 
- - 
- 
435.7631 [M+4]+ - - 
Br1Cl6DD 
467.7262 [M+2]+ 
0.85 
- - 
- 
469.7241 [M+4]+ - - 
Br1Cl7DD 
501.6872 [M+2]+ 
0.74 
- - 
- 
503.6851 [M+4]+ - - 
Br1Cl4B 
369.8299 [M+2]+ 
1.34 
381.8701 [M+2]+ 
1.34 
371.8279 [M+4]+ 383.8681 [M+4]+ 
Br2Cl3B 
413.7793 [M+2]+ 
1.03 
- - 
- 
415.7783 [M+4]+ - - 
Br3Cl2B 
457.7297 [M+2]+ 
0.76 
- - 
- 
459.7277 [M+4]+ - - 
Br1Cl5B 
403.7909 [M+2]+ 
1.03 
415.8312 [M+2]+ 
1.03 
405.7889 [M+4]+ 417.8292 [M+4]+ 
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Annex 4 
Concentrations of PCDD/Fs and HBCDs in Baltic wild salmon samples calculated on f.w. basis 
 
Sample Nr. 74505-1 74505-2 74505-3 74505-4 74505-5 74505-6 74505-7 74505-8 74505-9 74505-10 74505-11 74505-12 
Sex* F M F M F F M M M F M F 
Length, cm 74 57 59 63 83 83 71 65 56 81 58 84 
Age, years 2 1 2 1 2 2 1 1 1 2 1 2 
Weight, kg 4.4 2.5 3.5 3.0 5.8 5.8 3.8 3.6 2.0 5.3 2.6 5.6 
Place of sampling Daugava 
 River 
Daugava 
 River 
Daugava 
 River 
Daugava 
 River 
Daugava  
River 
Daugava  
River 
Daugava 
River 
Daugava  
River 
Daugava 
 River 
Daugava  
River 
Daugava  
River 
Daugava  
River 
Fat content, g/100 g of sample 2.4 3.5 7.9 6.3 2.9 6.1 3.5 5.8 5.3 5.5 4.8 5.2 
PCDD/Fs (pg g-1)                         
2,3,7,8-TetraCDF 9.34 7.30 8.98 5.01 6.39 9.79 8.23 5.63 4.99 8.83 4.58 7.92 
1,2,3,7,8-PentaCDF 0.51 0.60 0.78 0.61 0.71 1.00 1.02 0.57 0.49 0.65 0.44 0.97 
2,3,4,7,8-PentaCDF 4.74 4.66 6.29 4.02 4.96 6.03 5.78 3.50 3.20 5.20 3.26 5.67 
1,2,3,4,7,8-HexaCDF 0.07 0.07 0.10 0.08 0.08 0.13 0.13 0.08 0.06 0.09 0.06 0.14 
1,2,3,6,7,8-HexaCDF 0.12 0.13 0.16 0.13 0.14 0.22 0.23 0.13 0.09 0.14 0.10 0.22 
2,3,4,6,7,8-HexaCDF 0.12 0.13 0.17 0.12 0.14 0.19 0.18 0.11 0.07 0.15 0.10 0.18 
1,2,3,7,8,9-HexaCDF 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
1,2,3,4,6,7,8-HeptaCDF 0.07 0.06 0.05 0.03 0.05 0.08 0.05 0.05 0.03 0.07 0.04 0.09 
1,2,3,4,7,8,9-HeptaCDF 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
OctaCDF 0.04 0.02 0.02 0.02 0.02 0.02 0.01 0.02 0.01 0.03 0.02 0.03 
2,3,7,8-TetraCDD 0.34 0.36 0.44 0.28 0.37 0.55 0.46 0.28 0.32 0.42 0.23 0.47 
12378-PentaCDD 0.57 0.56 0.74 0.58 0.69 0.89 0.83 0.48 0.43 0.69 0.42 0.83 
1,2,3,4,7,8-HexaCDD 0.02 0.01 0.03 0.03 0.03 0.05 0.04 0.02 0.03 0.03 0.02 0.05 
1,2,3,6,7,8-HexaCDD 0.30 0.26 0.34 0.22 0.23 0.32 0.31 0.20 0.09 0.25 0.18 0.31 
1,2,3,7,8,9-HexaCDD 0.04 0.02 0.03 0.02 0.02 0.03 0.03 0.02 0.01 0.03 0.02 0.04 
1,2,3,4,6,7,8-HeptaCDD 0.03 0.02 0.03 0.02 0.02 0.02 0.02 0.02 0.02 0.03 0.01 0.03 
OctaCDD 0.05 0.04 0.03 0.04 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.04 
WHO2005-PCDD/F-TEQ (LB) 3.35 3.13 4.07 2.64 3.27 4.36 3.97 2.45 2.25 3.64 2.15 3.91 
WHO2005-PCDD/F-TEQ (UB) 3.35 3.13 4.07 2.64 3.27 4.36 3.97 2.45 2.25 3.64 2.15 3.91 
HBCDs (pg g-1)             
α-HBCD 720 900 870 970 1630 1800 1750 770 360 950 860 1700 
β-HBCD <10.0 <10.0 50.0 60.0 40.0 110 110 50.0 <10.0 40.0 50.0 80.0 
γ-HBCD 20.0 30.0 40.0 30.0 70.0 80.0 70.0 40.0 20.0 50.0 150 80.0 
Total-HBCD (LB) 750 940 960 1060 1740 1990 1930 860 390 1040 1060 1860 
Total-HBCD (UB) 740 930 960 1060 1740 1990 1930 860 390 1040 1060 1860 
 
* - F – female; M – male. 
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Annex 4 continues 
 
Sample Nr. 74505-13 74505-14 74505-15 79050-1 79050-2 79050-3 79050-4 79050-5 79050-6 79050-7 79050-8 79050-9 79050-10 
Sex* F F M M F M F M M M F F M 
Length, cm 86 78 69 62 76 77 81 76 93 78 83 83 68 
Age, years 3 3 1 1 2 2 3 2 3 2 3 3 2 
Weight, kg 7.1 6.6 3.5 3.5 5.1 6.3 6.4 5.8 11.3 6.5 6.2 10.2 5.0 
Place of sampling Daugava  
River 
Daugava 
 River 
Daugava  
River 
Venta  
River 
Venta 
 River 
Venta  
River 
Venta  
River 
Venta  
River 
Venta  
River 
Venta  
River 
Venta  
River 
Venta  
River 
Venta  
River 
Fat content, g/100 g of sample 8.2 4.3 5.8 5.7 4.8 6.2 3.6 5.6 6.1 8.2 4.8 12.0 7.1 
PCDD/Fs (pg g-1)                           
2,3,7,8-TetraCDF 11.3 8.07 5.30 6.23 7.04 13.2 7.31 9.69 9.97 11.8 7.25 12.8 9.19 
1,2,3,7,8-PentaCDF 1.41 1.01 0.41 0.59 0.69 1.56 0.82 0.90 1.20 1.42 0.81 1.50 1.15 
2,3,4,7,8-PentaCDF 8.44 6.83 3.19 4.01 5.03 8.53 4.67 6.49 6.48 7.25 4.32 7.94 7.13 
1,2,3,4,7,8-HexaCDF 0.19 0.13 0.04 0.07 0.08 0.22 0.10 0.12 0.17 0.22 0.13 0.24 0.15 
1,2,3,6,7,8-HexaCDF 0.31 0.23 0.08 0.12 0.13 0.33 0.15 0.20 0.27 0.34 0.18 0.33 0.26 
2,3,4,6,7,8-HexaCDF 0.28 0.19 0.08 0.11 0.12 0.26 0.13 0.17 0.22 0.26 0.17 0.28 0.22 
1,2,3,7,8,9-HexaCDF 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
1,2,3,4,6,7,8-HeptaCDF 0.05 0.07 0.04 0.05 0.04 0.04 0.04 0.04 0.05 0.05 0.05 0.06 0.07 
1,2,3,4,7,8,9-HeptaCDF 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
OctaCDF 0.02 0.03 0.02 0.02 0.02 0.01 0.02 0.02 0.02 0.02 0.02 0.01 0.03 
2,3,7,8-TetraCDD 0.63 0.50 0.23 0.30 0.38 0.73 0.43 0.46 0.58 0.66 0.36 0.67 0.57 
12378-PentaCDD 1.19 0.96 0.37 0.56 0.66 1.31 0.68 0.86 0.99 1.13 0.68 1.19 1.06 
1,2,3,4,7,8-HexaCDD 0.06 0.05 0.02 0.03 0.03 0.07 0.03 0.03 0.05 0.07 0.04 0.07 0.05 
1,2,3,6,7,8-HexaCDD 0.44 0.33 0.15 0.23 0.24 0.48 0.22 0.34 0.40 0.44 0.28 0.46 0.41 
1,2,3,7,8,9-HexaCDD 0.04 0.03 0.02 0.02 0.02 0.05 0.02 0.03 0.03 0.05 0.03 0.05 0.03 
1,2,3,4,6,7,8-HeptaCDD 0.03 0.03 0.01 0.02 0.02 0.05 0.02 0.02 0.03 0.04 0.02 0.04 0.03 
OctaCDD 0.04 0.04 0.03 0.03 0.04 0.04 0.04 0.03 0.04 0.05 0.02 0.04 0.04 
WHO2005-PCDD/F-TEQ (LB) 5.67 4.45 2.14 2.77 3.33 6.11 3.34 4.35 4.66 5.32 3.17 5.71 4.83 
WHO2005-PCDD/F-TEQ (UB) 5.67 4.45 2.14 2.77 3.33 6.11 3.34 4.35 4.66 5.32 3.17 5.71 4.83 
HBCDs (pg g-1)              
α-HBCD 3670 2060 620 990 1170 2580 1500 1520 2000 1700 830 2720 1840 
β-HBCD <10.0 70.0 30.0 <10.0 60.0 180 <10. 0 60.0 160 110 50.0 180 80.0 
γ-HBCD 150 80.0 30.0 40.0 50.0 120 80.0 60.0 90.0 90.0 50.0 140 70.0 
Total-HBCD (LB) 3830 2210 680 1040 1280 2880 1590 1640 2250 1900 930 3040 1990 
Total-HBCD (UB) 3820 2210 680 1030 1280 2880 1580 1640 2250 1900 930 3040 1990 
 
* - F – female; M – male. 
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Annex 5 
Concentrations of PBDD/Fs and PXDD/Fs in Baltic wild salmon samples calculated on f.w. basis 
 
Sample Nr. 74505-1 74505-2 74505-3 74505-4 74505-5 74505-6 74505-7 74505-8 74505-9 74505-10 74505-11 74505-12 
Sex* F M F M F F M M M F M F 
Length, cm 74 57 59 63 83 83 71 65 56 81 58 84 
Age, years 2 1 2 1 2 2 1 1 1 2 1 2 
Weight, kg 4.4 2.5 3.5 3.0 5.8 5.8 3.8 3.6 2.0 5.3 2.6 5.6 
Place of sampling Daugava 
 River 
Daugava 
 River 
Daugava 
 River 
Daugava 
 River 
Daugava  
River 
Daugava  
River 
Daugava 
River 
Daugava  
River 
Daugava 
 River 
Daugava  
River 
Daugava  
River 
Daugava  
River 
Fat content, g/100 g of sample 2.4 3.5 7.9 6.3 2.9 6.1 3.5 5.8 5.3 5.5 4.8 5.2 
PBDD/Fs (pg g-1)                         
2,3,7,8-TetraBDF 0.92 0.42 0.29 0.45 0.29 0.28 0.65 0.63 0.47 0.34 0.39 0.71 
2,4,6,8-TetraBDF 0.05 0.01 0.01 0.01 0.01 0.02 0.01 0.04 0.01 0.01 <0.01 0.02 
1,2,3,7,8-PentaBDF <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 
2,3,4,7,8-PentaBDF 0.02 0.02 <0.01 0.01 0.01 <0.01 <0.01 0.01 <0.004 <0.01 0.01 0.01 
1,2,3,4,7,8-HexaBDF 0.10 0.13 0.09 0.09 0.09 0.06 0.09 0.10 0.08 0.03 0.10 0.09 
1,2,3,4,6,7,8-HeptaBDF 0.90 1.36 0.69 0.81 0.67 0.78 1.05 1.12 0.68 0.27 0.91 1.06 
OctaBDF 1.06 1.39 0.75 0.84 0.74 0.75 1.12 1.06 0.81 <0.39 1.21 2.09 
2,3,7,8-TetraBDD 0.01 0.003 0.004 <0.003 <0.004 <0.004 <0.003 0.01 <0.003 <0.01 <0.01 <0.004 
1,2,3,7,8-PentaBDD <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 
1,2,3,4,7,8/1,2,3,6,7,8-HexaBDD 0.01 <0.01 <0.01 0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 
1,2,3,7,8,9-HexaBDD <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 0.01 <0.01 0.01 <0.01 
1,2,3,4,6,7,8-HeptaBDD 0.07 0.07 0.04 0.06 0.05 0.05 0.05 0.06 0.05 0.05 0.04 0.04 
OctaBDD <0.10 <0.07 <0.06 <0.10 <0.07 <0.08 <0.07 <0.06 <0.07 <0.25 <0.08 <0.07 
WHO2005-PBDD/F-TEQ (LB) 0.13 0.08 0.05 0.07 0.05 0.04 0.09 0.10 0.06 0.04 0.06 0.09 
WHO2005-PBDD/F-TEQ (UB) 0.14 0.09 0.06 0.08 0.06 0.06 0.10 0.11 0.08 0.06 0.08 0.11 
PXDD/Fs (pg g-1)                         
3-Br-2,7,8-TriClDF 0.02 0.02 0.03 0.03 0.04 0.05 0.05 0.02 0.02 0.03 0.02 0.04 
2-Br-3,7,8-TriClDD <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 
2,3-DiBr-7,8-DiClDD <0.004 <0.01 <0.003 <0.01 <0.01 <0.004 <0.01 <0.01 <0.002 <0.01 <0.003 <0.01 
1-Br-2,3,7,8-TetraClDF <0.004 <0.004 <0.002 <0.004 <0.004 <0.01 <0.01 <0.002 <0.004 <0.01 <0.003 <0.004 
1-Br-2,3,7,8-TetraClDD <0.004 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.004 <0.01 
2-Br-1,3,7,8-TetraClDD <0.004 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.004 <0.01 
2-Br-3,6,7,8,9-PentaClDD <0.004 <0.003 <0.002 <0.003 <0.003 <0.002 <0.002 <0.002 <0.003 <0.003 <0.002 <0.002 
1-Br-2,3,6,7,8,9-HexaClDD <0.01 <0.01 <0.004 <0.003 <0.004 <0.003 <0.004 <0.004 <0.01 <0.004 <0.003 <0.003 
1-Br-2,3,4,6,7,8,9-HeptaClDD <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 
WHO2005-PXDD/F-TEQ (LB) 0.002 0.002 0.003 0.003 0.004 0.005 0.01 0.002 0.002 0.003 0.002 0.004 
WHO2005-PXDD/F-TEQ (UB) 0.02 0.03 0.02 0.04 0.03 0.03 0.03 0.03 0.02 0.03 0.02 0.03 
 
* - F – female; M – male. 
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Annex 5 continues 
 
Sample Nr. 74505-13 74505-14 74505-15 79050-1 79050-2 79050-3 79050-4 79050-5 79050-6 79050-7 79050-8 79050-9 79050-10 
Sex* F F M M F M F M M M F F M 
Length, cm 86 78 69 62 76 77 81 76 93 78 83 83 68 
Age, years 3 3 1 1 2 2 3 2 3 2 3 3 2 
Weight, kg 7.1 6.6 3.5 3.5 5.1 6.3 6.4 5.8 11.3 6.5 6.2 10.2 5.0 
Place of sampling Daugava  
River 
Daugava 
 River 
Daugava  
River 
Venta  
River 
Venta 
 River 
Venta  
River 
Venta  
River 
Venta  
River 
Venta  
River 
Venta  
River 
Venta  
River 
Venta  
River 
Venta  
River 
Fat content, g/100 g of sample 8.2 4.3 5.8 5.7 4.8 6.2 3.6 5.6 6.1 8.2 4.8 12.0 7.1 
PBDD/Fs (pg g-1)                           
2,3,7,8-TetraBDF 0.49 0.60 0.42 0.16 0.29 0.22 0.33 0.22 0.17 0.26 0.28 0.56 0.36 
2,4,6,8-TetraBDF 0.02 0.01 0.01 0.004 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
1,2,3,7,8-PentaBDF <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 
2,3,4,7,8-PentaBDF 0.01 0.01 0.01 <0.01 0.01 <0.01 0.01 0.01 <0.01 0.01 0.01 <0.01 0.01 
1,2,3,4,7,8-HexaBDF 0.06 0.07 0.05 0.03 0.09 0.05 0.12 0.08 0.03 0.08 0.08 0.05 0.09 
1,2,3,4,6,7,8-HeptaBDF 0.69 0.82 0.66 0.32 0.93 0.44 1.03 0.65 0.40 0.59 0.63 0.44 1.01 
OctaBDF 0.87 0.94 0.76 <1.06 0.91 0.47 1.10 0.68 0.32 0.59 0.70 0.38 1.05 
2,3,7,8-TetraBDD <0.004 <0.01 <0.003 <0.002 <0.01 <0.01 <0.003 <0.002 <0.004 <0.01 <0.004 <0.003 <0.003 
1,2,3,7,8-PentaBDD <0.01 <0.004 <0.003 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.004 <0.01 <0.01 
1,2,3,4,7,8/1,2,3,6,7,8-HexaBDD <0.01 <0.003 <0.01 <0.01 <0.01 0.02 0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 
1,2,3,7,8,9-HexaBDD <0.01 <0.003 <0.004 0.01 0.02 <0.01 <0.01 <0.02 <0.01 <0.01 <0.01 <0.01 <0.01 
1,2,3,4,6,7,8-HeptaBDD 0.03 0.04 0.03 0.06 0.05 0.05 0.05 0.04 0.06 0.05 0.04 0.05 0.03 
OctaBDD <0.12 <0.06 <0.07 <0.47 <0.12 <0.21 <0.09 <0.08 <0.11 <0.14 <0.08 <0.09 <0.17 
WHO2005-PBDD/F-TEQ (LB) 0.07 0.08 0.06 0.02 0.05 0.03 0.06 0.04 0.03 0.04 0.04 0.07 0.06 
WHO2005-PBDD/F-TEQ (UB) 0.08 0.09 0.06 0.04 0.07 0.05 0.07 0.05 0.04 0.06 0.05 0.08 0.07 
PXDD/Fs (pg g-1)                           
3-Br-2,7,8-TriClDF 0.06 0.04 0.02 0.03 0.03 0.08 0.05 0.04 0.06 0.07 0.03 0.07 0.06 
2-Br-3,7,8-TriClDD <0.01 <0.02 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 
2,3-DiBr-7,8-DiClDD <0.002 <0.01 <0.01 <0.00 <0.001 <0.004 <0.002 <0.01 <0.01 <0.002 <0.002 <0.004 <0.01 
1-Br-2,3,7,8-TetraClDF <0.01 <0.004 <0.004 <0.01 <0.003 <0.004 <0.003 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 
1-Br-2,3,7,8-TetraClDD <0.01 <0.004 <0.01 <0.004 <0.01 <0.01 <0.004 <0.01 <0.01 <0.01 <0.003 <0.01 <0.01 
2-Br-1,3,7,8-TetraClDD <0.01 <0.004 <0.01 <0.004 <0.01 <0.01 <0.004 <0.01 <0.01 <0.01 <0.003 <0.01 <0.01 
2-Br-3,6,7,8,9-PentaClDD <0.002 <0.001 <0.003 <0.003 <0.003 <0.003 <0.002 <0.003 <0.002 <0.002 <0.001 <0.003 <0.002 
1-Br-2,3,6,7,8,9-HexaClDD <0.004 <0.003 <0.003 <0.004 <0.004 <0.003 <0.004 <0.004 <0.01 <0.003 <0.004 <0.003 <0.01 
1-Br-2,3,4,6,7,8,9-HeptaClDD <0.01 <0.01 <0.01 <0.02 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.02 
WHO2005-PXDD/F-TEQ (LB) 0.01 0.004 0.002 0.003 0.003 0.01 0.005 0.004 0.01 0.01 0.003 0.01 0.01 
WHO2005-PXDD/F-TEQ (UB) 0.03 0.03 0.03 0.02 0.03 0.03 0.02 0.03 0.04 0.03 0.02 0.03 0.04 
 
* - F – female; M – male. 
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Annex 6 
Concentrations of DL-PCBs and NDL-PCBs in Baltic wild salmon samples calculated on f.w. basis 
Sample Nr. 74505-1 74505-2 74505-3 74505-4 74505-5 74505-6 74505-7 74505-8 74505-9 74505-10 74505-11 74505-12 
Sex* F M F M F F M M M F M F 
Length, cm 74 57 59 63 83 83 71 65 56 81 58 84 
Age, years 2 1 2 1 2 2 1 1 1 2 1 2 
Weight, kg 4.4 2.5 3.5 3.0 5.8 5.8 3.8 3.6 2.0 5.3 2.6 5.6 
Place of sampling Daugava 
 River 
Daugava 
 River 
Daugava 
 River 
Daugava 
 River 
Daugava  
River 
Daugava  
River 
Daugava 
River 
Daugava  
River 
Daugava 
 River 
Daugava  
River 
Daugava  
River 
Daugava  
River 
Fat content, g/100 g of sample 2.4 3.5 7.9 6.3 2.9 6.1 3.5 5.8 5.3 5.5 4.8 5.2 
DL-PCBs (pg g-1)                         
2',3,4,4',5-PentaCB (#123) 440 323 396 250 310 364 336 201 174 336 214 286 
2,3',4,4',5-PentaCB (#118) 9110 8200 9750 4880 6390 7990 6450 4820 3900 8320 4600 6500 
2,3,4,4',5-PentaCB (#114) 205 116 178 94.7 127 149 133 89.7 70.1 157 78.9 153 
2,3,3,'4,4'-PentaCB (#105) 4030 3280 3820 1730 2250 2820 2410 1780 1250 3240 1770 2260 
2,3',4,4',5,5'-HexaCB (#167) 659 491 587 354 464 604 456 335 284 566 314 488 
2,3,3',4,4',5-HexaCB (#156) 1330 1080 1240 663 885 1060 918 632 510 1150 615 883 
2,3,3',4,4',5'-HexaCB (#157) 363 283 327 173 232 290 249 167 141 294 164 239 
2,3,3',4,4',5,5'-HeptaCB (#189) 104 98.6 113 69.8 103 118 92.4 61.8 54.9 115 60.1 99 
3,4,4',5-TetraCB (#81) 4.95 1.98 2.61 1.90 2.80 5.31 2.92 1.87 1.98 3.77 1.54 3.84 
3,3,’4,4'-TetraCB (#77) 157 139 153 87.9 92.6 142 134 91.2 57.9 155 81.7 120 
3,3',4,4',5-PentaCB (#126) 37.0 38.7 42.7 29.5 36.3 51.8 47.3 27.8 20.2 42.7 24.5 45.3 
3,3',4,4',5,5'-HexaCB (#169) 7.48 8.74 10.6 7.69 10.0 12.5 11.5 6.63 5.44 10.1 5.97 11.4 
WHO2005-PCB-TEQ (LB) 4.43 4.56 5.10 3.44 4.26 5.97 5.42 3.24 2.39 5.01 2.88 5.21 
WHO2005-PCB-TEQ (UB) 4.43 4.56 5.10 3.44 4.26 5.97 5.42 3.24 2.39 5.01 2.88 5.21 
NDL-PCBs (ng g-1)                         
2,2',5-TriCB (#18) 0.10 0.15 0.27 0.23 0.14 0.23 0.37 0.19 0.22 0.25 0.20 0.20 
2,2,4'-TriCB (#28) 1.19 1.07 1.53 1.04 0.89 1.40 1.54 0.94 0.92 1.46 0.94 1.22 
2',3,4-TriCB (#33) 0.11 0.12 0.18 0.14 0.07 0.14 0.22 0.13 0.11 0.12 0.11 0.11 
2,2',4,4'-TetraCB (#47) 0.49 0.45 0.53 0.32 0.36 0.49 0.48 0.32 0.27 0.52 0.32 0.48 
2,2',4,5'-TetraCB (#49) 0.85 0.67 0.78 0.53 0.52 0.83 0.68 0.50 0.37 0.82 0.49 0.68 
2,2',4,6'-TetraCB (#51) 0.01 0.01 0.01 0.01 0.01 0.02 0.02 0.01 0.01 0.01 0.01 0.01 
2,2',5,5'-TetraCB (#52) 1.46 1.27 1.54 1.08 1.14 1.70 1.50 1.02 0.78 1.62 0.99 1.59 
2,3,4,4'-TetraCB (#60) 0.52 0.53 0.66 0.37 0.38 0.50 0.44 0.37 0.27 0.53 0.32 0.40 
2,3',4,4'-TetraCB (#66) 1.16 1.48 1.71 0.81 0.96 1.02 0.88 0.80 0.66 1.21 0.81 0.87 
2,4,4',5-TetraCB (#74) 0.85 0.87 1.05 0.57 0.65 0.81 0.67 0.57 0.38 0.85 0.51 0.64 
2,2',4,4',5-PentaCB (#99) 3.45 3.00 3.50 1.68 2.13 2.59 1.97 1.78 1.45 2.90 1.74 2.00 
2,2',4,5,5'-PentaCB (#101) 4.88 5.01 5.57 3.24 3.99 4.96 4.08 3.30 1.94 4.83 3.06 3.98 
2,3,3',4',6-PentaCB (#110) 4.28 4.15 4.73 2.42 2.80 3.37 3.18 2.48 1.90 3.83 2.50 2.92 
2,2',3,4,4',5'-HexaCB (#138) 10.8 9.94 12.9 7.13 10.1 11.9 18.2 7.19 5.20 10.4 7.04 9.09 
2,2',4,4',5,5'-HexaCB (#153) 12.0 15.1 19.5 10.4 14.3 16.3 16.7 10.6 8.05 15.9 10.1 13.8 
2,2',3,4,4',5,5'-HeptaCB (#180) 5.27 5.45 6.12 3.46 4.93 5.81 4.56 3.06 2.93 5.71 2.96 4.63 
∑PCB (LB) 47.5 49.2 60.5 33.5 43.3 52.1 55.4 33.3 25.4 51.0 32.1 42.6 
∑PCB (UB) 47.5 49.2 60.5 33.5 43.3 52.1 55.4 33.3 25.4 51.0 32.1 42.6 
* - F – female; M – male. 
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Sample Nr. 74505-13 74505-14 74505-15 79050-1 79050-2 79050-3 79050-4 79050-5 79050-6 79050-7 79050-8 79050-9 79050-10 
Sex* F F M M F M F M M M F F M 
Length, cm 86 78 69 62 76 77 81 76 93 78 83 83 68 
Age, years 3 3 1 1 2 2 3 2 3 2 3 3 2 
Weight, kg 7.1 6.6 3.5 3.5 5.1 6.3 6.4 5.8 11.3 6.5 6.2 10.2 5.0 
Place of sampling Daugava  
River 
Daugava 
 River 
Daugava  
River 
Venta  
River 
Venta 
 River 
Venta  
River 
Venta  
River 
Venta  
River 
Venta  
River 
Venta  
River 
Venta  
River 
Venta  
River 
Venta  
River 
Fat content, g/100 g of sample 8.2 4.3 5.8 5.7 4.8 6.2 3.6 5.6 6.1 8.2 4.8 12.0 7.1 
DL-PCBs (pg g-1)                           
2',3,4,4',5-PentaCB (#123) 427 379 219 293 363 510 307 385 410 436 240 415 429 
2,3',4,4',5-PentaCB (#118) 9230 7300 5350 6210 7080 1100 5870 9110 7730 9370 5320 8410 9500 
2,3,4,4',5-PentaCB (#114) 223 160 103 129 145 244 109 171 164 203 118 196 176 
2,3,3,'4,4'-PentaCB (#105) 3280 2570 2110 2350 2520 3920 1970 3460 2770 3300 1910 2970 3490 
2,3',4,4',5,5'-HexaCB (#167) 723 547 327 402 480 764 465 619 598 740 417 658 684 
2,3,3',4,4',5-HexaCB (#156) 1340 1040 681 815 920 1430 823 1257 1070 1280 735 1190 1330 
2,3,3',4,4',5'-HexaCB (#157) 347 267 179 216 245 386 213 329 282 337 195 312 340 
2,3,3',4,4',5,5'-HeptaCB (#189) 139 122 57.3 78.5 91.4 141 92 125 113 129 79.7 131 135 
3,4,4',5-TetraCB (#81) 4.42 2.64 1.65 1.95 2.68 5.27 3.11 3.53 3.69 5.42 3.82 6.59 3.43 
3,3,’4,4'-TetraCB (#77) 171 109 96.2 99.1 109 188 101 144 143 187 96.8 169 135 
3,3',4,4',5-PentaCB (#126) 65.6 48.1 24.0 31.0 36.5 74.1 40.1 49.5 55.0 69.6 35.6 63.9 57.8 
3,3',4,4',5,5'-HexaCB (#169) 16.8 14.1 5.13 7.91 9.57 17.5 9.69 12.8 13.7 14.2 8.35 14.8 14.5 
WHO2005-PCB-TEQ (LB) 7.55 5.62 2.83 3.67 4.31 8.48 4.60 5.81 6.32 7.88 4.10 7.28 6.71 
WHO2005-PCB-TEQ (UB) 7.55 5.62 2.83 3.67 4.31 8.48 4.60 5.81 6.32 7.88 4.10 7.28 6.71 
NDL-PCBs (ng g-1)                           
2,2',5-TriCB (#18) 0.39 0.21 0.21 0.22 0.30 0.34 0.20 0.25 0.37 0.45 0.19 0.34 0.27 
2,2,4'-TriCB (#28) 1.96 1.24 0.94 1.16 1.21 1.96 0.95 1.52 1.51 1.85 0.98 1.82 1.61 
2',3,4-TriCB (#33) 0.24 0.11 0.11 0.12 0.13 0.19 0.09 0.13 0.17 0.23 0.09 0.15 0.17 
2,2',4,4'-TetraCB (#47) 0.66 0.50 0.32 0.40 0.40 0.75 0.34 0.57 0.52 0.50 0.37 0.64 0.57 
2,2',4,5'-TetraCB (#49) 1.01 0.71 0.49 0.56 0.53 1.09 0.53 0.91 0.82 1.09 0.58 1.03 0.88 
2,2',4,6'-TetraCB (#51) 0.02 0.01 0.01 0.01 0.01 0.03 0.01 0.02 0.02 0.03 0.01 0.02 0.02 
2,2',5,5'-TetraCB (#52) 2.21 1.62 0.97 0.99 1.30 2.43 1.11 1.80 1.91 2.12 1.18 2.12 1.82 
2,3,4,4'-TetraCB (#60) 0.62 0.47 0.37 0.42 0.37 0.70 0.33 0.55 0.41 0.53 0.32 0.56 0.68 
2,3',4,4'-TetraCB (#66) 1.50 1.13 0.85 1.13 0.96 1.68 0.64 1.40 1.14 1.06 0.76 1.24 1.76 
2,4,4',5-TetraCB (#74) 0.99 0.78 0.58 0.70 0.58 1.15 0.55 0.93 0.77 0.89 0.52 0.92 1.15 
2,2',4,4',5-PentaCB (#99) 3.11 2.47 1.98 2.14 1.87 3.53 1.74 3.18 2.11 2.65 1.80 2.83 3.60 
2,2',4,5,5'-PentaCB (#101) 6.17 4.92 3.26 3.66 2.98 6.86 3.59 5.64 3.99 5.37 3.40 5.59 6.84 
2,3,3',4',6-PentaCB (#110) 4.59 3.51 2.91 2.94 2.80 5.45 2.53 4.36 3.54 4.40 2.47 3.96 5.09 
2,2',3,4,4',5'-HexaCB (#138) 15.4 11.2 7.71 8.43 9.08 13.4 8.45 12.4 10.4 13.4 8.62 12.1 13.9 
2,2',4,4',5,5'-HexaCB (#153) 18.8 15.2 9.74 12.1 9.64 17.0 11.0 15.9 10.8 14.4 12.1 16.2 18.4 
2,2',3,4,4',5,5'-HeptaCB (#180) 6.82 5.66 3.24 4.15 3.86 6.63 4.41 6.41 4.80 5.35 3.91 7.21 6.56 
∑PCB (LB) 64.5 49.8 33.7 39.2 36.0 63.2 36.4 56.0 43.3 54.3 37.3 56.8 63.3 
∑PCB (UB) 64.5 49.8 33.7 39.2 36.0 63.2 36.4 56.0 43.3 54.3 37.3 56.8 63.3 
* - F – female; M – male. 
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Annex 7 
Concentrations of PBDEs in Baltic wild salmon samples calculated on f.w. basis 
Sample Nr. 74505-1 74505-2 74505-3 74505-4 74505-5 74505-6 74505-7 74505-8 74505-9 74505-10 74505-11 74505-12 
Sex* F M F M F F M M M F M F 
Length, cm 74 57 59 63 83 83 71 65 56 81 58 84 
Age, years 2 1 2 1 2 2 1 1 1 2 1 2 
Weight, kg 4.4 2.5 3.5 3.0 5.8 5.8 3.8 3.6 2.0 5.3 2.6 5.6 
Place of sampling Daugava 
 River 
Daugava 
 River 
Daugava 
 River 
Daugava 
 River 
Daugava  
River 
Daugava  
River 
Daugava 
River 
Daugava  
River 
Daugava 
 River 
Daugava  
River 
Daugava  
River 
Daugava  
River 
Fat content, g/100 g of sample 2.4 3.5 7.9 6.3 2.9 6.1 3.5 5.8 5.3 5.5 4.8 5.2 
PBDEs (ng g-1)             
2,4-DiBDE (#7) 0.001 0.001 0.001 0.001 0.0004 0.001 0.001 0.001 0.0003 0.001 0.0003 0.001 
4,4-DiBDE (#15) 0.001 0.001 0.002 0.001 0.001 0.002 0.002 0.001 0.001 0.001 0.001 0.001 
2,2',4-TriBDE (#17) 0.02 0.02 0.02 0.02 0.02 0.03 0.03 0.02 0.01 0.02 0.01 0.03 
2,4,4'-TriBDE (#28) 0.03 0.06 0.05 0.04 0.04 0.06 0.07 0.03 0.02 0.05 0.02 0.05 
2,2',4,4'-TetraBDE (#47) 0.89 1.19 1.15 0.84 1.12 1.41 1.41 0.83 0.47 1.14 0.47 1.31 
2,2',4,5'-TetraBDE (#49) 0.28 0.40 0.43 0.38 0.40 0.58 0.80 0.37 0.15 0.39 0.15 0.54 
2,3',4,4'-TetraBDE (#66) 0.03 0.04 0.05 0.05 0.06 0.08 0.08 0.04 0.02 0.05 0.02 0.08 
2,3',4',6-TetraBDE (#71) <0.0001 <0.0003 <0.0002 <0.0002 <0.0003 <0.0002 <0.0003 <0.0002 <0.0002 <0.0002 <0.0002 <0.0001 
3,3',4,4'-TetraBDE (#77) 0.01 0.01 0.01 0.01 0.01 0.02 0.02 0.01 0.01 0.01 0.01 0.02 
2,2',3,4,4'-PentaBDE (#85) 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.003 0.01 0.004 0.01 
2,2',4,4',5-PentaBDE (#99) 0.14 0.16 0.17 0.17 0.20 0.30 0.32 0.15 0.12 0.20 0.13 0.28 
2,2',4,4',6-PentaBDE (#100) 0.26 0.30 0.32 0.20 0.35 0.43 0.25 0.24 0.14 0.34 0.21 0.37 
2,3',4,4',6-PentaBDE (#119) 0.06 0.06 0.06 0.06 0.08 0.13 0.10 0.06 0.03 0.08 0.05 0.11 
3,3',4,4',5-PentaBDE (#126) <0.0001 <0.0002 0.001 0.001 0.001 0.0004 0.0003 0.0002 0.0001 0.0002 <0.0003 0.0003 
2,2',3,4,4',5'-HexaBDE (#138) 0.0004 0.0002 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.0003 0.0004 
2,2',4,4',5,5'-HexaBDE (#153) 0.06 0.05 0.06 0.06 0.08 0.12 0.10 0.05 0.02 0.08 0.04 0.11 
2,2',4,4',5,6'-HexaBDE (#154) 0.18 0.16 0.18 0.18 0.24 0.36 0.26 0.15 0.10 0.25 0.12 0.31 
2,2',4,4',6,6'-HexaBDE (#155) 0.07 0.08 0.10 0.08 0.12 0.15 0.11 0.07 0.03 0.11 0.05 0.13 
2,3,4,4',5,6-HexaBDE (#166) 0.0002 <0.0002 0.001 0.001 0.001 <0.001 <0.0003 <0.0004 0.0002 0.0004 <0.0002 <0.0003 
2,2',3,4,4',5,6'-HeptaBDE (#181) 0.001 0.0004 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.002 0.001 
2,2',3,4,4',5',6-HeptaBDE (#183) 0.003 0.002 0.003 0.003 0.003 0.004 0.004 0.002 0.002 0.002 0.003 0.01 
2,3,3',4,4',5,6-HeptaBDE (#190) 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 
2,2',3,4,4',5,5',6-OctaBDE (#203) 0.01 0.01 0.004 0.01 0.004 0.01 0.004 0.01 0.004 0.002 0.01 0.01 
2,3,3',4,4',5,5',6-OctaBDE (#205) 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.003 0.01 0.01 
2,2',3,3',4,4',5,5',6-NonaBDE (#206) 0.01 0.01 0.01 0.01 0.004 0.003 0.01 0.004 0.01 0.004 0.01 0.01 
2,2',3,3',4,4',5,6,6'-NonaBDE (#207) 0.04 0.04 0.02 0.03 0.02 0.02 0.02 0.02 0.02 0.01 0.04 0.04 
2,2',3,3',4,4',5,5',6,6'-DecaBDE (#209) 0.31 0.18 0.10 0.28 0.17 0.14 0.18 0.15 0.16 0.13 0.20 0.45 
∑PBDE (UB) 2.39 2.77 2.75 2.43 2.95 3.86 3.78 2.21 1.34 2.88 1.54 3.87 
∑PBDE (LB) 2.39 2.77 2.75 2.43 2.95 3.86 3.78 2.21 1.34 2.88 1.54 3.87 
 
* - F – female; M – male. 
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Annex 7 continues 
 
Sample Nr. 74505-13 74505-14 74505-15 79050-1 79050-2 79050-3 79050-4 79050-5 79050-6 79050-7 79050-8 79050-9 79050-10 
Sex* F F M M F M F M M M F F M 
Length, cm 86 78 69 62 76 77 81 76 93 78 83 83 68 
Age, years 3 3 1 1 2 2 3 2 3 2 3 3 2 
Weight, kg 7.1 6.6 3.5 3.5 5.1 6.3 6.4 5.8 11.3 6.5 6.2 10.2 5.0 
Place of sampling Daugava  
River 
Daugava 
 River 
Daugava  
River 
Venta  
River 
Venta 
 River 
Venta  
River 
Venta  
River 
Venta  
River 
Venta  
River 
Venta  
River 
Venta  
River 
Venta  
River 
Venta  
River 
Fat content, g/100 g of sample 8.2 4.3 5.8 5.7 4.8 6.2 3.6 5.6 6.1 8.2 4.8 12.0 7.1 
PBDEs (ng g-1)              
2,4-DiBDE (#7) 0.001 0.0004 0.0004 0.001 <0.0001 0.001 0.001 0.001 <0.00003 <0.0001 0.001 0.001 0.001 
4,4-DiBDE (#15) 0.002 0.001 0.001 0.001 <0.00004 0.004 0.003 0.002 0.003 0.01 0.001 0.002 0.002 
2,2',4-TriBDE (#17) 0.04 0.03 0.01 0.02 0.01 0.04 0.02 0.03 0.03 0.03 0.02 0.03 0.03 
2,4,4'-TriBDE (#28) 0.08 0.06 0.03 0.04 0.05 0.10 0.05 0.06 0.08 0.11 0.03 0.07 0.08 
2,2',4,4'-TetraBDE (#47) 1.79 1.51 0.65 0.92 1.10 2.14 1.21 1.47 1.62 2.08 0.98 1.67 1.70 
2,2',4,5'-TetraBDE (#49) 0.75 0.57 0.26 0.34 0.49 0.90 0.44 0.51 0.66 0.94 0.37 0.67 0.69 
2,3',4,4'-TetraBDE (#66) 0.11 0.10 0.03 0.04 0.05 0.14 0.07 0.08 0.09 0.13 0.05 0.09 0.10 
2,3',4',6-TetraBDE (#71) <0.0003 <0.0002 <0.0001 <0.0002 <0.0001 <0.0001 <0.0004 <0.0002 <0.0001 <0.0002 <0.0002 <0.0002 <0.0001 
3,3',4,4'-TetraBDE (#77) 0.02 0.02 0.01 0.01 0.01 0.03 0.02 0.01 0.02 0.03 0.01 0.02 0.02 
2,2',3,4,4'-PentaBDE (#85) 0.02 0.01 0.003 0.01 0.01 0.02 0.01 0.01 0.01 0.02 0.01 0.02 0.01 
2,2',4,4',5-PentaBDE (#99) 0.41 0.28 0.10 0.16 0.20 0.48 0.29 0.26 0.39 0.51 0.20 0.36 0.36 
2,2',4,4',6-PentaBDE (#100) 0.53 0.39 0.16 0.24 0.37 0.74 0.34 0.46 0.48 0.59 0.31 0.39 0.49 
2,3',4,4',6-PentaBDE (#119) 0.15 0.11 0.04 0.06 0.08 0.18 0.10 0.10 0.13 0.17 0.09 0.15 0.13 
3,3',4,4',5-PentaBDE (#126) <0.001 <0.0002 <0.0001 <0.0003 <0.0002 <0.0002 <0.0002 <0.0003 <0.0003 <0.0003 <0.0001 0.0002 <0.0002 
2,2',3,4,4',5'-HexaBDE (#138) 0.0004 <0.0003 0.0003 0.0002 0.0002 <0.0003 <0.0003 <0.0003 <0.0003 <0.0004 <0.0002 <0.0002 <0.0003 
2,2',4,4',5,5'-HexaBDE (#153) 0.15 0.10 0.03 0.06 0.07 0.14 0.10 0.09 0.13 0.15 0.08 0.15 0.12 
2,2',4,4',5,6'-HexaBDE (#154) 0.39 0.29 0.10 0.17 0.21 0.36 0.26 0.27 0.33 0.40 0.22 0.42 0.33 
2,2',4,4',6,6'-HexaBDE (#155) 0.17 0.13 0.04 0.08 0.10 0.16 0.11 0.12 0.15 0.17 0.09 0.17 0.15 
2,3,4,4',5,6-HexaBDE (#166) <0.0003 <0.0004 <0.0002 <0.0002 <0.0003 <0.0003 <0.0003 <0.0003 <0.0003 <0.001 <0.0002 <0.0002 <0.0003 
2,2',3,4,4',5,6'-HeptaBDE (#181) 0.001 0.001 0.001 <0.0002 0.0004 <0.0003 0.0004 0.0003 0.0002 0.001 <0.0003 0.0002 0.001 
2,2',3,4,4',5',6-HeptaBDE (#183) 0.004 0.004 0.002 0.001 0.002 0.002 0.003 0.002 0.002 0.003 0.002 0.003 0.003 
2,3,3',4,4',5,6-HeptaBDE (#190) 0.001 0.001 0.001 <0.0002 0.001 <0.0004 0.001 0.001 0.0003 <0.0004 0.0004 <0.001 0.001 
2,2',3,4,4',5,5',6-OctaBDE (#203) 0.004 0.01 0.003 0.001 0.003 0.002 0.004 0.004 0.001 0.003 0.003 0.002 0.003 
2,3,3',4,4',5,5',6-OctaBDE (#205) 0.01 0.01 0.004 0.002 0.004 0.003 0.01 0.004 0.002 0.004 0.004 0.002 0.01 
2,2',3,3',4,4',5,5',6-NonaBDE (#206) 0.003 0.001 0.003 0.002 0.004 0.001 0.002 0.002 0.003 0.003 0.002 0.002 0.003 
2,2',3,3',4,4',5,6,6'-NonaBDE (#207) 0.02 0.03 0.02 0.01 0.03 0.01 0.03 0.02 0.01 0.02 0.02 0.01 0.03 
2,2',3,3',4,4',5,5',6,6'-DecaBDE (#209) 0.18 0.28 0.16 0.08 0.15 0.11 0.16 0.11 0.07 0.11 0.13 0.09 0.20 
∑PBDE (UB) 4.85 3.93 1.65 2.22 2.94 5.56 3.22 3.60 4.20 5.47 2.62 4.34 4.45 
∑PBDE (LB) 4.85 3.93 1.65 2.22 2.94 5.56 3.22 3.60 4.20 5.47 2.62 4.34 4.44 
 
* - F – female; M – male. 
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Annex 8 
Concentrations of PCDD/Fs and HBCDs in eel samples calculated on f.w. basis 
 
Sample Nr. 1/14 2/14 3/14 4/14 5/14 6/14 7/14 8/14 9/14 12/14 13/14 14/14 15/14 
Length, cm 81 83 95 78 74 82 76 88 76 70 78 85 71 
Weight, kg 1.0 1.1 1.6 0.8 0.8 1.1 0.8 1.0 0.9 0.6 0.8 1.0 0.5 
Place of sampling Aluksnes Aluksnes Aluksnes Aluksnes Aluksnes Aluksnes Aluksnes Aluksnes Aluksnes Usmas Usmas Usmas Usmas 
 Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake 
Fat content, g/100 g of sample 28.8 20.3 29.1 23.8 28 26.6 35.3 21.2 24.4 21.2 22.0 26.9 21.8 
PCDD/Fs (pg g-1)                           
2,3,7,8-TetraCDF 0.04 0.03 0.05 0.02 0.03 0.04 0.05 0.01 0.04 0.24 0.05 0.05 0.30 
1,2,3,7,8-PentaCDF 0.02 0.02 <0.01 0.01 0.02 0.04 0.03 0.01 0.01 0.11 <0.01 0.04 0.09 
2,3,4,7,8-PentaCDF 0.44 0.53 0.71 0.28 0.63 0.51 0.63 0.50 0.45 0.91 0.71 <0.01 0.97 
1,2,3,4,7,8-HexaCDF 0.06 0.08 0.10 0.06 0.11 0.08 0.09 0.11 0.06 0.50 0.10 0.18 0.41 
1,2,3,6,7,8-HexaCDF 0.06 0.09 0.09 0.06 0.11 0.07 0.10 0.11 0.06 0.41 0.09 0.17 0.39 
2,3,4,6,7,8-HexaCDF 0.06 0.08 0.10 0.05 0.11 0.08 0.10 0.12 0.07 0.31 0.10 0.15 0.29 
1,2,3,7,8,9-HexaCDF 0.01 0.01 <0.01 0.01 0.01 0.05 0.02 0.01 0.01 0.06 <0.01 0.01 0.05 
1,2,3,4,6,7,8-HeptaCDF 0.03 0.04 0.04 0.04 0.05 0.05 0.04 0.06 0.05 0.24 0.04 0.06 0.18 
1,2,3,4,7,8,9-HeptaCDF <0.01 0.01 <0.01 0.01 0.01 0.04 0.02 0.01 0.01 0.01 0.01 <0.01 0.01 
OctaCDF 0.01 0.01 0.02 0.02 0.01 0.06 0.02 0.03 0.03 0.14 0.02 0.05 0.12 
2,3,7,8-TetraCDD 0.10 0.09 0.17 0.17 0.11 0.13 0.11 0.13 0.09 0.31 0.17 0.14 0.20 
12378-PentaCDD 0.15 0.18 0.27 0.13 0.23 0.22 0.19 0.27 0.15 0.80 0.27 0.43 0.64 
1,2,3,4,7,8-HexaCDD 0.03 0.03 0.06 0.03 0.05 0.05 0.04 0.06 0.03 0.56 0.06 0.08 0.43 
1,2,3,6,7,8-HexaCDD 0.12 0.12 0.19 0.10 0.17 0.12 0.12 0.20 0.11 2.76 0.19 0.34 1.75 
1,2,3,7,8,9-HexaCDD 0.02 0.03 0.05 0.02 0.04 0.05 0.04 0.05 0.03 0.15 0.05 0.05 0.12 
1,2,3,4,6,7,8-HeptaCDD 0.04 0.05 0.07 0.05 0.07 0.07 0.06 0.09 0.04 0.47 0.07 0.09 0.35 
OctaCDD 0.09 0.08 0.14 0.06 0.06 0.13 0.08 0.09 0.06 0.23 0.14 0.10 0.20 
WHO2005-PCDD/F-TEQ (LB) 0.42 0.48 0.71 0.42 0.59 0.56 0.55 0.62 0.42 1.89 0.71 0.68 1.52 
WHO2005-PCDD/F-TEQ (UB) 0.42 0.48 0.71 0.42 0.59 0.56 0.55 0.62 0.42 1.89 0.71 0.68 1.52 
WHO1998-PCDD/F-TEQ (UB) 0.51 0.58 0.86 0.48 0.72 0.66 0.67 0.72 0.51 2.07 0.86 0.68 1.71 
HBCDs (pg g-1)              
α-HBCD NA NA NA NA NA NA NA NA NA NA NA NA NA 
β-HBCD NA NA NA NA NA NA NA NA NA NA NA NA NA 
γ-HBCD NA NA NA NA NA NA NA NA NA NA NA NA NA 
Total-HBCD (LB) NA NA NA NA NA NA NA NA NA NA NA NA NA 
Total-HBCD (UB) NA NA NA NA NA NA NA NA NA NA NA NA NA 
 
NA - not analyzed 
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Annex 8 continues 
Sample Nr. 16/14 17/14 18/14 19/14 20/14 21/14 22/14 23/14 24/14 25/14 26/14 27/14 28/14 29/14 30/14 
Length, cm 68 64 71 53 68 58 84 96 86 84 99 93 90 89 84 
Weight, kg 0.5 0.4 0.5 0.2 0.5 0.3 1.0 1.9 1.1 0.9 1.5 1.4 1.2 1.3 1.0 
Place of sampling Usmas Usmas Usmas Usmas Usmas Usmas Sivers Sivers Sivers Sivers Sivers Sivers Sivers Sivers Sivers 
 Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake 
Fat content, g/100 g of sample 24.3 21.9 22.1 27.6 24.0 22.4 25.2 26.8 23.9 26.0 22.9 23.8 25.5 25.9 27.1 
PCDD/Fs (pg g-1)                               
2,3,7,8-TetraCDF 0.02 0.03 0.01 0.26 0.02 0.03 0.89 0.27 0.73 0.23 0.35 0.38 0.35 0.16 0.25 
1,2,3,7,8-PentaCDF 0.01 0.02 0.01 0.10 0.02 0.02 0.31 0.10 0.73 0.08 0.15 0.08 <0.04 0.08 0.10 
2,3,4,7,8-PentaCDF 0.70 0.74 0.85 0.61 0.49 0.29 0.93 0.81 1.23 0.81 0.92 0.67 0.89 2.02 0.59 
1,2,3,4,7,8-HexaCDF 0.38 0.20 0.35 0.16 0.26 0.10 0.31 0.18 0.59 0.16 0.20 0.15 0.18 0.25 0.16 
1,2,3,6,7,8-HexaCDF 0.34 0.19 0.32 0.16 0.22 0.10 0.37 0.18 0.60 0.14 0.20 0.15 0.16 0.25 0.17 
2,3,4,6,7,8-HexaCDF 0.22 0.25 0.30 0.19 0.28 0.11 0.30 0.19 0.56 0.13 0.19 0.15 0.17 0.26 0.17 
1,2,3,7,8,9-HexaCDF 0.01 0.02 0.01 0.04 0.02 0.01 0.17 0.08 0.33 0.04 0.10 0.04 0.04 0.04 0.08 
1,2,3,4,6,7,8-HeptaCDF 0.19 0.11 0.14 0.11 0.14 0.06 0.30 0.10 0.43 0.07 0.12 0.07 0.08 0.08 0.13 
1,2,3,4,7,8,9-HeptaCDF 0.02 0.02 0.02 <0.01 0.02 0.01 <0.03 <0.01 <0.05 <0.01 0.01 <0.01 <0.01 0.01 <0.01 
OctaCDF 0.03 0.02 0.02 0.12 0.02 0.03 0.50 0.12 0.99 0.08 0.22 0.11 0.16 0.09 0.16 
2,3,7,8-TetraCDD 0.09 0.07 0.10 0.12 0.05 0.04 0.30 0.20 0.62 <0.07 0.21 0.10 0.43 0.26 0.15 
12378-PentaCDD 0.66 0.35 0.60 0.26 0.25 0.11 0.56 0.38 0.53 0.28 0.37 0.32 0.08 0.61 0.29 
1,2,3,4,7,8-HexaCDD 0.43 0.09 0.30 0.11 0.10 0.04 0.40 0.11 0.88 0.11 0.15 0.09 0.19 0.12 0.12 
1,2,3,6,7,8-HexaCDD 2.17 0.36 1.46 0.28 0.46 0.14 0.91 0.23 1.50 0.33 0.32 0.26 0.36 0.48 0.26 
1,2,3,7,8,9-HexaCDD 0.08 0.07 0.11 0.10 0.12 0.04 0.35 0.11 0.65 0.07 0.14 0.08 0.09 0.09 0.11 
1,2,3,4,6,7,8-HeptaCDD 0.38 0.12 0.29 0.13 0.21 0.21 0.34 0.12 0.60 0.12 0.15 0.11 0.14 0.11 0.14 
OctaCDD 0.13 0.12 0.14 0.14 0.14 0.10 0.48 0.17 1.14 0.14 0.23 0.15 0.14 0.11 0.18 
WHO2005-PCDD/F-TEQ (LB) 1.33 0.76 1.24 0.70 0.60 0.29 1.52 0.97 2.14 0.65 1.03 0.76 0.94 1.65 0.76 
WHO2005-PCDD/F-TEQ (UB) 1.33 0.76 1.24 0.70 0.60 0.29 1.52 0.97 2.14 0.72 1.03 0.76 0.94 1.65 0.76 
WHO1998-PCDD/F-TEQ (UB) 1.47 0.91 1.41 0.82 0.70 0.35 1.71 1.13 2.40 0.88 1.22 0.89 1.12 2.06 0.88 
HBCDs (pg g-1)                
α-HBCD NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 
β-HBCD NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 
γ-HBCD NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 
Total-HBCD (LB) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 
Total-HBCD (UB) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 
 
NA - not analyzed 
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Annex 8 continues 
Sample Nr. 31/14 32/14 33/14 34/14 35/14 36/14 37/14 38/14 39/14 40/14 41/14 42/14 43/14 1 2 
Length, cm 89 93 72 82 75 94 101 95 94 92 95 83 83 55 50 
Weight, kg 1.1 1.3 0.6 0.9 0.6 1.6 1.8 1.6 1.4 1.5 1.3 0.9 1.0 0.8 1.0 
Place of sampling Sivers Sivers Liepajas Liepajas Liepajas Kisezers Kisezers Kisezers Kisezers Kisezers Liepajas Liepajas Liepajas Usmas Usmas 
 Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake 
Fat content, g/100 g of sample 23.0 25.5 28.9 41.3 33.2 37.0 36.9 34.7 27.2 32.2 27.2 32.1 34.2 24.4 20.6 
PCDD/Fs (pg g-1)                               
2,3,7,8-TetraCDF <0.08 <0.29 0.23 0.63 0.36 0.33 0.58 0.28 0.50 0.61 0.68 0.26 0.49 0.05 0.03 
1,2,3,7,8-PentaCDF 0.06 0.04 0.05 0.18 0.06 0.07 0.16 0.06 0.07 0.16 0.09 0.05 0.07 0.03 0.03 
2,3,4,7,8-PentaCDF 0.78 1.20 1.57 3.68 0.87 1.03 1.57 1.97 1.63 1.36 1.35 1.69 1.59 1.00 0.56 
1,2,3,4,7,8-HexaCDF 0.16 0.15 0.38 0.30 0.46 0.16 0.31 0.23 0.14 0.19 0.17 0.28 0.17 0.21 0.10 
1,2,3,6,7,8-HexaCDF 0.17 0.16 0.20 0.25 0.21 0.15 0.32 0.17 0.14 0.17 0.14 0.23 0.12 0.21 0.11 
2,3,4,6,7,8-HexaCDF 0.18 0.15 0.18 0.22 0.15 0.17 0.31 0.18 0.15 0.16 0.12 0.21 0.14 0.20 0.07 
1,2,3,7,8,9-HexaCDF 0.05 0.02 0.06 0.04 <0.01 0.04 0.12 0.02 <0.02 0.07 0.03 0.01 <0.01 <0.01 <0.01 
1,2,3,4,6,7,8-HeptaCDF 0.08 0.05 0.07 0.13 0.09 0.09 0.20 0.07 0.06 0.10 0.05 0.09 0.04 0.13 0.07 
1,2,3,4,7,8,9-HeptaCDF <0.01 <0.01 0.01 0.01 <0.02 0.01 <0.03 <0.01 <0.01 0.01 <0.01 0.01 <0.01 <0.03 <0.02 
OctaCDF 0.11 0.31 0.10 0.08 0.10 0.09 0.28 0.08 0.06 0.17 0.07 0.04 0.03 0.04 0.02 
2,3,7,8-TetraCDD 0.11 0.30 0.17 0.55 1.00 0.24 0.67 0.37 0.41 0.43 0.47 0.85 1.29 0.10 0.06 
12378-PentaCDD 0.36 0.48 0.46 0.87 0.45 0.32 0.41 0.47 0.32 0.43 0.44 0.54 0.58 0.31 0.21 
1,2,3,4,7,8-HexaCDD 0.09 0.09 0.15 0.13 0.09 0.09 0.24 0.11 0.06 0.12 0.06 0.10 0.07 0.09 0.05 
1,2,3,6,7,8-HexaCDD 0.24 0.26 0.33 0.39 0.30 0.26 0.44 0.38 0.24 0.25 0.19 0.32 0.22 0.31 0.17 
1,2,3,7,8,9-HexaCDD 0.08 0.07 0.11 0.10 0.06 0.07 0.20 0.07 <0.02 0.12 0.06 0.09 0.08 0.07 0.03 
1,2,3,4,6,7,8-HeptaCDD 0.11 0.08 0.18 0.10 0.17 0.10 0.20 0.11 0.09 0.13 0.10 0.16 0.10 0.12 0.08 
OctaCDD 0.14 0.52 0.33 0.13 0.53 0.16 0.39 0.19 0.14 0.21 0.13 0.13 0.21 0.10 0.08 
WHO2005-PCDD/F-TEQ (LB) 0.80 1.24 1.27 2.74 1.87 1.01 1.82 1.57 1.34 1.44 1.47 2.05 2.48 0.83 0.50 
WHO2005-PCDD/F-TEQ (UB) 0.81 1.27 1.27 2.74 1.88 1.01 1.82 1.57 1.35 1.44 1.47 2.05 2.48 0.83 0.50 
WHO1998-PCDD/F-TEQ (UB) 0.97 1.51 1.58 3.48 2.05 1.21 2.13 1.97 1.68 1.72 1.74 2.39 2.80 1.03 0.61 
HBCDs (pg g-1)                
α-HBCD NA NA NA NA NA NA NA NA NA NA NA NA NA 168 188 
β-HBCD NA NA NA NA NA NA NA NA NA NA NA NA NA 60.0 34.8 
γ-HBCD NA NA NA NA NA NA NA NA NA NA NA NA NA 18.0 17.2 
Total-HBCD (LB) NA NA NA NA NA NA NA NA NA NA NA NA NA 246 240 
Total-HBCD (UB) NA NA NA NA NA NA NA NA NA NA NA NA NA 246 240 
 
NA - not analyzed 
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Annex 8 continues 
Sample Nr. 3 4 5 6 7 8 1a 2a 3a 4a 5a 6a 7a 8a 9a 
Length, cm 55 67 55 55 55 50 87 40 77 81 79 75 39 42 42 
Weight, kg 0.9 1.7 0.9 1.1 0.9 0.9 1.2 0.1 0.9 1.0 0.9 0.9 1.0 0.1 0.1 
Place of sampling Usmas Usmas Usmas Usmas Usmas Usmas Usmas Usmas Usmas Usmas Usmas Usmas Usmas Usmas Usmas 
 Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake 
Fat content, g/100 g of sample 26.0 29.4 22.8 24.4 24.2 23.7 21.2 31.5 29.2 30.0 28.0 23.1 30.1 35.2 31.7 
PCDD/Fs (pg g-1)                               
2,3,7,8-TetraCDF 0.04 0.10 0.05 0.08 0.04 0.06 0.05 0.05 0.03 <0.03 0.04 0.02 0.02 0.04 0.04 
1,2,3,7,8-PentaCDF 0.02 0.05 <0.01 0.05 0.03 0.04 0.03 0.05 0.02 <0.02 0.03 0.02 0.02 0.02 0.02 
2,3,4,7,8-PentaCDF 0.69 1.42 0.88 1.27 1.26 1.80 1.08 2.35 1.82 1.32 1.32 1.50 0.68 1.38 0.56 
1,2,3,4,7,8-HexaCDF 0.12 0.37 0.23 0.41 0.29 0.33 0.21 0.95 0.30 0.37 0.28 0.37 0.38 0.58 0.07 
1,2,3,6,7,8-HexaCDF 0.13 0.34 0.19 0.44 0.28 0.29 0.17 0.89 0.31 0.33 0.23 0.33 0.33 0.54 0.07 
2,3,4,6,7,8-HexaCDF 0.12 0.33 0.20 0.36 0.24 0.29 0.14 0.80 0.29 0.34 0.26 0.35 0.40 0.51 0.08 
1,2,3,7,8,9-HexaCDF <0.01 <0.01 0.23 0.32 <0.01 <0.01 0.01 0.03 0.01 <0.02 0.02 0.01 0.01 0.02 0.01 
1,2,3,4,6,7,8-HeptaCDF 0.08 0.12 0.10 0.12 0.10 0.12 0.05 0.37 0.11 0.20 0.10 0.12 0.20 0.29 0.05 
1,2,3,4,7,8,9-HeptaCDF <0.05 <0.02 <0.03 <0.03 <0.03 <0.02 0.01 0.03 0.02 0.04 0.01 0.02 0.03 0.02 0.004 
OctaCDF 0.04 0.03 0.03 0.02 0.02 0.03 0.01 0.06 <0.01 0.05 0.03 0.02 0.03 0.02 0.02 
2,3,7,8-TetraCDD 0.08 0.18 0.09 0.14 0.14 0.17 0.10 0.22 0.16 0.12 0.14 0.13 0.06 0.14 0.14 
12378-PentaCDD 0.37 0.52 0.43 0.50 0.66 0.73 0.32 1.31 0.56 0.64 0.51 0.51 0.27 0.78 0.22 
1,2,3,4,7,8-HexaCDD 0.07 0.08 0.10 0.15 0.13 0.14 0.07 0.76 0.11 0.14 0.14 0.13 0.13 0.38 0.04 
1,2,3,6,7,8-HexaCDD 0.22 0.53 0.37 0.34 0.63 0.66 0.29 2.89 0.52 0.55 0.48 0.62 0.58 1.36 0.10 
1,2,3,7,8,9-HexaCDD 0.05 0.10 0.06 <0.08 0.06 0.09 0.04 0.40 0.06 0.10 0.10 0.09 0.17 0.20 0.02 
1,2,3,4,6,7,8-HeptaCDD 0.09 0.15 0.14 0.14 0.14 0.14 0.14 1.02 0.13 0.39 0.15 0.18 0.33 0.52 0.05 
OctaCDD 0.12 0.09 0.11 0.11 0.11 0.11 0.06 0.32 0.08 0.19 0.09 0.13 0.16 0.22 0.07 
WHO2005-PCDD/F-TEQ (LB) 0.73 1.31 0.93 1.23 1.35 1.63 0.84 2.93 1.43 1.34 1.20 1.29 0.74 1.71 0.58 
WHO2005-PCDD/F-TEQ (UB) 0.74 1.31 0.93 1.24 1.35 1.63 0.84 2.93 1.43 1.35 1.20 1.29 0.74 1.71 0.58 
WHO1998-PCDD/F-TEQ (UB) 0.87 1.59 1.11 1.50 1.60 1.99 1.06 3.40 1.79 1.61 1.46 1.59 0.87 1.98 0.69 
HBCDs (pg g-1)                
α-HBCD 168 168 188 269 360 562 NA NA NA NA NA NA NA NA NA 
β-HBCD 64.0 35.0 30.0 34.8 <13.0 22.0 NA NA NA NA NA NA NA NA NA 
γ-HBCD 24.0 21.0 13.2 16.0 12.0 12.8 NA NA NA NA NA NA NA NA NA 
Total-HBCD (LB) 256 224 231 320 372 597 NA NA NA NA NA NA NA NA NA 
Total-HBCD (UB) 256 224 231 320 385 597 NA NA NA NA NA NA NA NA NA 
 
NA - not analyzed 
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Annex 9 
Concentrations of PBDD/Fs, PXDD/Fs and PXBs in eel samples calculated on f.w. basis 
Sample Nr. 1/14 2/14 3/14 4/14 5/14 6/14 7/14 8/14 9/14 12/14 13/14 14/14 15/14 
Length, cm 81 83 95 78 74 82 76 88 76 70 78 85 71 
Weight, kg 1.0 1.1 1.6 0.8 0.8 1.1 0.8 1.0 0.9 0.6 0.8 1.0 0.5 
Place of sampling Aluksnes Aluksnes Aluksnes Aluksnes Aluksnes Aluksnes Aluksnes Aluksnes Aluksnes Usmas Usmas Usmas Usmas 
 Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake 
Fat content, g/100 g of sample 28.8 20.3 29.1 23.8 28 26.6 35.3 21.2 24.4 21.2 22.0 26.9 21.8 
PBDD/Fs (pg g-1)                           
2,3,7,8-TetraBDF <0.01 <0.02 <0.01 0.02 0.02 <0.02 0.03 0.02 <0.01 <0.01 0.02 0.03 <0.004 
1,2,3,7,8-PentaBDF <0.02 0.06 <0.01 <0.01 <0.02 <0.04 <0.01 <0.02 <0.01 <0.01 <0.02 <0.01 <0.01 
2,3,4,7,8-PentaBDF <0.02 <0.03 <0.01 0.02 <0.02 <0.04 <0.01 <0.02 <0.01 <0.01 <0.02 0.03 <0.01 
1,2,3,4,7,8-HexaBDF <0.08 <0.14 <0.08 0.04 <0.08 <0.09 <0.05 <0.05 <0.05 <0.03 0.10 0.13 <0.04 
1,2,3,4,6,7,8-HeptaBDF 0.28 0.36 0.17 0.18 0.24 0.27 0.46 0.18 0.11 0.07 0.32 0.41 0.05 
2,3,7,8-TetraBDD <0.01 <0.01 <0.004 <0.002 <0.004 <0.02 <0.004 <0.01 <0.004 <0.003 <0.004 <0.004 <0.003 
1,2,3,7,8-PentaBDD <0.02 <0.02 <0.01 <0.01 <0.02 <0.05 <0.02 <0.02 <0.01 <0.02 <0.02 <0.02 <0.01 
1,2,3,4,7,8/1,2,3,6,7,8-HexaBDD <0.07 <0.08 <0.04 <0.02 <0.04 <0.10 <0.05 <0.06 <0.04 <0.04 <0.03 <0.02 <0.02 
1,2,3,7,8,9-HexaBDD <0.04 <0.05 <0.03 <0.02 <0.03 <0.06 <0.03 <0.04 <0.02 <0.03 <0.02 <0.01 <0.02 
WHO2005-PBDD/F-TEQ (LB) 0.003 0.01 0.002 0.01 0.004 0.003 0.01 0.003 0.001 0.001 0.02 0.03 0.001 
WHO2005-PBDD/F-TEQ (UB) 0.06 0.07 0.04 0.03 0.05 0.10 0.05 0.05 0.03 0.04 0.05 0.06 0.03 
PXDD/Fs (pg g-1)                           
3-Br-2,7,8-TriClDF <0.03 <0.04 <0.01 <0.01 <0.01 <0.02 <0.01 <0.01 <0.01 <0.002 <0.01 <0.02 <0.004 
2-Br-3,7,8-TriClDD <0.07 <0.18 <0.01 <0.02 <0.04 <0.07 <0.04 <0.03 <0.02 <0.01 <0.02 <0.004 <0.01 
2,3-DiBr-7,8-DiClDD <0.03 <0.06 <0.01 <0.01 <0.01 <0.02 <0.01 <0.01 <0.01 <0.05 <0.01 <0.02 <0.06 
1-Br-2,3,7,8-TetraClDF <0.06 <0.06 <0.01 <0.01 <0.01 <0.04 <0.01 <0.01 <0.01 <0.003 <0.01 <0.03 <0.01 
1-Br-2,3,7,8-TetraClDD <0.03 <0.07 <0.01 <0.01 <0.01 <0.03 <0.02 <0.01 <0.01 <0.003 <0.02 <0.03 <0.01 
2-Br-1,3,7,8-TetraClDD <0.03 <0.06 <0.01 <0.01 <0.01 <0.03 <0.02 <0.01 <0.004 <0.003 <0.01 <0.03 <0.004 
2-Br-3,6,7,8,9-PentaClDD <0.02 <0.04 <0.003 <0.003 <0.01 <0.02 <0.01 <0.01 <0.003 <0.002 <0.004 0.01 <0.003 
1-Br-2,3,6,7,8,9-HexaClDD <0.08 <0.18 <0.01 <0.02 <0.03 <0.06 <0.03 <0.02 <0.01 <0.01 <0.02 <0.05 <0.01 
1-Br-2,3,4,6,7,8,9-HeptaClDD <0.14 <0.15 <0.02 <0.04 <0.05 <0.05 <0.03 <0.02 <0.02 <0.01 <0.03 <0.04 <0.02 
WHO2005-PXDD/F-TEQ (LB) ND ND ND ND ND ND ND ND ND ND ND 0.001 ND 
WHO2005-PXDD/F-TEQ (UB) 0.16 0.39 0.04 0.04 0.08 0.15 0.08 0.05 0.03 0.07 0.06 0.13 0.08 
PXBs (pg g-1)                           
4'-Br-2,3',4,5-Cl-XB (#118 mono-Br) 0.22 0.16 0.43 NA 0.29 0.32 0.23 0.41 0.32 NA 0.30 0.34 NA 
4'-Br-2,3,3',4-Cl-XB (#105 mono-Br) 0.08 0.05 0.14 NA 0.09 0.11 0.09 0.15 0.13 NA 0.12 0.15 NA 
4'-Br-2,3,3',4,5-Cl-XB (#156 mono-Br) 0.09 0.05 0.12 NA 0.06 0.08 <0.06 0.11 0.06 NA 0.13 0.13 NA 
4'-Br-3,3',4,5-Cl-XB (#126 mono-Br) 0.01 0.02 0.02 NA <0.01 0.02 0.02 <0.01 0.02 NA 0.01 0.02 NA 
3,4-Br-3',4',5'-Cl-XB (#126 di-Br) <0.004 <0.01 <0.01 NA <0.01 <0.01 <0.01 <0.01 <0.04 NA <0.01 <0.004 NA 
3',4',5-Br-3,4-Cl-XB (#126 tri-Br) <0.03 <0.06 <0.03 NA <0.03 <0.04 <0.05 <0.04 <0.04 NA <0.04 <0.03 NA 
WHO2005-PXB-TEQ (LB) 0.001 0.002 0.002 NA 0.00001 0.002 0.002 0.00002 0.002 NA 0.001 0.002 NA 
WHO2005-PXB-TEQ (UB) 0.004 0.01 0.01  NA 0.01 0.01 0.01 0.01 0.01 NA  0.01 0.01 NA  
ND - not detected since none of the analyzed congeners show the levels above the LOQ 
NA - not analyzed 
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Annex 9 continues 
Sample Nr. 16/14 17/14 18/14 19/14 20/14 21/14 22/14 23/14 24/14 25/14 26/14 27/14 28/14 29/14 30/14 
Length, cm 68 64 71 53 68 58 84 96 86 84 99 93 90 89 84 
Weight, kg 0.5 0.4 0.5 0.2 0.5 0.3 1.0 1.9 1.1 0.9 1.5 1.4 1.2 1.3 1.0 
Place of sampling Usmas Usmas Usmas Usmas Usmas Usmas Sivers Sivers Sivers Sivers Sivers Sivers Sivers Sivers Sivers 
 Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake 
Fat content, g/100 g of sample 24.3 21.9 22.1 27.6 24.0 22.4 25.2 26.8 23.9 26.0 22.9 23.8 25.5 25.9 27.1 
PBDD/Fs (pg g-1)                               
2,3,7,8-TetraBDF 0.02 0.02 0.02 <0.02 <0.01 0.03 0.05 0.10 <0.01 <0.01 0.25 <0.01 <0.01 <0.01 0.14 
1,2,3,7,8-PentaBDF <0.02 <0.01 0.03 <0.02 <0.01 <0.02 0.02 <0.02 <0.02 <0.02 <0.05 <0.01 <0.01 <0.01 <0.01 
2,3,4,7,8-PentaBDF 0.02 <0.01 <0.01 <0.02 <0.01 0.03 <0.01 <0.02 <0.02 <0.02 <0.04 <0.01 <0.01 <0.01 <0.01 
1,2,3,4,7,8-HexaBDF 0.20 <0.02 <0.06 <0.09 <0.06 0.14 <0.04 <0.11 <0.11 <0.08 <0.07 <0.07 <0.07 <0.02 <0.07 
1,2,3,4,6,7,8-HeptaBDF 1.05 0.16 0.22 0.16 0.31 0.84 0.12 0.21 0.03 0.11 0.17 0.09 0.16 0.05 0.06 
2,3,7,8-TetraBDD <0.01 <0.004 <0.003 <0.004 <0.01 0.01 <0.004 <0.004 <0.01 <0.01 <0.004 <0.002 <0.002 <0.07 <0.002 
1,2,3,7,8-PentaBDD <0.01 <0.01 <0.02 <0.05 <0.02 <0.02 <0.01 <0.01 <0.02 <0.02 <0.05 <0.01 <0.01 <0.02 <0.01 
1,2,3,4,7,8/1,2,3,6,7,8-HexaBDD <0.04 <0.02 <0.05 <0.07 <0.06 <0.03 <0.03 <0.03 <0.06 <0.03 <0.07 <0.05 <0.05 <0.04 <0.05 
1,2,3,7,8,9-HexaBDD <0.02 <0.01 <0.03 <0.04 <0.04 <0.02 <0.02 <0.02 <0.04 <0.02 <0.04 <0.03 <0.03 <0.02 <0.03 
WHO2005-PBDD/F-TEQ (LB) 0.04 0.004 0.01 0.002 0.003 0.04 0.01 0.01 0.0003 0.001 0.03 0.001 0.002 0.001 0.01 
WHO2005-PBDD/F-TEQ (UB) 0.06 0.02 0.04 0.09 0.05 0.06 0.04 0.05 0.06 0.04 0.12 0.04 0.04 0.10 0.05 
PXDD/Fs (pg g-1)                               
3-Br-2,7,8-TriClDF <0.01 0.01 <0.004 <0.01 <0.01 <0.01 <0.02 <0.004 <0.003 <0.003 <0.003 <0.01 <0.003 <0.003 <0.01 
2-Br-3,7,8-TriClDD <0.01 <0.01 <0.01 <0.01 <0.03 <0.03 <0.03 <0.01 <0.01 <0.01 <0.01 <0.03 <0.01 <0.01 <0.01 
2,3-DiBr-7,8-DiClDD <0.01 <0.01 <0.01 <0.08 <0.01 <0.02 <0.11 <0.05 <0.05 <0.05 <0.05 <0.12 <0.03 <0.08 <0.07 
1-Br-2,3,7,8-TetraClDF <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.04 <0.003 <0.004 <0.003 <0.004 <0.03 <0.01 <0.004 <0.01 
1-Br-2,3,7,8-TetraClDD <0.01 <0.01 <0.01 <0.02 <0.01 <0.01 <0.04 <0.01 <0.01 <0.01 <0.01 <0.04 <0.004 <0.01 <0.01 
2-Br-1,3,7,8-TetraClDD <0.01 <0.01 <0.01 <0.02 <0.01 <0.01 <0.03 <0.004 <0.01 <0.01 <0.004 <0.04 <0.003 <0.01 <0.01 
2-Br-3,6,7,8,9-PentaClDD 0.02 <0.04 0.01 <0.003 <0.004 <0.01 <0.01 <0.002 <0.002 <0.002 <0.002 <0.01 <0.002 <0.002 <0.004 
1-Br-2,3,6,7,8,9-HexaClDD <0.01 <0.02 <0.02 <0.01 <0.03 <0.03 <0.02 <0.01 <0.01 <0.01 <0.02 <0.03 <0.01 <0.01 <0.02 
1-Br-2,3,4,6,7,8,9-HeptaClDD <0.03 <0.02 <0.03 <0.03 <0.04 <0.04 <0.06 <0.02 <0.03 <0.02 <0.01 <0.05 <0.02 <0.01 <0.03 
WHO2005-PXDD/F-TEQ (LB) 0.002 0.001 0.001 ND ND ND ND ND ND ND ND ND ND ND ND 
WHO2005-PXDD/F-TEQ (UB) 0.04 0.04 0.05 0.13 0.06 0.06 0.21 0.07 0.07 0.08 0.07 0.23 0.05 0.10 0.11 
PXBs (pg g-1)                               
4'-Br-2,3',4,5-Cl-XB (#118 mono-Br) NA NA 0.15 NA 0.18 0.07 NA 0.66 NA NA 0.47 0.37 NA NA 0.23 
4'-Br-2,3,3',4-Cl-XB (#105 mono-Br) NA NA 0.07 NA 0.08 0.03 NA 0.27 NA NA 0.21 0.16 NA NA 0.10 
4'-Br-2,3,3',4,5-Cl-XB (#156 mono-Br) NA NA 0.08 NA <0.05 <0.04 NA <0.18 NA NA <0.28 0.10 NA NA <0.11 
4'-Br-3,3',4,5-Cl-XB (#126 mono-Br) NA NA 0.01 NA 0.01 0.01 NA 0.05 NA NA 0.03 0.01 NA NA 0.02 
3,4-Br-3',4',5'-Cl-XB (#126 di-Br) NA NA <0.01 NA <0.01 <0.003 NA <0.02 NA NA <0.02 <0.01 NA NA <0.01 
3',4',5-Br-3,4-Cl-XB (#126 tri-Br) NA NA <0.04 NA <0.04 <0.02 NA <0.05 NA NA <0.08 <0.02 NA NA <0.02 
WHO2005-PXB-TEQ (LB) NA NA 0.001 NA 0.001 0.001 NA 0.002 NA NA 0.001 0.001 NA NA 0.002 
WHO2005-PXB-TEQ (UB) NA NA 0.01  NA 0.01 0.003 NA  0.01 NA NA 0.01 0.004 NA NA 0.004 
ND - not detected since none of the analyzed congeners show the levels above the LOQ 
NA - not analyzed 
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Annex 9 continues 
Sample Nr. 31/14 32/14 33/14 34/14 35/14 36/14 37/14 38/14 39/14 40/14 41/14 42/14 43/14 1 2 
Length, cm 89 93 72 82 75 94 101 95 94 92 95 83 83 55 50 
Weight, kg 1.1 1.3 0.6 0.9 0.6 1.6 1.8 1.6 1.4 1.5 1.3 0.9 1.0 0.8 1.0 
Place of sampling Sivers Sivers Liepajas Liepajas Liepajas Kisezers Kisezers Kisezers Kisezers Kisezers Liepajas Liepajas Liepajas Usmas Usmas 
 Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake 
Fat content, g/100 g of sample 23.0 25.5 28.9 41.3 33.2 37.0 36.9 34.7 27.2 32.2 27.2 32.1 34.2 24.4 20.6 
PBDD/Fs (pg g-1)                               
2,3,7,8-TetraBDF 0.07 <0.01 <0.01 <0.01 <0.01 0.17 0.12 <0.01 <0.01 <0.05 <0.02 0.21 <0.01 0.02 0.03 
1,2,3,7,8-PentaBDF <0.01 <0.01 <0.05 <0.01 <0.01 <0.01 0.02 <0.01 <0.02 <0.01 <0.02 <0.01 <0.01 <0.01 0.02 
2,3,4,7,8-PentaBDF <0.01 0.02 <0.04 <0.01 <0.01 <0.01 <0.02 <0.01 <0.02 0.02 <0.02 <0.01 <0.01 <0.01 <0.01 
1,2,3,4,7,8-HexaBDF <0.03 <0.03 <0.07 0.14 <0.07 <0.03 <0.09 <0.03 <0.07 <0.05 <0.09 <0.05 <0.07 <0.05 0.12 
1,2,3,4,6,7,8-HeptaBDF 0.09 0.19 0.13 0.28 0.26 0.22 0.20 0.15 0.13 0.09 0.14 0.16 0.12 0.13 0.08 
2,3,7,8-TetraBDD <0.003 <0.004 <0.002 <0.003 <0.002 <0.004 <0.004 <0.003 <0.01 <0.09 <0.01 <0.09 <0.002 <0.002 0.01 
1,2,3,7,8-PentaBDD 0.04 <0.01 <0.01 <0.02 <0.01 <0.01 <0.01 <0.01 <0.03 <0.02 <0.03 <0.01 <0.01 <0.01 <0.02 
1,2,3,4,7,8/1,2,3,6,7,8-HexaBDD <0.03 0.05 <0.05 <0.02 <0.05 <0.03 <0.03 <0.08 <0.06 <0.05 <0.09 <0.05 <0.07 <0.03 <0.04 
1,2,3,7,8,9-HexaBDD <0.02 <0.02 0.05 <0.01 <0.03 <0.02 <0.02 <0.05 <0.04 <0.03 0.14 <0.03 <0.04 <0.02 <0.03 
WHO2005-PBDD/F-TEQ (LB) 0.04 0.01 0.01 0.02 0.003 0.02 0.01 0.002 0.001 0.01 0.02 0.02 0.001 0.003 0.02 
WHO2005-PBDD/F-TEQ (UB) 0.06 0.03 0.05 0.04 0.04 0.05 0.05 0.04 0.06 0.13 0.08 0.14 0.04 0.03 0.05 
PXDD/Fs (pg g-1)                               
3-Br-2,7,8-TriClDF <0.002 <0.01 <0.003 <0.002 <0.01 <0.003 <0.01 <0.003 <0.004 <0.002 0.01 <0.003 <0.003 <0.003 0.01 
2-Br-3,7,8-TriClDD <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.03 <0.01 <0.02 <0.01 <0.02 <0.01 <0.01 <0.01 <0.01 
2,3-DiBr-7,8-DiClDD <0.02 <0.04 <0.05 <0.09 <0.12 <0.07 <0.08 <0.04 <0.06 <0.08 <0.13 <0.03 <0.08 <0.003 <0.003 
1-Br-2,3,7,8-TetraClDF <0.004 <0.01 <0.004 <0.01 <0.01 <0.01 <0.01 <0.002 <0.004 <0.003 <0.01 <0.01 <0.04 <0.004 0.01 
1-Br-2,3,7,8-TetraClDD <0.003 <0.02 <0.01 <0.004 <0.01 <0.004 <0.02 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.004 <0.01 
2-Br-1,3,7,8-TetraClDD <0.003 <0.01 <0.004 <0.004 <0.01 <0.003 <0.02 <0.01 <0.01 <0.01 <0.01 <0.004 <0.004 <0.003 <0.01 
2-Br-3,6,7,8,9-PentaClDD <0.002 <0.003 <0.002 <0.002 <0.003 <0.002 <0.01 <0.003 <0.003 <0.002 <0.01 <0.002 <0.003 <0.002 0.01 
1-Br-2,3,6,7,8,9-HexaClDD <0.01 <0.02 <0.01 <0.01 <0.01 <0.01 <0.02 <0.01 <0.01 <0.01 <0.02 <0.01 <0.01 <0.02 <0.01 
1-Br-2,3,4,6,7,8,9-HeptaClDD <0.01 <0.02 <0.02 <0.02 <0.02 <0.02 <0.05 <0.01 <0.02 <0.01 <0.02 <0.01 <0.02 <0.02 <0.02 
WHO2005-PXDD/F-TEQ (LB) ND ND ND ND ND ND ND ND ND ND 0.001 ND ND ND 0.002 
WHO2005-PXDD/F-TEQ (UB) 0.04 0.08 0.07 0.11 0.15 0.08 0.15 0.07 0.09 0.10 0.17 0.05 0.10 0.02 0.02 
PXBs (pg g-1)                               
4'-Br-2,3',4,5-Cl-XB (#118 mono-Br) NA NA 0.58 NA 3.18 NA NA NA NA 0.87 0.84 1.45 NA NA NA 
4'-Br-2,3,3',4-Cl-XB (#105 mono-Br) NA NA 0.22 NA 0.77 NA NA NA NA 0.26 0.24 0.52 NA NA NA 
4'-Br-2,3,3',4,5-Cl-XB (#156 mono-Br) NA NA <0.16 NA <0.30 NA NA NA NA <0.21 <0.11 <0.26 NA NA NA 
4'-Br-3,3',4,5-Cl-XB (#126 mono-Br) NA NA 0.03 NA 0.01 NA NA NA NA 0.02 0.02 0.03 NA NA NA 
3,4-Br-3',4',5'-Cl-XB (#126 di-Br) NA NA <0.01 NA <0.01 NA NA NA NA <0.01 <0.01 <0.01 NA NA NA 
3',4',5-Br-3,4-Cl-XB (#126 tri-Br) NA NA <0.02 NA <0.01 NA NA NA NA <0.02 <0.01 <0.02 NA NA NA 
WHO2005-PXB-TEQ (LB) NA NA 0.003 NA 0.001 NA NA NA NA 0.002 0.002 0.003 NA NA NA 
WHO2005-PXB-TEQ (UB) NA NA 0.01  NA 0.003 NA NA NA NA 0.01 0.003 0.01 NA NA NA 
ND - not detected since none of the analyzed congeners show the levels above the LOQ 
NA - not analyzed 
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Annex 9 continues 
Sample Nr. 3 4 5 6 7 8 1a 2a 3a 4a 5a 6a 7a 8a 9a 
Length, cm 55 67 55 55 55 50 87 40 77 81 79 75 39 42 42 
Weight, kg 0.9 1.7 0.9 1.1 0.9 0.9 1.2 0.1 0.9 1.0 0.9 0.9 1.0 0.1 0.1 
Place of sampling Usmas Usmas Usmas Usmas Usmas Usmas Usmas Usmas Usmas Usmas Usmas Usmas Usmas Usmas Usmas 
 Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake 
Fat content, g/100 g of sample 26.0 29.4 22.8 24.4 24.2 23.7 21.2 31.5 29.2 30.0 28.0 23.1 30.1 35.2 31.7 
PBDD/Fs (pg g-1)                               
2,3,7,8-TetraBDF 0.03 0.02 0.04 <0.01 0.02 <0.004 0.03 0.03 <0.01 <0.02 0.03 0.03 0.03 0.02 <0.01 
1,2,3,7,8-PentaBDF <0.01 <0.02 <0.01 <0.01 <0.01 <0.01 <0.02 <0.01 <0.02 <0.02 <0.05 0.02 <0.02 <0.02 <0.01 
2,3,4,7,8-PentaBDF <0.01 <0.02 0.03 <0.01 <0.01 <0.01 0.02 <0.01 <0.02 <0.02 <0.04 <0.01 <0.02 0.02 <0.01 
1,2,3,4,7,8-HexaBDF 0.10 <0.04 0.08 0.10 <0.04 <0.03 <0.06 0.06 <0.08 <0.09 <0.07 <0.07 <0.07 <0.11 <0.03 
1,2,3,4,6,7,8-HeptaBDF 0.43 0.15 0.33 0.45 0.21 0.23 0.52 0.24 0.28 0.58 0.15 0.11 0.20 0.37 0.15 
2,3,7,8-TetraBDD <0.003 <0.002 <0.003 <0.002 0.01 <0.003 <0.01 <0.004 <0.01 <0.01 <0.004 <0.002 <0.01 <0.01 <0.004 
1,2,3,7,8-PentaBDD <0.02 <0.02 <0.01 <0.01 <0.01 <0.01 <0.02 <0.01 <0.01 <0.03 <0.05 <0.01 <0.03 <0.02 <0.01 
1,2,3,4,7,8/1,2,3,6,7,8-HexaBDD <0.02 <0.03 <0.02 <0.03 <0.03 <0.02 <0.03 <0.03 <0.08 <0.09 <0.07 <0.05 <0.06 <0.06 <0.03 
1,2,3,7,8,9-HexaBDD <0.01 <0.02 <0.02 <0.02 <0.02 <0.01 <0.02 <0.02 <0.05 <0.06 <0.04 <0.03 <0.04 <0.04 <0.02 
WHO2005-PBDD/F-TEQ (LB) 0.02 0.003 0.02 0.01 0.01 0.002 0.01 0.01 0.003 0.01 0.01 0.01 0.01 0.01 0.001 
WHO2005-PBDD/F-TEQ (UB) 0.04 0.04 0.04 0.04 0.04 0.02 0.05 0.04 0.05 0.08 0.09 0.04 0.06 0.06 0.03 
PXDD/Fs (pg g-1)                               
3-Br-2,7,8-TriClDF <0.01 <0.004 <0.003 0.004 0.01 0.003 0.01 <0.01 <0.01 <0.03 <0.01 <0.01 <0.004 <0.004 <0.01 
2-Br-3,7,8-TriClDD <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.02 <0.01 <0.04 <0.05 <0.02 <0.02 <0.01 <0.01 <0.02 
2,3-DiBr-7,8-DiClDD <0.01 <0.01 <0.003 <0.003 <0.01 <0.01 <0.004 <0.01 <0.01 <0.01 <0.004 <0.004 <0.004 <0.01 <0.01 
1-Br-2,3,7,8-TetraClDF <0.02 <0.003 <0.01 <0.01 <0.01 <0.004 <0.01 <0.01 <0.01 <0.06 <0.01 <0.01 <0.01 <0.01 <0.01 
1-Br-2,3,7,8-TetraClDD <0.02 <0.01 <0.003 <0.01 <0.01 <0.004 <0.01 <0.01 <0.02 <0.10 <0.01 <0.01 <0.01 <0.01 <0.01 
2-Br-1,3,7,8-TetraClDD <0.02 <0.01 <0.003 <0.04 <0.01 <0.003 <0.01 <0.01 <0.02 <0.09 <0.01 <0.01 <0.01 <0.01 <0.01 
2-Br-3,6,7,8,9-PentaClDD <0.01 <0.002 <0.001 <0.002 <0.003 <0.003 <0.003 <0.002 <0.01 <0.03 <0.01 <0.01 <0.003 0.01 <0.004 
1-Br-2,3,6,7,8,9-HexaClDD <0.03 <0.01 <0.01 <0.01 <0.01 <0.01 <0.02 <0.01 <0.01 <0.06 <0.04 <0.01 <0.01 <0.02 <0.02 
1-Br-2,3,4,6,7,8,9-HeptaClDD <0.04 <0.02 <0.02 <0.01 <0.02 <0.01 <0.03 <0.03 <0.02 <0.07 <0.03 <0.02 <0.02 <0.03 <0.02 
WHO2005-PXDD/F-TEQ (LB) ND ND ND 0.0004 0.001 0.0003 0.001 ND ND ND ND ND ND 0.001 ND 
WHO2005-PXDD/F-TEQ (UB) 0.06 0.04 0.02 0.02 0.03 0.02 0.03 0.03 0.09 0.25 0.04 0.05 0.02 0.03 0.05 
PXBs (pg g-1)                               
4'-Br-2,3',4,5-Cl-XB (#118 mono-Br) NA 0.31 NA NA 0.43 0.56 0.20 NA NA NA NA NA NA NA NA 
4'-Br-2,3,3',4-Cl-XB (#105 mono-Br) NA 0.15 NA NA 0.18 0.22 0.10 NA NA NA NA NA NA NA NA 
4'-Br-2,3,3',4,5-Cl-XB (#156 mono-Br) NA 0.10 NA NA 0.18 0.24 0.08 NA NA NA NA NA NA NA NA 
4'-Br-3,3',4,5-Cl-XB (#126 mono-Br) NA 0.03 NA NA 0.02 0.03 0.02 NA NA NA NA NA NA NA NA 
3,4-Br-3',4',5'-Cl-XB (#126 di-Br) NA <0.004 NA NA <0.01 <0.01 <0.004 NA NA NA NA NA NA NA NA 
3',4',5-Br-3,4-Cl-XB (#126 tri-Br) NA <0.03 NA NA <0.03 <0.03 <0.03 NA NA NA NA NA NA NA NA 
WHO2005-PXB-TEQ (LB) NA 0.003 NA NA 0.002 0.003 0.002 NA NA NA NA NA NA NA NA 
WHO2005-PXB-TEQ (UB) NA 0.01 NA NA 0.01 0.01 0.01 NA NA NA NA NA NA NA NA 
ND - not detected since none of the analyzed congeners show the levels above the LOQ 
NA - not analyzed 
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 Annex 10 
Concentrations of DL-PCBs and NDL-PCBs in eel samples calculated on f.w. basis 
Sample Nr. 1/14 2/14 3/14 4/14 5/14 6/14 7/14 8/14 9/14 12/14 13/14 14/14 15/14 
Length, cm 81 83 95 78 74 82 76 88 76 70 78 85 71 
Weight, kg 1.0 1.1 1.6 0.8 0.8 1.1 0.8 1.0 0.9 0.6 0.8 1.0 0.5 
Place of sampling Aluksnes Aluksnes Aluksnes Aluksnes Aluksnes Aluksnes Aluksnes Aluksnes Aluksnes Usmas Usmas Usmas Usmas 
 Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake 
Fat content, g/100 g of sample 28.8 20.3 29.1 23.8 28.0 26.6 35.3 21.2 24.4 21.2 22.0 26.9 21.8 
DL-PCBs (pg g-1)                           
2',3,4,4',5-PentaCB (#123) 141 87.9 240 188 169 145 82.7 170 124 146 31.4 76.0 78.2 
2,3',4,4',5-PentaCB (#118) 6150 4990 7180 6620 6520 6570 4880 6830 6100 8030 3670 3660 4430 
2,3,4,4',5-PentaCB (#114) 202 134 379 388 236 230 149 315 232 182 104 116 102 
2,3,3,'4,4'-PentaCB (#105) 2580 1840 4490 4410 2850 2980 1750 3960 3140 2430 1350 1500 1480 
2,3',4,4',5,5'-HexaCB (#167) 486 318 931 695 568 535 321 769 543 387 444 433 267 
2,3,3',4,4',5-HexaCB (#156) 1010 655 1740 1530 1150 1090 645 1580 1150 777 844 848 608 
2,3,3',4,4',5'-HexaCB (#157) 203 141 351 304 240 227 137 318 236 143 158 162 119 
2,3,3',4,4',5,5'-HeptaCB (#189) 58.5 34.7 99.3 67.9 70.6 61.6 36.6 100 60.9 91.8 121 102 75.7 
3,4,4',5-TetraCB (#81) 0.51 0.27 0.55 0.14 0.23 0.45 0.40 <0.04 0.31 0.11 0.10 0.17 0.10 
3,3,’4,4'-TetraCB (#77) 2.01 0.99 2.38 1.01 1.23 2.13 1.85 0.97 1.87 0.62 0.54 0.88 0.71 
3,3',4,4',5-PentaCB (#126) 35.1 26.7 47.1 25.8 39.1 38.2 26.7 46.7 36.8 11.5 18.9 23.3 11.6 
3,3',4,4',5,5'-HexaCB (#169) 3.17 2.62 4.67 2.35 3.99 3.19 2.46 5.29 3.38 7.08 8.86 7.00 6.13 
WHO2005-PCB-TEQ (LB) 3.93 2.99 5.31 3.07 4.39 4.27 2.99 5.25 4.13 1.73 2.36 2.75 1.56 
WHO2005-PCB-TEQ (UB) 3.93 2.99 5.31 3.07 4.39 4.27 2.99 5.25 4.13 1.73 2.36 2.75 1.56 
WHO1998-PCB-TEQ (UB) 5.14 3.86 7.20 4.85 5.73 5.61 3.84 6.95 5.47 2.85 3.05 3.50 2.24 
NDL-PCBs (ng g-1)                           
2,2',5-TriCB (#18) <0.0002 0.01 0.03 0.01 0.04 0.09 0.06 0.03 0.03 0.02 0.03 0.03 0.04 
2,2,4'-TriCB (#28) 0.50 0.33 0.76 0.52 0.48 0.76 0.59 0.48 0.48 0.43 0.76 0.27 0.58 
2',3,4-TriCB (#33) 0.02 0.00 0.02 <0.0001 0.02 0.08 0.04 0.02 0.01 0.01 0.02 0.02 0.03 
2,2',4,4'-TetraCB (#47) 0.58 0.26 0.58 0.85 0.38 0.47 0.31 0.59 0.38 0.98 0.58 0.19 0.49 
2,2',4,5'-TetraCB (#49) 0.08 0.02 0.07 0.15 0.05 0.11 0.06 0.05 0.04 0.25 0.07 0.04 0.10 
2,2',4,6'-TetraCB (#51) 0.003 0.003 0.002 0.002 0.002 0.01 0.004 0.002 0.002 0.003 0.002 0.001 0.01 
2,2',5,5'-TetraCB (#52) 1.43 0.60 1.25 1.98 1.13 1.37 0.82 1.46 0.83 1.41 1.25 0.52 1.05 
2,3,4,4'-TetraCB (#60) 0.19 0.15 0.35 0.42 0.22 0.26 0.17 0.29 0.23 0.22 0.35 0.15 0.23 
2,3',4,4'-TetraCB (#66) 0.70 0.77 1.84 1.78 0.46 1.25 0.83 1.27 0.89 1.26 1.84 0.25 0.76 
2,4,4',5-TetraCB (#74) 0.74 0.59 1.41 1.56 0.86 0.97 0.66 1.13 0.85 0.77 1.41 0.36 0.53 
2,2',4,4',5-PentaCB (#99) 4.62 3.40 7.25 7.12 4.79 5.43 3.35 7.16 4.98 4.33 7.25 1.81 2.12 
2,2',4,5,5'-PentaCB (#101) 2.13 1.39 4.50 3.15 3.29 2.79 2.37 4.37 1.97 1.94 4.50 1.24 1.14 
2,3,3',4',6-PentaCB (#110) 3.99 2.76 5.63 5.25 4.34 4.67 2.84 5.72 4.14 2.97 5.63 2.33 2.25 
2,2',3,4,4',5'-HexaCB (#138) 9.38 6.70 14.2 10.5 8.95 9.96 6.49 10.7 9.59 9.32 14.2 7.97 6.32 
2,2',4,4',5,5'-HexaCB (#153) 8.23 6.96 12.0 8.53 9.30 9.84 5.55 9.93 8.34 10.7 12.0 7.48 7.92 
2,2',3,4,4',5,5'-HeptaCB (#180) 7.24 3.02 8.00 7.35 7.21 3.37 2.83 9.28 6.10 3.65 8.00 11.4 2.90 
∑PCB (UB) 39.8 27.0 58.0 49.1 41.5 41.4 27.0 52.4 38.8 38.3 58.0 34.1 26.5 
∑PCB (LB) 39.8 27.0 58.0 49.1 41.5 41.4 27.0 52.4 38.8 38.3 58.0 34.1 26.5 
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Annex 10 continues 
Sample Nr. 16/14 17/14 18/14 19/14 20/14 21/14 22/14 23/14 24/14 25/14 26/14 27/14 28/14 29/14 30/14 
Length, cm 68 64 71 53 68 58 84 96 86 84 99 93 90 89 84 
Weight, kg 0.5 0.4 0.5 0.2 0.5 0.3 1.0 1.9 1.1 0.9 1.5 1.4 1.2 1.3 1.0 
Place of sampling Usmas Usmas Usmas Usmas Usmas Usmas Sivers Sivers Sivers Sivers Sivers Sivers Sivers Sivers Sivers 
 Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake 
Fat content, g/100 g of sample 24.3 21.9 22.1 27.6 24.0 22.4 25.2 26.8 23.9 26.0 22.9 23.8 25.5 25.9 27.1 
DL-PCBs (pg g-1)                               
2',3,4,4',5-PentaCB (#123) 36.9 27.8 26.4 54.1 29.0 12.2 34.0 50.3 19.0 56.4 52.8 86.1 34.1 161 66.6 
2,3',4,4',5-PentaCB (#118) 2180 1840 2060 2920 1970 924 2050 3340 1630 3220 3010 5480 2130 7820 3870 
2,3,4,4',5-PentaCB (#114) 66.2 47.4 57.3 51.8 47.9 26.8 50.7 78.8 43.2 78.4 67.7 124 50.7 182 94.7 
2,3,3,'4,4'-PentaCB (#105) 830 775 770 843 779 376 645 1120 457 988 965 1710 681 2370 1250 
2,3',4,4',5,5'-HexaCB (#167) 262 170 235 239 146 57.6 133 193 123 192 179 342 125 474 222 
2,3,3',4,4',5-HexaCB (#156) 508 345 485 474 306 132 263 398 221 400 371 696 252 967 476 
2,3,3',4,4',5'-HexaCB (#157) 79.7 77.2 85.5 77.7 65.1 27.1 48.5 82.4 35.0 77.2 75.2 144 50.1 190 98.8 
2,3,3',4,4',5,5'-HeptaCB (#189) 93.1 40.6 73.8 43.3 30.5 10.5 35.7 40.7 37.5 46.3 40.6 76.7 29.1 119 48.6 
3,4,4',5-TetraCB (#81) <0.04 0.08 0.09 0.16 0.07 0.14 0.11 0.17 0.11 0.21 0.23 0.12 0.20 0.13 0.17 
3,3,’4,4'-TetraCB (#77) 0.49 0.55 0.49 0.84 0.66 0.77 0.70 0.88 0.68 0.82 1.24 0.69 1.01 0.70 0.96 
3,3',4,4',5-PentaCB (#126) 14.3 11.2 16.4 8.63 10.2 4.69 9.64 16.5 6.59 16.2 15.3 22.5 10.9 40.1 17.8 
3,3',4,4',5,5'-HexaCB (#169) 7.25 4.48 6.26 2.39 4.16 1.40 3.77 4.20 3.40 4.45 4.21 6.69 3.14 10.8 5.10 
WHO2005-PCB-TEQ (LB) 1.77 1.35 1.94 1.08 1.24 0.56 1.17 1.94 0.84 1.90 1.80 2.71 1.28 4.70 2.12 
WHO2005-PCB-TEQ (UB) 1.77 1.35 1.94 1.08 1.24 0.56 1.17 1.94 0.84 1.90 1.80 2.71 1.28 4.70 2.12 
WHO1998-PCB-TEQ (UB) 2.15 1.66 2.31 1.58 1.55 0.71 1.46 2.43 1.06 2.37 2.24 3.54 1.58 5.84 2.69 
NDL-PCBs (ng g-1)                               
2,2',5-TriCB (#18) <0.0001 0.01 0.01 0.05 0.05 0.04 0.04 0.05 0.03 0.03 0.11 0.03 0.04 0.02 0.04 
2,2,4'-TriCB (#28) 0.19 0.12 0.22 0.29 0.31 0.25 0.32 0.47 0.33 0.38 0.52 0.36 0.39 0.79 0.40 
2',3,4-TriCB (#33) <0.0001 <0.00002 <0.0001 0.04 0.03 0.02 0.04 0.05 0.03 0.02 0.09 0.03 0.03 0.02 0.05 
2,2',4,4'-TetraCB (#47) 0.19 0.12 0.16 0.16 0.17 0.09 0.19 0.25 0.18 0.22 0.19 0.28 0.20 0.54 0.26 
2,2',4,5'-TetraCB (#49) 0.02 0.01 0.04 0.06 0.04 0.05 0.04 0.07 0.08 0.04 0.10 0.04 0.06 0.04 0.07 
2,2',4,6'-TetraCB (#51) 0.003 0.003 0.002 0.004 0.003 0.003 0.003 0.003 0.003 0.003 0.01 0.01 0.01 0.003 0.01 
2,2',5,5'-TetraCB (#52) 0.46 0.22 0.37 0.65 0.60 0.32 0.48 0.65 0.59 0.60 0.80 0.67 0.58 1.64 0.81 
2,3,4,4'-TetraCB (#60) 0.11 0.08 0.10 0.10 0.11 0.06 0.10 0.13 0.08 0.13 0.13 0.17 0.11 0.33 0.14 
2,3',4,4'-TetraCB (#66) 0.33 0.12 0.37 0.25 0.33 0.18 0.28 0.42 0.23 0.43 0.33 0.35 0.38 1.00 0.49 
2,4,4',5-TetraCB (#74) 0.27 0.19 0.26 0.23 0.26 0.14 0.26 0.33 0.21 0.36 0.34 0.46 0.28 0.87 0.38 
2,2',4,4',5-PentaCB (#99) 1.25 0.72 1.12 1.02 0.99 0.49 0.99 1.40 0.83 1.47 1.35 2.21 1.03 3.59 1.75 
2,2',4,5,5'-PentaCB (#101) 0.86 0.42 0.73 1.11 0.75 0.35 0.48 0.67 0.79 0.91 0.86 1.31 1.07 2.51 1.38 
2,3,3',4',6-PentaCB (#110) 1.39 1.15 1.26 1.75 1.07 0.51 1.00 1.16 0.80 1.49 1.46 2.31 1.11 3.89 1.85 
2,2',3,4,4',5'-HexaCB (#138) 5.38 3.60 3.86 5.20 3.02 1.33 2.67 3.86 2.21 3.92 3.63 7.15 2.55 9.73 4.61 
2,2',4,4',5,5'-HexaCB (#153) 5.37 3.76 3.67 6.13 3.04 1.41 3.30 4.86 2.87 4.86 4.85 9.11 3.53 12.6 5.92 
2,2',3,4,4',5,5'-HeptaCB (#180) 5.82 3.93 6.40 1.95 1.96 1.12 1.24 1.52 1.24 1.72 1.56 3.11 1.14 4.60 1.92 
∑PCB (UB) 21.6 14.4 18.6 19.0 12.7 6.37 11.4 15.9 10.5 16.6 16.3 27.6 12.5 42.2 20.1 
∑PCB (LB) 21.6 14.4 18.6 19.0 12.7 6.37 11.4 15.9 10.5 16.6 16.3 27.6 12.5 42.2 20.1 
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Annex 10 continues 
Sample Nr. 31/14 32/14 33/14 34/14 35/14 36/14 37/14 38/14 39/14 40/14 41/14 42/14 43/14 1 2 
Length, cm 89 93 72 82 75 94 101 95 94 92 95 83 83 55 50 
Weight, kg 1.1 1.3 0.6 0.9 0.6 1.6 1.8 1.6 1.4 1.5 1.3 0.9 1.0 0.8 1.0 
Place of sampling Sivers Sivers Liepajas Liepajas Liepajas Kisezers Kisezers Kisezers Kisezers Kisezers Liepajas Liepajas Liepajas Usmas Usmas 
 Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake 
Fat content, g/100 g of sample 23.0 25.5 28.9 41.3 33.2 37.0 36.9 34.7 27.2 32.2 27.2 32.1 34.2 24.4 20.6 
DL-PCBs (pg g-1)                               
2',3,4,4',5-PentaCB (#123) 78.8 37.5 78.1 819 2100 271 420 611 463 519 372 781 659 49.2 35.3 
2,3',4,4',5-PentaCB (#118) 3740 2470 4470 27300 39300 11500 17000 21500 20100 22800 28500 34800 26400 2280 1710 
2,3,4,4',5-PentaCB (#114) 88.2 58.9 96.0 1480 3540 232 409 430 388 494 581 983 747 56.3 41.4 
2,3,3,'4,4'-PentaCB (#105) 1250 859 1090 17300 30500 3860 5770 7630 6300 7560 8920 14400 10400 839 610 
2,3',4,4',5,5'-HexaCB (#167) 224 133 330 2770 4650 617 797 1320 1020 1200 1270 2140 1610 151 158 
2,3,3',4,4',5-HexaCB (#156) 472 283 639 7260 10500 1150 1730 2480 1950 2280 2440 3980 3010 310 314 
2,3,3',4,4',5'-HexaCB (#157) 98.2 59.2 137 1760 2220 289 388 613 464 558 601 966 713 65.1 58.6 
2,3,3',4,4',5,5'-HeptaCB (#189) 49.8 28.2 74.3 360 269 70.1 84.6 151 104 113 103 179 135 36.7 43.4 
3,4,4',5-TetraCB (#81) 0.22 0.14 0.50 2.24 1.21 0.66 1.49 0.87 2.05 1.07 1.48 2.72 2.35 0.22 0.11 
3,3,’4,4'-TetraCB (#77) 1.04 0.98 2.82 18.9 11.9 3.83 9.48 4.59 14.1 11.7 7.82 13.0 13.5 0.62 0.34 
3,3',4,4',5-PentaCB (#126) 20.2 14.6 23.6 109 81.1 25.5 44.0 49.8 42.7 79.9 50.1 86.9 64.6 12.4 9.71 
3,3',4,4',5,5'-HexaCB (#169) 4.79 3.78 5.95 13.9 4.72 3.81 4.25 5.29 3.74 4.84 4.14 7.06 5.26 3.38 2.97 
WHO2005-PCB-TEQ (LB) 2.35 1.69 2.75 13.1 11.0 3.21 5.33 6.18 5.31 9.20 6.42 10.7 7.93 1.45 1.15 
WHO2005-PCB-TEQ (UB) 2.35 1.69 2.75 13.1 11.0 3.21 5.33 6.18 5.31 9.20 6.42 10.7 7.93 1.45 1.15 
WHO1998-PCB-TEQ (UB) 2.92 2.03 3.44 20.9 23.6 5.00 8.04 9.79 8.42 12.8 10.7 26.8 12.5 1.81 1.45 
NDL-PCBs (ng g-1)                               
2,2',5-TriCB (#18) 0.04 0.04 0.10 0.08 0.22 0.07 0.12 0.05 0.09 0.10 0.06 0.15 0.05 0.01 0.01 
2,2,4'-TriCB (#28) 0.36 0.41 1.14 8.82 6.05 2.13 2.74 4.32 4.44 5.10 5.11 8.59 6.27 0.31 0.13 
2',3,4-TriCB (#33) 0.03 0.05 0.08 0.06 0.15 0.05 0.11 0.03 0.06 0.07 0.06 0.15 0.04 0.01 0.003 
2,2',4,4'-TetraCB (#47) 0.23 0.20 0.64 8.60 24.0 1.21 1.66 2.72 2.17 2.47 4.13 6.70 4.69 0.18 0.09 
2,2',4,5'-TetraCB (#49) 0.04 0.06 0.23 1.39 6.65 0.33 1.20 0.95 1.26 1.03 0.71 0.76 1.20 0.05 0.01 
2,2',4,6'-TetraCB (#51) 0.004 0.01 0.01 0.01 0.07 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.01 0.002 0.001 
2,2',5,5'-TetraCB (#52) 0.68 0.60 1.71 14.6 27.0 4.27 7.81 10.7 7.74 9.28 7.44 10.9 7.70 0.49 0.20 
2,3,4,4'-TetraCB (#60) 0.14 0.11 0.31 3.69 3.02 0.61 0.76 1.22 1.10 1.36 1.56 2.52 1.76 0.12 0.07 
2,3',4,4'-TetraCB (#66) 0.40 0.39 1.08 12.5 21.8 2.15 3.38 4.68 4.14 3.73 4.71 9.23 7.12 0.44 0.25 
2,4,4',5-TetraCB (#74) 0.38 0.29 0.70 8.52 13.7 1.40 1.97 2.70 2.35 3.03 3.98 6.46 4.59 0.30 0.17 
2,2',4,4',5-PentaCB (#99) 1.59 1.08 2.00 20.5 36.6 6.23 9.80 13.8 10.1 12.4 14.9 23.4 17.0 1.07 0.75 
2,2',4,5,5'-PentaCB (#101) 1.32 0.96 1.94 14.8 27.4 4.38 10.5 13.4 10.5 12.4 3.76 12.3 10.8 1.35 0.50 
2,3,3',4',6-PentaCB (#110) 1.79 1.24 2.76 18.0 26.5 7.32 10.3 15.6 11.3 14.4 10.4 15.5 12.9 1.37 0.83 
2,2',3,4,4',5'-HexaCB (#138) 4.90 2.66 7.24 37.1 56.9 13.3 19.7 26.7 23.0 28.1 26.5 38.1 28.7 3.50 3.32 
2,2',4,4',5,5'-HexaCB (#153) 5.87 3.40 10.9 31.6 41.9 16.6 22.2 26.2 25.7 27.9 28.2 34.8 26.8 4.65 4.40 
2,2',3,4,4',5,5'-HeptaCB (#180) 2.09 0.99 5.53 22.8 28.1 3.96 5.27 9.37 6.78 8.17 6.69 12.4 11.1 1.58 2.08 
∑PCB (UB) 19.9 12.5 36.4 203 320 64.0 97.5 132 111 130 118 182 141 15.4 12.8 
∑PCB (LB) 19.9 12.5 36.4 203 320 64.0 97.5 132 111 130 118 182 141 15.4 12.8 
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Annex 10 continues 
Sample Nr. 3 4 5 6 7 8 1a 2a 3a 4a 5a 6a 7a 8a 9a 
Length, cm 55 67 55 55 55 50 87 40 77 81 79 75 39 42 42 
Weight, kg 0.9 1.7 0.9 1.1 0.9 0.9 1.2 0.1 0.9 1.0 0.9 0.9 1.0 0.1 0.1 
Place of sampling Usmas Usmas Usmas Usmas Usmas Usmas Usmas Usmas Usmas Usmas Usmas Usmas Usmas Usmas Usmas 
 Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake 
Fat content, g/100 g of sample 26.0 29.4 22.8 24.4 24.2 23.7 21.2 31.5 29.2 30.0 28.0 23.1 30.1 35.2 31.7 
DL-PCBs (pg g-1)                               
2',3,4,4',5-PentaCB (#123) 45.6 58.7 56.8 99.9 91.5 117 39.4 63.9 63.8 88.2 54.2 74.5 76.3 39.8 206 
2,3',4,4',5-PentaCB (#118) 2570 3150 3560 4830 6100 7190 2280 4400 4090 5570 2600 4790 8650 2980 8810 
2,3,4,4',5-PentaCB (#114) 55.8 73.3 84.8 116 142 174 69.6 137 103 153 75.1 136 321 91.0 285 
2,3,3,'4,4'-PentaCB (#105) 945 1120 1230 1680 2040 2380 972 1940 1600 2070 1030 1870 4230 1130 3710 
2,3',4,4',5,5'-HexaCB (#167) 217 243 307 457 641 761 224 324 447 671 280 531 702 231 682 
2,3,3',4,4',5-HexaCB (#156) 412 532 641 918 1260 1490 453 746 885 1190 558 1070 1640 487 1360 
2,3,3',4,4',5'-HexaCB (#157) 81.6 107 125 175 241 287 92.4 148 176 216 108 212 329 87.3 280 
2,3,3',4,4',5,5'-HeptaCB (#189) 55.3 65.7 80.9 112 167 194 58.1 85.7 118 160 75.8 137 135 57.0 76.2 
3,4,4',5-TetraCB (#81) <0.22 0.49 <0.29 0.33 <0.25 0.36 0.26 0.21 0.22 <0.06 0.12 0.10 0.10 0.17 0.54 
3,3,’4,4'-TetraCB (#77) 0.60 0.93 0.42 1.07 0.31 0.65 1.02 0.77 0.47 0.58 0.71 0.45 0.75 0.66 1.74 
3,3',4,4',5-PentaCB (#126) 12.2 18.5 17.2 23.7 31.2 38.2 17.3 25.5 27.8 25.0 16.2 25.9 23.4 18.8 46.0 
3,3',4,4',5,5'-HexaCB (#169) 4.03 5.00 5.80 7.86 11.9 13.8 4.37 7.91 8.38 9.20 5.85 9.20 7.89 5.47 3.78 
WHO2005-PCB-TEQ (LB) 1.47 2.16 2.08 2.85 3.80 4.62 1.99 3.02 3.26 3.08 1.94 3.13 3.06 2.20 5.18 
WHO2005-PCB-TEQ (UB) 1.47 2.16 2.08 2.85 3.80 4.62 1.99 3.02 3.26 3.08 1.94 3.13 3.06 2.20 5.18 
WHO1998-PCB-TEQ (UB) 1.89 2.69 2.70 3.73 4.90 5.93 2.42 3.79 4.04 4.17 2.43 4.09 4.88 2.69 6.89 
NDL-PCBs (ng g-1)                               
2,2',5-TriCB (#18) 0.01 0.02 0.02 0.02 0.03 0.02 0.01 0.01 0.02 0.02 0.02 0.01 0.01 0.01 <0.0001 
2,2,4'-TriCB (#28) 0.19 0.49 0.21 0.30 0.24 0.34 0.27 0.27 0.23 0.26 0.26 0.18 0.23 0.30 0.57 
2',3,4-TriCB (#33) 0.01 0.01 0.01 0.01 0.01 0.01 0.02 <0.0001 0.01 0.002 0.02 <0.0001 <0.0001 <0.0001 <0.0001 
2,2',4,4'-TetraCB (#47) 0.14 0.19 0.13 0.16 0.18 0.21 0.25 0.37 0.30 0.37 0.38 0.31 0.28 0.29 0.43 
2,2',4,5'-TetraCB (#49) 0.02 0.06 0.02 0.03 0.02 0.03 0.08 0.10 0.05 0.05 0.07 0.02 0.03 0.06 0.04 
2,2',4,6'-TetraCB (#51) 0.002 0.002 0.001 0.001 0.001 0.001 0.01 0.003 0.01 0.01 0.01 0.01 0.001 0.004 0.002 
2,2',5,5'-TetraCB (#52) 0.36 0.48 0.32 0.42 0.47 0.61 0.86 1.03 0.74 1.07 0.63 0.83 0.63 0.73 1.12 
2,3,4,4'-TetraCB (#60) 0.10 0.14 0.12 0.17 0.18 0.21 0.10 0.17 0.16 0.20 0.13 0.17 0.20 0.14 0.30 
2,3',4,4'-TetraCB (#66) 0.30 0.47 0.28 0.48 0.48 0.60 0.21 0.49 0.18 0.48 0.41 0.30 0.62 0.42 1.42 
2,4,4',5-TetraCB (#74) 0.22 0.34 0.32 0.41 0.42 0.49 0.24 0.49 0.41 0.49 0.31 0.40 0.59 0.38 1.11 
2,2',4,4',5-PentaCB (#99) 1.01 1.25 1.25 1.71 2.27 2.65 1.68 3.44 2.94 4.28 2.24 3.65 3.78 2.28 6.31 
2,2',4,5,5'-PentaCB (#101) 1.10 1.18 1.06 1.08 1.27 2.41 1.39 2.99 2.24 3.33 1.18 1.38 1.08 1.89 3.16 
2,3,3',4',6-PentaCB (#110) 1.38 1.25 1.59 2.13 2.85 3.26 2.06 3.69 4.00 5.33 2.65 4.12 2.82 2.15 5.35 
2,2',3,4,4',5'-HexaCB (#138) 4.77 5.27 6.40 9.03 13.5 16.5 6.81 9.54 13.2 18.7 8.55 15.2 12.2 6.44 14.4 
2,2',4,4',5,5'-HexaCB (#153) 6.13 7.00 7.95 12.5 18.0 22.0 8.10 9.86 14.6 16.9 10.3 14.9 11.7 6.92 13.2 
2,2',3,4,4',5,5'-HeptaCB (#180) 2.67 2.95 3.82 5.61 8.16 10.2 4.80 3.54 6.81 9.09 4.04 7.36 6.65 2.32 3.77 
∑PCB (UB) 18.4 21.1 23.5 34.1 48.0 59.5 26.9 36.0 45.9 60.6 31.2 48.8 40.8 24.4 51.3 
∑PCB (LB) 18.4 21.1 23.5 34.1 48.0 59.5 26.9 36.0 45.9 60.6 31.2 48.8 40.8 24.4 51.3 
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Annex 11 
Concentrations of PBDEs in eel samples calculated on f.w. basis 
Sample Nr. 1/14 2/14 3/14 4/14 5/14 6/14 7/14 8/14 9/14 12/14 13/14 14/14 
Length, cm 81 83 95 78 74 82 76 88 76 70 78 85 
Weight, kg 1.0 1.1 1.6 0.8 0.8 1.1 0.8 1.0 0.9 0.6 0.8 1.0 
Place of sampling Aluksnes Aluksnes Aluksnes Aluksnes Aluksnes Aluksnes Aluksnes Aluksnes Aluksnes Usmas Usmas Usmas 
 Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake 
Fat content, g/100 g of sample 28.8 20.3 29.1 23.8 28 26.6 35.3 21.2 24.4 21.2 22.0 26.9 
PBDEs (ng g-1)                         
2,4-DiBDE (#7) <0.0001 <0.0001 <0.002 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.00004 <0.001 <0.0001 <0.0001 
4,4-DiBDE (#15) <0.0001 <0.00004 <0.001 <0.00003 <0.0001 <0.0001 <0.00004 <0.00004 <0.00002 0.01 <0.0001 <0.00004 
2,2',4-TriBDE (#17) 0.001 0.001 0.001 0.0004 0.002 0.002 0.002 0.002 0.001 0.02 0.001 0.001 
2,4,4'-TriBDE (#28) 0.004 0.004 0.01 0.004 0.01 0.01 0.004 0.010 0.004 0.04 0.004 0.01 
2,2',4,4'-TetraBDE (#47) 0.48 0.38 0.88 0.51 0.58 0.56 0.39 0.69 0.60 2.39 0.50 0.69 
2,2',4,5'-TetraBDE (#49) 0.16 0.10 0.20 0.08 0.15 0.15 0.12 0.17 0.17 1.06 0.15 0.22 
2,3',4,4'-TetraBDE (#66) 0.01 0.004 0.004 0.010 0.02 0.01 0.01 0.02 0.01 0.05 0.01 0.01 
2,3',4',6-TetraBDE (#71) <0.0001 <0.0001 0.02 <0.0001 <0.0002 <0.0001 <0.0001 <0.0002 0.02 <0.002 <0.0001 <0.0001 
3,3',4,4'-TetraBDE (#77) 0.001 0.0004 0.001 <0.0001 0.001 0.001 0.001 0.001 0.002 0.004 0.0004 0.001 
2,2',3,4,4'-PentaBDE (#85) 0.002 0.002 0.002 0.001 0.002 0.002 0.002 0.002 0.002 0.04 0.003 0.003 
2,2',4,4',5-PentaBDE (#99) 0.003 0.004 0.002 0.01 0.01 0.004 0.01 0.003 0.01 0.04 0.003 0.02 
2,2',4,4',6-PentaBDE (#100) 0.08 0.06 0.19 0.09 0.12 0.12 0.06 0.15 0.19 0.70 0.20 0.18 
2,3',4,4',6-PentaBDE (#119) 0.02 0.02 0.04 0.02 0.04 0.04 0.02 0.04 0.03 0.14 0.03 0.04 
3,3',4,4',5-PentaBDE (#126) <0.0002 <0.0002 <0.0002 <0.0002 <0.0002 <0.0001 <0.0002 <0.0002 <0.0002 <0.002 <0.0002 <0.0003 
2,2',3,4,4',5'-HexaBDE (#138) <0.0002 <0.0002 <0.0002 <0.0002 0.0004 <0.0004 <0.0003 <0.0003 <0.0002 <0.002 <0.001 <0.0003 
2,2',4,4',5,5'-HexaBDE (#153) 0.02 0.02 0.03 0.02 0.04 0.04 0.03 0.05 0.03 0.23 0.03 0.05 
2,2',4,4',5,6'-HexaBDE (#154) 0.10 0.07 0.11 0.07 0.12 0.13 0.07 0.14 0.12 0.75 0.09 0.17 
2,2',4,4',6,6'-HexaBDE (#155) 0.02 0.02 0.03 0.01 0.02 0.02 0.01 0.02 0.02 0.24 0.03 0.03 
2,3,4,4',5,6-HexaBDE (#166) <0.0002 <0.0003 <0.0002 <0.0003 <0.0003 <0.0004 <0.0003 <0.0003 <0.0002 <0.003 <0.001 <0.0003 
2,2',3,4,4',5,6'-HeptaBDE (#181) <0.0002 <0.0002 <0.0002 <0.0002 <0.0002 <0.0001 <0.0001 <0.0002 <0.0004 <0.01 <0.001 <0.0003 
2,2',3,4,4',5',6-HeptaBDE (#183) 0.001 0.001 0.001 0.001 0.002 0.001 0.002 0.001 0.001 0.02 0.001 0.001 
2,3,3',4,4',5,6-HeptaBDE (#190) <0.0002 <0.0003 <0.0002 <0.0003 <0.0004 <0.0002 <0.0002 <0.0002 <0.001 <0.01 <0.001 <0.0004 
2,2',3,4,4',5,5',6-OctaBDE (#203) 0.004 0.003 0.003 <0.01 0.003 <0.0004 0.002 <0.001 <0.01 <0.01 <0.01 0.004 
2,3,3',4,4',5,5',6-OctaBDE (#205) <0.004 <0.003 <0.004 <0.01 <0.004 <0.001 <0.003 <0.001 <0.01 <0.01 <0.01 <0.01 
2,2',3,3',4,4',5,5',6-NonaBDE (#206) <0.001 <0.001 <0.0004 <0.001 <0.001 <0.001 <0.001 <0.001 <0.002 <0.001 <0.001 <0.001 
2,2',3,3',4,4',5,6,6'-NonaBDE (#207) 0.001 0.002 0.0003 0.01 0.001 0.002 0.001 0.001 0.003 0.01 0.002 0.002 
2,2',3,3',4,4',5,5',6,6'-DecaBDE (#209) 0.04 0.04 0.01 0.09 0.03 0.03 0.038 0.01 <0.01 0.07 0.05 0.05 
∑PBDE (UB) 0.96 0.72 1.55 0.95 1.16 1.12 0.777 1.30 1.26 5.88 1.12 1.48 
∑PBDE (LB) 0.95 0.71 1.54 0.93 1.16 1.12 0.772 1.30 1.22 5.82 1.11 1.47 
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Annex 11 continues 
Sample Nr. 16/14 17/14 18/14 19/14 20/14 21/14 22/14 23/14 24/14 25/14 26/14 27/14 
Length, cm 68 64 71 53 68 58 84 96 86 84 99 93 
Weight, kg 0.5 0.4 0.5 0.2 0.5 0.3 1.0 1.9 1.1 0.9 1.5 1.4 
Place of sampling Usmas Usmas Usmas Usmas Usmas Usmas Sivers Sivers Sivers Sivers Sivers Sivers 
 Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake 
Fat content, g/100 g of sample 24.3 21.9 22.1 27.6 24.0 22.4 25.2 26.8 23.9 26.0 22.9 23.8 
PBDEs (ng g-1)                         
2,4-DiBDE (#7) <0.0001 <0.0001 <0.0001 <0.0004 <0.0001 <0.0001 <0.0004 <0.0004 <0.001 <0.001 <0.0004 <0.001 
4,4-DiBDE (#15) <0.00004 <0.00003 <0.00004 0.002 <0.0001 <0.0001 0.004 0.01 0.01 0.01 0.01 0.002 
2,2',4-TriBDE (#17) 0.001 0.0004 0.0003 0.01 0.001 0.001 0.03 0.04 0.03 0.04 0.04 0.04 
2,4,4'-TriBDE (#28) 0.01 0.002 0.01 0.02 0.003 0.002 0.02 0.06 0.04 0.04 0.04 0.02 
2,2',4,4'-TetraBDE (#47) 0.31 0.24 0.32 2.26 0.25 0.14 1.28 2.78 1.00 2.55 2.12 3.36 
2,2',4,5'-TetraBDE (#49) 0.13 0.07 0.13 0.46 0.09 0.03 0.42 0.62 0.49 1.08 0.83 1.02 
2,3',4,4'-TetraBDE (#66) 0.01 0.002 0.003 0.02 0.01 0.003 0.04 0.08 0.04 0.08 0.03 0.02 
2,3',4',6-TetraBDE (#71) <0.0002 <0.0002 <0.0002 <0.002 <0.0001 <0.0001 <0.001 <0.001 <0.001 <0.002 <0.001 <0.001 
3,3',4,4'-TetraBDE (#77) 0.001 <0.0001 <0.0001 <0.001 0.001 0.0003 0.01 <0.02 0.003 0.01 0.004 0.001 
2,2',3,4,4'-PentaBDE (#85) 0.01 0.002 0.004 0.01 0.001 0.0002 <0.002 0.01 0.01 0.003 0.004 0.01 
2,2',4,4',5-PentaBDE (#99) 0.01 0.004 0.003 0.03 0.01 0.01 0.01 0.01 0.004 0.01 0.01 0.01 
2,2',4,4',6-PentaBDE (#100) 0.11 0.08 0.08 0.47 0.09 0.02 0.09 0.07 0.03 0.13 0.03 0.07 
2,3',4,4',6-PentaBDE (#119) 0.03 0.01 0.02 0.06 0.01 0.004 0.03 0.02 0.01 0.04 0.01 0.01 
3,3',4,4',5-PentaBDE (#126) <0.0003 <0.0002 <0.0003 <0.001 <0.0002 <0.0001 <0.001 <0.003 <0.001 <0.002 <0.002 <0.001 
2,2',3,4,4',5'-HexaBDE (#138) <0.0003 0.0003 <0.0003 <0.002 <0.0003 <0.0002 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 
2,2',4,4',5,5'-HexaBDE (#153) 0.06 0.02 0.03 0.11 0.01 0.01 0.10 0.13 0.11 0.16 0.11 0.17 
2,2',4,4',5,6'-HexaBDE (#154) 0.19 0.05 0.12 0.24 0.04 0.01 0.30 0.41 0.51 0.52 0.43 0.66 
2,2',4,4',6,6'-HexaBDE (#155) 0.05 0.01 0.04 0.07 0.01 0.002 0.10 0.11 0.20 0.10 0.11 0.15 
2,3,4,4',5,6-HexaBDE (#166) <0.0004 <0.0003 <0.0004 <0.002 <0.0004 <0.0002 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 
2,2',3,4,4',5,6'-HeptaBDE (#181) <0.0003 <0.0002 <0.0004 <0.01 <0.0003 <0.0001 <0.003 <0.004 <0.003 <0.004 <0.01 <0.01 
2,2',3,4,4',5',6-HeptaBDE (#183) 0.01 0.001 0.003 0.01 0.001 0.001 0.02 0.02 0.03 <0.003 0.01 0.01 
2,3,3',4,4',5,6-HeptaBDE (#190) <0.001 <0.0003 <0.001 <0.02 <0.001 <0.0002 <0.004 <0.01 <0.004 <0.01 <0.01 <0.01 
2,2',3,4,4',5,5',6-OctaBDE (#203) 0.01 0.01 0.003 <0.01 <0.004 0.01 <0.004 <0.003 <0.01 <0.01 <0.01 <0.004 
2,3,3',4,4',5,5',6-OctaBDE (#205) <0.01 <0.01 <0.004 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 
2,2',3,3',4,4',5,5',6-NonaBDE (#206) <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
2,2',3,3',4,4',5,6,6'-NonaBDE (#207) 0.003 0.002 0.002 0.01 0.002 0.002 0.01 0.01 0.01 0.01 0.01 0.004 
2,2',3,3',4,4',5,5',6,6'-DecaBDE (#209) 0.02 0.02 0.05 0.11 0.04 0.04 0.08 0.10 0.08 0.07 0.12 0.06 
∑PBDE (UB) 0.96 0.53 0.81 3.96 0.58 0.28 2.55 4.51 2.65 4.89 3.97 5.66 
∑PBDE (LB) 0.95 0.52 0.80 3.90 0.56 0.27 2.52 4.48 2.61 4.85 3.92 5.61 
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Annex 11 continues., 
Sample Nr. 31/14 32/14 33/14 34/14 35/14 36/14 37/14 38/14 39/14 40/14 41/14 42/14 
Length, cm 89 93 72 82 75 94 101 95 94 92 95 83 
Weight, kg 1.1 1.3 0.6 0.9 0.6 1.6 1.8 1.6 1.4 1.5 1.3 0.9 
Place of sampling Sivers Sivers Liepajas Liepajas Liepajas Kisezers Kisezers Kisezers Kisezers Kisezers Liepajas Liepajas 
 Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake 
Fat content, g/100 g of sample 23.0 25.5 28.9 41.3 33.2 37.0 36.9 34.7 27.2 32.2 27.2 32.1 
PBDEs (ng g-1)                         
2,4-DiBDE (#7) <0.0002 <0.0003 <0.001 <0.001 <0.0004 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.0001 
4,4-DiBDE (#15) 0.003 0.01 0.02 0.03 0.004 0.02 0.06 0.07 0.06 0.10 0.01 0.002 
2,2',4-TriBDE (#17) 0.03 0.03 0.04 0.09 0.03 0.04 0.05 0.07 0.05 0.05 0.02 0.01 
2,4,4'-TriBDE (#28) 0.05 0.03 0.20 0.19 0.02 0.05 0.31 0.36 0.43 0.43 0.05 0.01 
2,2',4,4'-TetraBDE (#47) 2.40 1.67 11.5 15.2 1.28 4.13 5.25 13.8 12.8 14.6 2.46 0.78 
2,2',4,5'-TetraBDE (#49) 0.81 0.63 1.69 2.61 0.42 1.13 0.76 1.31 0.90 1.36 0.47 0.22 
2,3',4,4'-TetraBDE (#66) 0.04 0.05 0.15 0.36 0.04 0.04 0.13 0.17 0.14 0.19 0.03 0.01 
2,3',4',6-TetraBDE (#71) <0.001 <0.001 <0.002 <0.002 <0.001 <0.001 <0.002 <0.003 <0.002 <0.002 <0.001 <0.0001 
3,3',4,4'-TetraBDE (#77) 0.004 0.01 0.01 0.01 0.01 0.01 <0.002 <0.002 <0.002 <0.002 <0.001 0.001 
2,2',3,4,4'-PentaBDE (#85) 0.02 0.01 0.02 0.16 <0.002 0.05 0.03 0.03 0.03 0.04 0.02 0.01 
2,2',4,4',5-PentaBDE (#99) 0.03 0.02 0.08 0.58 0.01 0.13 0.34 0.45 0.61 0.32 0.08 0.02 
2,2',4,4',6-PentaBDE (#100) 0.55 0.31 0.23 3.71 0.09 0.81 0.86 1.66 1.55 1.80 0.56 0.22 
2,3',4,4',6-PentaBDE (#119) 0.14 0.10 0.03 0.34 0.03 0.15 0.11 0.130 0.15 0.12 0.08 0.04 
3,3',4,4',5-PentaBDE (#126) <0.001 <0.001 <0.004 <0.01 <0.001 <0.01 <0.01 <0.004 <0.003 <0.01 <0.002 <0.001 
2,2',3,4,4',5'-HexaBDE (#138) <0.001 <0.002 <0.02 <0.002 <0.01 <0.002 <0.001 <0.002 <0.002 <0.002 <0.001 <0.0003 
2,2',4,4',5,5'-HexaBDE (#153) 0.15 0.11 0.44 0.82 0.10 0.29 0.26 0.33 0.36 0.32 0.14 0.05 
2,2',4,4',5,6'-HexaBDE (#154) 0.44 0.28 1.00 1.67 0.30 0.74 0.41 0.50 0.68 0.69 0.38 0.14 
2,2',4,4',6,6'-HexaBDE (#155) 0.08 0.06 0.34 0.69 0.10 0.25 0.10 0.11 0.15 0.18 0.12 0.05 
2,3,4,4',5,6-HexaBDE (#166) <0.001 <0.002 <0.02 <0.002 <0.01 <0.002 0.002 <0.002 <0.003 <0.002 <0.001 <0.0003 
2,2',3,4,4',5,6'-HeptaBDE (#181) <0.003 <0.001 <0.01 <0.01 <0.003 <0.01 0.01 <0.02 <0.02 <0.01 <0.004 <0.001 
2,2',3,4,4',5',6-HeptaBDE (#183) 0.01 0.01 0.02 0.01 0.02 0.01 0.01 0.01 0.01 0.01 0.01 <0.001 
2,3,3',4,4',5,6-HeptaBDE (#190) <0.004 <0.002 <0.02 0.02 <0.004 <0.01 <0.02 <0.02 <0.03 <0.01 <0.01 <0.001 
2,2',3,4,4',5,5',6-OctaBDE (#203) <0.004 0.002 <0.01 0.004 <0.01 0.003 <0.01 <0.01 <0.01 <0.01 0.002 <0.01 
2,3,3',4,4',5,5',6-OctaBDE (#205) <0.01 <0.01 <0.01 <0.02 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 
2,2',3,3',4,4',5,5',6-NonaBDE (#206) <0.001 <0.001 <0.002 <0.002 <0.003 <0.002 <0.002 <0.003 <0.001 <0.003 <0.001 <0.0004 
2,2',3,3',4,4',5,6,6'-NonaBDE (#207) 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.001 
2,2',3,3',4,4',5,5',6,6'-DecaBDE (#209) 0.06 0.08 0.10 0.19 0.14 0.12 0.14 0.12 0.09 0.08 0.08 0.02 
∑PBDE (UB) 4.84 3.43 16.0 26.7 2.64 8.04 8.88 19.2 18.1 20.3 4.55 1.58 
∑PBDE (LB) 4.82 3.41 15.9 26.7 2.59 7.99 8.83 19.1 18.0 20.3 4.52 1.56 
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Annex 11 continues 
Sample Nr. 3 4 5 6 7 8 1a 2a 3a 4a 5a 6a 
Length, cm 55 67 55 55 55 50 87 40 77 81 79 75 
Weight, kg 0.9 1.7 0.9 1.1 0.9 0.9 1.2 0.1 0.9 1.0 0.9 0.9 
Place of sampling Usmas Usmas Usmas Usmas Usmas Usmas Usmas Usmas Usmas Usmas Usmas Usmas 
 Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake 
Fat content, g/100 g of sample 26.0 29.4 22.8 24.4 24.2 23.7 21.2 31.5 29.2 30.0 28.0 23.1 
PBDEs (ng g-1)                         
2,4-DiBDE (#7) <0.0001 <0.00003 <0.00003 <0.0001 <0.00003 <0.00003 <0.0001 <0.00003 <0.00003 <0.00003 <0.00004 <0.00003 
4,4-DiBDE (#15) <0.00004 0.001 0.0002 <0.00004 <0.00002 <0.00001 <0.00004 0.0002 <0.00001 <0.00002 0.0001 <0.00001 
2,2',4-TriBDE (#17) 0.002 0.003 0.001 0.001 0.002 0.003 0.0003 0.002 0.001 0.002 0.004 0.0004 
2,4,4'-TriBDE (#28) 0.004 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.004 
2,2',4,4'-TetraBDE (#47) 0.34 0.66 0.53 0.79 0.77 1.14 0.47 0.38 0.84 0.79 0.50 0.72 
2,2',4,5'-TetraBDE (#49) 0.14 0.20 0.20 0.26 0.31 0.49 0.15 0.17 0.33 0.32 0.18 0.29 
2,3',4,4'-TetraBDE (#66) 0.01 0.02 0.01 0.01 0.01 0.02 0.01 0.01 0.00 0.00 0.01 0.004 
2,3',4',6-TetraBDE (#71) <0.0001 <0.0001 <0.0002 <0.0002 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 
3,3',4,4'-TetraBDE (#77) 0.001 0.002 0.001 0.0001 0.001 0.001 <0.0001 0.001 <0.0001 0.0002 0.0003 <0.0001 
2,2',3,4,4'-PentaBDE (#85) 0.002 0.01 0.003 0.003 0.01 0.01 0.002 0.003 0.01 0.01 0.004 0.01 
2,2',4,4',5-PentaBDE (#99) 0.01 0.03 0.01 0.01 0.02 0.01 0.02 0.01 0.01 0.004 0.01 0.01 
2,2',4,4',6-PentaBDE (#100) 0.10 0.13 0.20 0.33 0.30 0.43 0.10 0.12 0.23 0.34 0.14 0.32 
2,3',4,4',6-PentaBDE (#119) 0.02 0.03 0.03 0.04 0.06 0.07 0.02 0.03 0.05 0.03 0.02 0.04 
3,3',4,4',5-PentaBDE (#126) <0.0003 <0.0003 <0.0001 <0.0001 <0.0002 <0.0003 <0.0004 <0.0001 <0.0002 <0.0004 <0.0003 <0.0002 
2,2',3,4,4',5'-HexaBDE (#138) <0.0002 <0.0002 <0.0004 <0.0002 <0.0001 <0.0001 <0.0003 <0.001 <0.0001 <0.0002 0.0003 <0.0002 
2,2',4,4',5,5'-HexaBDE (#153) 0.03 0.05 0.04 0.04 0.08 0.07 0.04 0.03 0.07 0.03 0.03 0.04 
2,2',4,4',5,6'-HexaBDE (#154) 0.11 0.13 0.08 0.16 0.24 0.29 0.10 0.13 0.21 0.20 0.10 0.19 
2,2',4,4',6,6'-HexaBDE (#155) 0.02 0.02 0.03 0.03 0.02 0.04 0.01 0.04 0.02 0.03 <0.00003 0.02 
2,3,4,4',5,6-HexaBDE (#166) <0.0002 <0.0002 <0.0004 <0.0002 <0.0002 <0.0001 <0.0003 <0.001 <0.0001 <0.0002 <0.0001 <0.0002 
2,2',3,4,4',5,6'-HeptaBDE (#181) <0.0004 <0.001 <0.001 <0.001 <0.001 <0.0004 <0.0002 <0.002 <0.001 <0.001 <0.0004 <0.0004 
2,2',3,4,4',5',6-HeptaBDE (#183) 0.001 0.01 0.001 0.002 0.003 0.001 0.002 0.01 0.001 0.001 0.001 0.001 
2,3,3',4,4',5,6-HeptaBDE (#190) <0.001 <0.002 <0.002 <0.001 <0.002 <0.001 <0.0002 <0.002 <0.001 <0.001 <0.001 <0.001 
2,2',3,4,4',5,5',6-OctaBDE (#203) <0.001 <0.001 <0.004 <0.004 <0.001 <0.001 0.004 <0.004 <0.001 <0.002 <0.001 <0.001 
2,3,3',4,4',5,5',6-OctaBDE (#205) <0.001 <0.001 <0.01 <0.01 <0.001 <0.001 <0.004 <0.01 <0.001 <0.003 <0.001 <0.001 
2,2',3,3',4,4',5,5',6-NonaBDE (#206) 0.0003 <0.0001 <0.001 <0.001 <0.0001 <0.0001 <0.001 <0.0002 <0.0002 <0.0001 <0.0002 <0.0002 
2,2',3,3',4,4',5,6,6'-NonaBDE (#207) 0.001 0.001 <0.001 0.001 0.0003 0.001 0.002 0.001 0.0004 0.001 0.0002 0.0003 
2,2',3,3',4,4',5,5',6,6'-DecaBDE (#209) 0.02 0.01 0.04 0.02 0.01 0.01 0.05 0.01 0.01 0.01 0.01 0.01 
∑PBDE (UB) 0.81 1.33 1.19 1.72 1.85 2.60 0.97 0.95 1.78 1.79 1.00 1.66 
∑PBDE (LB) 0.81 1.32 1.17 1.70 1.84 2.59 0.97 0.94 1.77 1.78 1.00 1.66 
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Annex 11 continues 
Sample Nr. 15/14 28/14 29/14 30/14 43/14 1 2 7a 8a 9a 
Length, cm 71 90 89 84 83 55 50 39 42 42 
Weight, kg 0.5 1.2 1.3 1.0 1.0 0.8 1.0 1.0 0.1 0.1 
Place of sampling Usmas Sivers Sivers Sivers Liepajas Usmas Usmas Usmas Usmas Usmas 
 Lake Lake Lake Lake Lake Lake Lake Lake Lake Lake 
Fat content, g/100 g of sample 21.8 25.5 25.9 27.1 34.2 24.4 20.6 30.1 35.2 31.7 
PBDEs (ng g-1)                     
2,4-DiBDE (#7) <0.001 <0.001 <0.0004 <0.0004 <0.001 <0.0001 0.0001 <0.00004 <0.00002 <0.00004 
4,4-DiBDE (#15) 0.01 0.01 0.01 0.01 0.02 0.00002 <0.00001 <0.00003 <0.00001 <0.00003 
2,2',4-TriBDE (#17) 0.02 0.04 0.11 0.04 0.04 0.002 0.001 0.002 0.002 0.003 
2,4,4'-TriBDE (#28) 0.04 0.05 0.06 0.04 0.05 0.01 0.01 0.01 0.01 0.01 
2,2',4,4'-TetraBDE (#47) 2.39 1.92 7.44 2.39 4.13 0.42 0.52 0.55 0.37 0.67 
2,2',4,5'-TetraBDE (#49) 1.06 0.60 3.34 0.90 1.13 0.15 0.20 0.07 0.15 0.22 
2,3',4,4'-TetraBDE (#66) 0.05 0.06 0.27 0.06 0.04 0.01 0.01 0.01 0.01 0.01 
2,3',4',6-TetraBDE (#71) <0.002 <0.002 <0.003 <0.002 <0.001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0002 
3,3',4,4'-TetraBDE (#77) 0.004 0.01 0.01 0.01 0.01 0.001 0.0003 0.001 0.0004 0.002 
2,2',3,4,4'-PentaBDE (#85) 0.04 0.004 0.07 0.004 0.05 0.001 0.003 0.001 0.003 0.003 
2,2',4,4',5-PentaBDE (#99) 0.04 0.01 0.05 0.01 0.13 0.01 0.01 0.01 0.004 0.01 
2,2',4,4',6-PentaBDE (#100) 0.70 0.09 1.64 0.33 0.81 0.11 0.12 0.33 0.08 0.16 
2,3',4,4',6-PentaBDE (#119) 0.14 0.02 0.49 0.09 0.15 0.02 0.02 0.02 0.02 0.05 
3,3',4,4',5-PentaBDE (#126) <0.002 <0.001 <0.003 <0.003 <0.01 <0.0002 <0.0001 <0.0001 <0.0002 <0.0002 
2,2',3,4,4',5'-HexaBDE (#138) <0.002 <0.02 <0.001 <0.003 <0.002 <0.0002 <0.0001 <0.0003 <0.0002 <0.0002 
2,2',4,4',5,5'-HexaBDE (#153) 0.23 0.08 0.65 0.13 0.29 0.03 0.02 0.03 0.03 0.04 
2,2',4,4',5,6'-HexaBDE (#154) 0.75 0.34 1.97 0.38 0.74 0.07 0.11 0.05 0.07 0.15 
2,2',4,4',6,6'-HexaBDE (#155) 0.24 0.09 0.30 0.07 0.25 0.01 0.02 0.01 0.01 0.02 
2,3,4,4',5,6-HexaBDE (#166) <0.003 <0.02 <0.002 <0.003 <0.002 <0.0003 <0.0001 <0.0003 <0.0002 <0.0002 
2,2',3,4,4',5,6'-HeptaBDE (#181) <0.01 <0.01 <0.01 <0.003 <0.01 <0.001 <0.001 <0.0004 <0.001 <0.0003 
2,2',3,4,4',5',6-HeptaBDE (#183) 0.02 0.01 0.02 0.01 0.01 0.002 0.001 0.002 0.01 0.001 
2,3,3',4,4',5,6-HeptaBDE (#190) <0.01 <0.01 <0.01 <0.004 <0.01 <0.001 <0.001 <0.001 <0.002 <0.001 
2,2',3,4,4',5,5',6-OctaBDE (#203) <0.004 <0.01 <0.003 <0.003 <0.01 <0.004 <0.004 <0.001 <0.001 <0.003 
2,3,3',4,4',5,5',6-OctaBDE (#205) <0.01 <0.01 <0.004 <0.004 <0.01 <0.01 <0.01 <0.001 <0.001 <0.004 
2,2',3,3',4,4',5,5',6-NonaBDE (#206) <0.002 <0.002 <0.001 0.0002 <0.002 <0.0002 <0.0002 <0.0002 <0.0002 <0.001 
2,2',3,3',4,4',5,6,6'-NonaBDE (#207) 0.01 0.01 0.004 0.01 0.01 0.001 0.001 0.001 0.001 0.0003 
2,2',3,3',4,4',5,5',6,6'-DecaBDE (#209) 0.11 0.11 0.07 0.08 0.09 0.01 0.01 0.01 0.01 0.01 
∑PBDE (UB) 5.91 3.51 16.6 4.58 7.99 0.86 1.07 1.10 0.78 1.36 
∑PBDE (LB) 5.86 3.43 16.5 4.55 7.95 0.85 1.06 1.10 0.77 1.35 
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